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AD8TRACT
Experimental autoimmune thyroiditis (EAT) induced in mice
rats with thyroglobulin (Tg) emulsified in complete
Freund's adjuvant (eFA) has been a model system to understand
the Immunopathogcncsis of Hashimoto's thyroiditis (RT).
I have demonstrated, by the immunotargeting approach, that
adjuvant-free challenge of mice with small doses of mTg
conjugated to monoclonal antibodies (HAbs) specific for class
II Mile (I-Akl expressed on APe, induces an mTg-spocific IgG
rCfJponse in eBA (H_2 k) but not in 96 (H-2b) mice. Priming of
CBA mice with mTg conjugated to an irrelevant MAb (control)
did not elicit an autoimmune response. Despite the induction
of an m'fg-apecif!c IgG rcoponoo, mononuclear colI infiltration
of the thyroid was not detected in CBA mice thus indicating a
clear divergence in the requirements Cor autoantibody (AAb)
production and the requirements for disease. These findings
may help elucidate the role of various APC subsets in
autoimmunity and facilitate stUdy of the initial events that
trigger autoreactivit:y outside a crA-induced granuloma &ite.
Investigation in rats of the immunopathogenicity of a
17mer homologous (rat) Tg peptide, rTgPl (2495-2511), revealed
that TgPl-primlng at FJJ4, WKY and WF rats elicits lymph node
cell (LNC) proliferative responses to the peptide~
without concomitant specific primary IgG responses. we
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proliferative assays demonstrated that specific CD.· T cells
recognizo TgPl in the context of class II Mile and that TCjPl
contains cryptic T cell epitope(s). strong Tgpl-speciflc IgG
responses were not observed despite the presenc20 of EAT in
rats. These results provide the first evidence that a self-Tg
peptide, TgPl, is immunopathogenic 1n rats. In contrast to
17rner TgPl, examination in rats of the 1111lllunopathogenlcity of
an IBmElt" rTg poptide, rTgP2 (2695-2713) revealed that T9P2~
priming of rats induced specific LNC proliferative responncs
in 1"344, WRY but not in WF rats, although concomitant specific
IgG responses were elicited in all three rat strains.
Thyroiditis was readily induced in F344 rats both by direct
ch"allenge with TgP2 and by adoptive transfer with TgP2-
specific T cells (CD4·, CDS·, TCR a/S') indicating that
peptide-induced rat EAT is a CD4· T colI-mediated disease.
Specific T cells recognize TgP2 in tho context of class II
molecules in an MHC-unrestricted fashion and TgP2 contains
non-dominant T cell dctenainants. The TqP2-specific IqG (day
2S) readily binds intact rTg and such binding could be
abrogated by free peptide indicatinq the absence ot
11determinant spreading". These results indicate that TgP2 is
pathogenic in rats but differs in its immunogenicity from that
of TgPl.
Class II· rat thyrocytes (IFN-y treated), to address
their putative APC function in TgP2-l'ledlated EAT, were
axa:ainad by testing their ability to present endogenous Tg
epitopc to the TgP2-specific cloned T cells. Both unpulsed
or peptide pUlsed class II· thyrocytes failed to activate the
hybridoma (assessed by IL-2 release) suggesting that
thyrocytes by themselves do not function as APC.1n....Yi..t.r2. The
findings that both qlutaraldehyde fixation and irradiation of
spleenocytcs abolished their capacity to present TgP2 leading
to activation of tho 8F7-5 hybrldoma raiscd tho possibility
that thyrocytes may be deficient in the. expression of certain
costimulatory molecules. These findings have implications for
understanding Ag-presentatlon in thyroid autoimmunity.
Examination of the relative serological Immunodominance
of the pathogenic TqPl and TqP2 peptides revealed contrasting
findings. priming of F344 rats either with homologous or
heterologous Tg5 did not elicit TgPl~spec1fic IgG responses
indicating the non-dollinance of TgPl. In contrast, homologous
Tg-priming elicited TgP2-specific IgG response. The
immunogenicity of the TgP2 Clpitope(8) on heterologous Tgs
varied dramatically, being highest on bovine Tg, intenediate
on mouse Tg and undetectable on human and porcine Tgs although
peptido-specific IgG readily cross-reacted with Tgs of various
species. Epitope analysis of heterologous Tq-primed sera
l:eve.aled that TgP2-reactivity is directed to distinct B
cpitopes within TgP2. These data provide the first evidence
in EAT that variable irlUllunodorainance may partially explain why
vi
distinct Tg epltopes are recognized by HAbs in various
speclcs/Tg combinations and may have implications 1n
serol~gical screening of pathogenic Tg epltopes.
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Introduction
Recently, Rose and Bona (1993) put forvard the following
criteria to establish whether a disease is actually autoimillune
in origin: (1) induction or T cell and antibody (Ab) responses
to the self-antigen(s), (2) identification of Abs and T cells
within the lesions of the target organ, (J) transfer of
disease to syngeneic animals by either lymphocytes or Abs, (01)
reproduction of silllilar autoimmune disease in experimental
animals by immunization with autoantigen(s) or its synthutic
peptides, and (5) transfer of disease by lymphocyt.... s
(collected rrom patients affected with autoiuune disease) to
severe combined iuunodeficient (SeID) mice. Autolliliune
thyroid disease (AlTO) in humans fulfils lIany of the above
criteria.
AITO is an o1'9an-specific autoillmune disorder which
affects llpproxlllately 5' of the huaan population (We:etll'3,n and
McGregor, 1984a). The thyroid gland is the target organ that
is affected in AlTO. Based on the spectrum of clinical
manifestations, AlTO is classified into Hashimoto's
thyroiditis (HT) or Graves' disease (GO). HT is a chronic form
of autoim1llune thyroiditis characterized by hypothyroidism,
Ilutoantibodies (AAba) to thyroqlobul1n (Tg) and thyroid
peroxidase (TPO) , infiltration of thyroid with lymphocytes,
monocytes, and plasma cells and the fOl"1llation ot genlinal
centre.s leading to destruction of thyroid follicles (Weetman
and McGreqor, 1994). On the other hand, GO is characterized
by chronic and excessivE! sti.-ulation ct thyroid gland by
"tilyroid stillulating antibodies" (TSAb) to thyroid stimulating
hormone receptor (TSKR) si.ulating the effacts of thyroid
stillulating hornone ITSH) leading to hyperthyroidislI (Zakarija
et aI, 1980; WeetClan and McGregor, 1994). Frequently, high
titers of AAbs to T9 and TPO are also detected (Mullins et 811,
1995). Histological exuination of GO thyroids ro:vealed that
thyroid follicles are small and are lined by both
hypertrophied and hyperplllstic columnar epitheliUJll. In
addition, a marked loss of colloid with neo-follicle formation
and infiltration with lym.phocytes and piaslia cells which form
aggregates or follicles have also been observed.
The initial triggering events and subsequent
hmunopathogenic mechanisas leading to AlTO in huans are not
yet fully understood. This is partly because the Ilechanisms
of abroqation of natural tolerance to self-antIgen{s) are not
well understood. Understanding of the immunopathogenesis of
AlTO was further complicated because the analysis ot Ilolecular
structure of thyroid antigens (Tg, TPO and TSHr.') was slow. In
addition, this was technically difficult because most of the
autoantigens (TPO and TSHR except Tg) occur at very loW"
concentrations and their purification is extremely laborious.
To study the immunopathogenic mechanisms at HT, various animal
models have been developed (Sactioll 1.2.1). On th.e other hand,
to study the inununopathogenic mechanisms of GO. good anilllal
models have not yet been establish.ed. Howover, recent efforts
focused in that direction have shown promising resUlts
(Costagliola et al, 1994l Hidaka at aI, 1995).
1.1 Thyroid gland and thyroid antigen_
Our understanding of the immunopathogenesis of human
thYroid disease has been dramatically iDproved in the last few
years due to major developments in recombinant DNA and T cell
cloning tech.noloqy. A few of th.e autoantigens that are
thought to be responsible for AlTO have now been
characterized. The autoimmune respcnse has been shown to be
directed against three distinct thyroid Ag5: Tg, TPO, and
TSHR. Rr.cently, Two thyroid Ags, a 70 kDa (Chan et aI, 1989)
and a 64 kDa (Dong et aI, 1991) molecules, have been shown to
be the additional target Ag5 in GO. More recently, Na·;r
cotransporter has been identified as a potential autoantigen
in HT (Raspe et aI, 1995). It has been well established that
Tg and TPO are recognized by autoreactive T- and B-cells in HT
patients, whereas TSHR is recognized by autoreactive T- and B-
cells in GO patients (Weetman and McGregor, 1994). The
presence of AAbs to Tg and TPO has also been described in lIany
GD patients (Mullins et aI, 1995). At present, whether or not
the expression of heat shock proteins (HSP) in the thyroid
(Heufelder et aI, 19921 will serve as additional tarqets
rerna ins conj ectural. Before describing the molecular
structure or thyroid antigens: Tg, TPO and TSHR, I will
discuss the salient features of the thyroid gland.
1.1.1 Normal Tbyroi4 glan4
The thyroid gland (the term thyroid comes from Greek
meaning oblong shield) consists of two lobes connected by an
isthmus wrapped around the trachea in the anterior compartment
of the neck. It is the largest of all the endocrine glands.
The thyroid is composed of innumerable discrete follicles
clustered together. The cells lining the follicles produce
thyroid hormones, triiodothyronine (T3) and thyroxine (T4).
These hormones are stored in the lumen of the follicles for
subsequent controlled release. In humans, the gland begins to
sy thesize thyroxine from about the third month of fetal life.
The follicles are filled by a structureless semifluid protein,
the colloid, which contains 1'9. The gland is highly vascular
and is essential for growth of the body and physical and
mental well-belng.
1.1.2 Thyroqlobulln (Tql
Tg is a hOllodimeric 660-kDa glycoprotein and serves as a
prohormone for the blo.oynthesls of thyroid hormones. Tq is
available in large quantities. It is synthesized by thyroid
epithelial cells (TEe) or thyrocytes. Tg is iodinated (O.J-
0.5\ of the lIOlecule) and phosphorylated (10-12 phosphate
groups/aolecule) (reviewed in Charreire, 1989). Tq is stored
as colloid in the lUIl.n of thyroid follicl~s and is an
extracellular glycoprotein (Vassart et ai, 1975). '!'l;I reenters
TEC in the form of colloid droplets.
Tg that reenters TEC has been shown to undergo
proteolysis under the influence of lyslJsomal enzymes
(Cathepsins a, 0, and L) reSUlting in the generation of Tg
peptidos (Dunn et ai, 1991). In that stUdy, the authors
identified three cleavage sites for the enzymes Cathepsin B,
D, and L. The Tg peptide frllqJIents thus generated have been
shown to contain three of the four major hontOnogenic sites.
The authors sU9qested that generation of these nailer Tq
peptides is one of the steps in the biosynthesis of thyroid
hornones. Thyroid honones fOnl at discrete sites within the
Tg. Four horaonogenic sites in Tg have been identified
(Fassler et al, 19881. Two of these sites occupy terminal
location in the polypeptide chain: site A, the .ajor T4-
forninq site, near the HH2-tendnus corresponding to human
residue 5, and site C, the JIlajor T3-fondng site,
corresponding to hUllan residue 2746 near the COOH-tenninus.
Sitss Band Dare .ore internaL These two sites correspond
to hullan residues 2553 and 1290.
Production of thyroid hO[1llones involves the iodination of
tyrosine (Tyr) residues within the Tg molecule by TPO.
Enzymatic iodination of Tg has revealed that both initi~.l
iodine concentration and native structure of Tg influence the
hydrolysis of Tg (Lamas et aI, 1986). It has been shown that
when Tg is highly iodinated, three out of four hornonogenic
sites localized at the COOH·end of the molecule, are most
susceptible to proteolysis (Mll.rriq et aI, 1982; Dunn et aI,
1983; Lejeune et aI, 1983). In contrast, excessive iodination
of Tg has been shown to inhibit the hydrolysis of T9 and
subsequent thyroid hormone secretion (Bagchi et aI, 19Mb;
~cks et aI, 1987).
The follicular activity and T9 production are under the
physiological control of T5H. T5H is released frol'll pituitary
gland in a typical "feedback" manner when the serum levels of
T3 "nd T4 are decreased. Transcription of Tg is under the
positive control of T5H Which is probably mediated by cyclic
AMP (cAMP) following T5H binding to T5HR (Van Heuverswyn et
aI, 1985). It has been suggested that TSH and its cAMP signal
are not the prilllary policemen directing the T9 synthesis, but
rather that this is controlled by insulin-like growth factor-l
(IGF-l) Le., TSH/cAMP may amplify and regUlate more than
they initiate the 19 synthesis (Santisteban et aI, 1987). It
has been shown that Tg contains approlClmately 120 Tyr
residues. Only 25-30 of these Tyr residues are available for
iodination and only 8 residues can couple to synthesize
hormone.
The primary structure of bovine Tg (bTg) (Mercken et al,
1985a), of human Tg (hTqj (Malthiery and I.issitzky, 1987) and
of a part of rat Tq (rTg) (Musti et al, 1986) derived from the
sequence of their complementary DNA (cONI.) have been reported.
COlllparison of their primary a.a. sequences indicated that 1'gs
of various species are highly conserved. The presence of
structural differences near the thyroxine-forming sites has
been demonstrated using MAbs to Tgs (Chan et aI, 1986).
Availability of Tg in large quantities has made easier to
establish animal I:lcdels for studying the immunopathogenesis of
HT. It should be mentioned here that although the molecular
structure of Tg molecule has been knOWn for a while, the
putative Butoantigenic T~ and a-cell epitopes largely remain
undefined. This was mllinly because of its large size.
1.1.3 'rhyroi4 peroxidase (TPO) or Microsolllal ..DUgen (Mie Agi
Since the first description of a "thyroid microsomal
antigen" (Mic 1I.g) by il\Jllunofluorescent studies using sera from
patients with AlTO (Trotter et aI, 1957), the precise
molecular nature of th:.s autoantigen remained elusive for
decades. folic Ag is expressed at low levels in the thyroid.
It has now been shOWn by illmlunochemical and biochemical
studies that Hic Ag is identical to TPO in that the reactivity
of TPO was immunoprecipitated by sera containing anti-
microsomal Aba (anti-Hie Abs) and, conversely, TPO was able to
absorb Ilnti-Hie Abs (CzarnocJea et Ill, 19851 portmann et aI,
1985). The idontity between TPO and Mic Ag was once aqain
confirmed usinq HAb specific for Hie Ag (Portmann et aI,
1988). It is well docunented that purified TPO protein is
visualized on qel electrophoresis as a doublet of
approximately 107 JeD and 100kD (Czarnocka et aI, 1985: Kajita
et aI, 1985). The TPO is involved in two important steps in
the biosynthesis of the thyroid hormone: Iodination of Tyr
residues on Tg-, and intramolecular coupling of iodotyroaines,
leading- to the formation of TJ and T4 (DeGroot and
Niepomniszcze, 1977).
The TPO enzyme has been shown to be expressed on the cell
surface (apical membrane) of the TEC (Khoury et aI, 1981:
Chiovato et aI, 1985). On the other hand, the possible
expression of the TPO on the basal lIlembrane of the TEC
(Hanafusa et aI, 1984), a region normally exposed to the
effectors of the illll'llune system, has been a matter of
considerable debate (Khoury et al, 1984). TPO is II
trans.embrane glycoprotein and contains 5 potential
qlycosylation sites (for a review, see Banga et aI, 1991).
The complete nucleotide sequence of pig- TPO (pTPO) eDNA that
codes for a 926 a.a. protein has been reported (Magnusson et
ai, 1987). Three different qroups independently reported the
nucleotide sequence of hUMn TPO (hTPO) eDNA, which codes for
a 933 a.a. protein (Kiaura et aI, 1987: Magnusson at aI, 1987;
Libert et aI, 19871. The nucleotide sequence of eDNA for rat
TOO (rTPO) vas also reported (Dervahl, 1989). The analysis of
1II.olecular structure of 'fPO and its availability in recollbinant
forms hastened the proqresc in understanding the
immunopathogenesis of autoimmune thyroid disease and ."ill be
discussed later.
1.1. ( Thyroid Itbulat!ng hormone (T8B) receptor (T8RR)
TSHR is expressed in very low abundance on TEC (101-10'
receptors/cell) (Rees SlIith et aI, 1988). ltnow1edge ot TSHR
at the aolecular level began when Paraentier et al (1989)
isolated a dog TSHR eDNA (eDNA) from a thyroid eDNA library.
Simultaneously, eDNA clones tor a human (tfagayalla et aI,
1989; Libert et aI, 1989: Hisrahi et al, 1989) and for a rat
(Akamizu et aI, 1990) TSHRs were reported.
The TSHR is a 120 kDa glycoprotein consisting of 164
a.ino acids including a 20mer signal peptide. The molecular
veight of the N-teminal TSHR is approxblahly 84.5 kDa
(NagaYllma and Rapoport, 1992). The extracellular region (398
amino acids) of TSHR of human, dog, and rat bears 8S-90\: a.a
sequence homology. The translII.embrane/intracellular C-terminal
hal! of the TSHR consits of 346 amino acids with 7 hydrophobic
transmembrane segments. It has been shown that TSH does not
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bind chinese hamster ovary (CHO) cells transfected with a TSHR
eDNA in which the N-terminal a.a. 38-45 sequence is deleted or
substituted suggesting that a.a. 36-45 sequence is important
in TSH binding (Wadsworth et aI, 1990). Recently, using
mammalian cells transfected with deletion mutants of TSHR
eDNA, it has been shown that amino acids at positions 390,
385, 301 of the N-terminal (extracellular) TSHR are involved
in TSH binding (Kosugi et aI, 1991). It has also been shown
that TSH interacts with mUltiple discrete regions of TSAR
since anti-peptide Aba of distinct specificities inhibit the
binding of TSH to its receptor (Dallas et aI, 1994). The
extracellular region of TSHR has also been shown to be
important in signal transduction (Nagayama et ai, 1991). By
si te-directed mutagenesis of the TSHR cytoplasmic regions, a
10mer (441-450) sequence of the cytoplasmic loop of c-terminal
TSHR has been shown to be important in cAMP generation
(Chazenbalk at ai, 1990).
1.2 Experi.ental autoimmune thyroiditis (EAT)
EAT is an animal model for HT and has been widely used
for decades to elucidate the mechanisms of self-tol'<lrance and
of immunopathogenesis in h1~~an thyroid disease. EAT is
characterized by autoreactive T- and B- cell responses, a
marked mononuclear cell infiltration of the thyroid gland, and
the occurrence of circulating Abs to thyroid Ags (Rose at ai,
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1971) •
There are four main EAT models. The first model deponds
on immunization with thyroid antigens (Ags) in the presence or
absence of adjuvants, whereas the second model depends on the
manipulation of the T cell population either by thymectomy and
irradiation (Tx-X) or by treatment with Aba to T cells. In
the third model, the disease spontaneously develops in
experimental animals and the fourth model lnva} ves
xenografting ot thyroid tissue from HT patients into SC!D
mice.
1.2.1 EA'l' induotion in various species
EAT has been induced in various animal species by
immunization with crude thyroid extract or Tg emulsified in
complete Freund's adjuvant (CFA). Initially, it was not
possible to decide whether establishment of autoimmune
response to thyroid Ags is responsible for the development of
thyroid lesions or is merely ill non-pathogenic consequence of
tissue destruction. This ambiguity in thyroid autoimmunity
was resolved when EAT was induced for the first time in
rabbits by subcutaneous (s.c.) immunization into four footpads
with CFA emulsion containing syngeneic thyroid gland
homogenate (Witebsky and Rose, 1956; Rose and Witebsky, 1956).
On the other hand, challenge of rabbits with CFA emulsion only
did not result in the development of an immune response to
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thyroid Ags. The authors demonstrated the f./resence of Mbs to
thyroid Age by complement fixation, precipitation, and
hemagglutination (HAl tests. These pioneering studies have
provided the first evidence that thyroid Ag(s) is the target
Ag in thyroid autoimmunity.
Later, EAT was induced in various species: rats (Jones
and Raitt, 1961), guinea pigs (Me Haster et aI, 1961), dogs
(Terplan et aI, 1960), and mice (Rose et aI, 1971). The
thyroid disease induced in these various species closely
resemble:> the characteristic features of HT in humans in terms
of lesions generated, T-cell and Ab responses and genetic
makeup. However, the pathological changes induced by active
immunization with crude thyroid extract in CFA differ in
cert03in respects from that of HT. In EAT, assessment of
hypothyroidism by thyroid hormone production has rarely been
done. These animals often develop severe mononuclear cell
infiltration of the thyroid and SUbsequent hypothyroidism due
to their thyroid gland destruction, but do not contain the
germinal centres in the thyroid that is a hallmaI.k of human
HT.
One may wonder why induced EAT has been widely used to
stUdy the immunopathogenesis of HT when the latter disease
develops spontaneously in humans. The answer to this question
is multifaceted. EAT induced with thyroid Ags will allow the
researche"cs to stUdy the regUlation of the immune response at
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the levels of both the central lymphoid and target organs, the
kinetics of the disease development, T- and B-cell responses,
analysis of the respective specificities and functions of
lymphocyte subsets found during thyroiditis, and the site of
initial prill.ing and the inductive signals required to induce
thyroiditis. However, it should be noted that EAT induced
under controlled experimental concHtlons is quite different
from that found in spontaneous thyroid disease in humans
because in the latter the triggering events in terms of the
immunogen, the site of initial-priming and the site of chronic
i1lUllunization remain a black-box. Nevertholess, EAT studios
have provided valuable information concerning the nature ot
autoantigens, initiation, progression, and immuno-pathogenesis
of autoimmune thyroiditis (Charreire, 1989).
1.2.1.1 BAT induction with thyroid Aq_ udnq adjuvant_
In contrast to a spontaneous autollDl'll.une disease,
induction of EAT with thyroid Ags in susceptible strains of
mice and rats often requires the use of a potent adjuvant. 1 t
is assumed that inflammatory responses induced by the complete
Freund's adjuvant (CFA) emulsion may have an influence on the
pathological manifestations of the disease. Even then, CPA
has been the adjuvant of choice to induce EAT in various
species. However, CPA has been shown to induce undesirable
effects such as a chronic inflammatory response at the site of
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injection (WiedMe.nn et aI, 19911 Yamanaka et aI, 1992).
EAT was induced in lIIice for the first tillle with Tg + erA,
employing inbred 1II1c8 of various strains (Vllidutiu and Rose,
1911a). These authors de.onstrated variations in the onset ot
Ab production: the strains that had delayed onset of AD
response showed little or no mononuclear cell infilt.:ation of
the thyroid, whereas the mouse strains that had rapid onset ot
Ab production showed exten~ive mononuclear infiltration ot the
thyroid.
In additlon to crA, various other adjuvants have also
been used to enhance the immunogenicity of Tq and to induco
EAT. These adjuvants include incomplete Freund's adjuvant
(IFA) (Esquivel at aI, 1977; Vladutiu and Rose, 1972). silica
(Rose et aI, 1965), alhydrogel (Twarog et aI, 1970), latex
particles (Esquivel et aI, 1977), lipopolysaccharide (Esquivel
et aI, 1977), polyadenylic-polyuridylic acid complex (Poly
1I.:poly U) (Esquivel et aI, 1978). Horeover, adjuvants such as
Bordetella pertyssis (Twarog and Rose, 1969), l&9.i2DillA
pncufIlophilia (McMaster et aI, 1986) and lIluramyl dipeptide
(MOP) (Kong et aI, 1985) have also been used either to enhance
the immunogenicity of Tg or to accelerate the onset of
autoimmune thyroiditis. It should be noted that the response
of a given mouse strain to mTg varies depending upon the type
of adjuvant used. For example, the use of LPS, a weak
adjuvant, for EAT studies has demonstrated a distinction
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between inbred lIouse strains in te~& of both Ab titor and
thyroid pathology (Esquivel et aI, 1971). More interestingly,
Tq-induced EAT persists transientlY in lIice (Braley-Mullen et
ai, 1994a) possibly due to induction ot requlator cells (CDS'
T cells). In that study, it has been shown that depletion of
CDS' T cells in the recipient mice exacerbated severity oC
thyroid lesions Whereas their presence resulted in the
resolution of thyroid lesions.
EAT was InducE:d for the fb:st time in Lewis rats by
injecting intradermally at the base of the tall \>lith CFA
emulsion containing either Tg or thyroid extract (Jones and
Raitt, 19611. In that stUdy. the antigenic challenge of rats
was done on day 0 and 21. The rats were examined for EAT
characteristics on various ti_e points after the first.
injection itself. It was found that injection of rats with
two doses of Tg (on days 0 and 21) increases the severity of
the thyroiditis compared with a single injection of Tq on day
O. Subsequently, Twaroq and Rose (1969) dellonstrated that
injection of Lewis rats with erA emulsion containing
homologous thyroid extract followed by concoMitant injection
of Bordetella pertussis organisms (pertussis voccine) induceD
marked thyroiditis. In contrast, thyroids collected from rats
that received eFA emulsion containing rat thyroid extract only
showed minor thyroid lesions. In that study, the importance
of erA was also highlighted in its ability at enhancing the
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immunogenicity of Tq because the use of other adjuvants such
as alhydrogel, IFA, or pertussis vaccine in the pl~ce of CFA
did not result in the production of either thyroid lesions or
Abs to thyroid Ags. In another study, it has been shown that
the need for a booster Tg inj ection to induce thyroiditis was
circumvented if rats were given Bordetella pertussis organisms
on the day of first injection of Tg (Paterson and Drobish,
1968). This accelerated form of EAT might be attributed to
the histamine sensitization factor "pertussigen", the active
ing~edient of Bordete!la pertussis, that increases vascular
permeability (Bergman et aI, 197B). Finally, the putative
pathogenic self-Tg epitopes that cause EAT in rats have not
yet been demonstrated.
1.2.1.2 :Induction of EAT witb thyroid Ags in the absenca of
adjuvants
Though CFA has been known at enhancing the immunogenicity
of Tg, it has also been shown to induce inflammation at the
site of priming. To avoid this influence on Tg-induced EAT
and to understand how the tolerance to autoantigena is
abrogated, EAT studies have been carried out with Tg in
saline. In that direction, Weigle, (1965) has demonstrated
that chemical modification of Tg enhances its itTUllunogenicity.
In that study, the author modified the homologous Tg by
coupling to chemically defined haptens. Injection of rabbits
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with chemically modified soluble ho.ologous Tg «Tq is coupled
to diazonium derivatives of arsanillc acid and sulfanilic acid
(arG:anil-supfanil Tq» but not unaltered homologous Tq in the
abs€:nce of adjuvants, readily circumvented the natural
tolerance to TcJ and resulted in the induction of thyroid
lesions and Aba to thyroid Ags. In contrast, injection of
native heterologouB Tg (unaltered Tg) in soluble form resul ted
in the induction of Ab response to hOfl,ologous and heterologous
Tgs. No thyroid lesions were i'lduced. These findings
suggested that pathogenic autoimmunity can be triggered
through modification of autoantigens. Similar results ,",ere
obtained in rabbits vith altered heterologous (bovine and
human) Tgs. subsequently, it was shown that this imllunization
regimen induces in rabbits not only thyroid lesions but also
chronic glomerulonephritis (weigle and Nakamura, 1969).
Moreover, priming at rabbits ....ith fragments of Tg in saline
(the Tg fraggenta were obtained either .... ith proteolytic
digestion of 1'9 with papain or with pepsir.~ (Anderson and
Rose, 1971; Stylos and Rose, 19681 Weigle et aI, 1969)
elicited anti-Tg Abs.
It has also been shown that in some highly susceptible
strains of mice, repeated injection of unaltered homologous Tg
in larger doses in the absence of adjuvants, induced both
thyroid lesions and Ahs to Tg in good responder (CBA) mica
(EIRehewy et aI, 1981). In that study, it was shown that 57\
,.
of the CBA mice had thyroid lesions. In contrast, no thyroid
lesions were observed in poor responder BALB/c mice. 'I'hese
authors suggested that pathoqenic 8utoreactive lymphocytes
normally exist in the body. A marked shift in circulating Tg
levels temporarily perturbs normal homeostatic controls and
activates the self-Tg reactive lymphocytes leading to the
initiation of an autol1l1I1'1une response. Although Tg-specific
At.3 can be elicited in animals by repeated immunization with
homologous or heterologous Tg(s) without adjuvants (EIRehewy
at aI, 1981), the use of adjuvants dramatically increased the
vigour of Ab responses.
1.2.2 EAT induotion using '1' cell depletion
EAT can also be induced in mice or rats by~
manipulation of the T cell population. The first set of
experiments performed by Penhale et al (1973) delY'onstrated
that depletion of T lymphocytes in rats by thymectomy and
irradiation (Tx-X) [thymectomy was done at 5 weeks of age and
was followed by four doses of sublethal whole body irradiation
(200 rad each at 2 weeks intervals) J induces typical EAT in
Wistar (RT1U ) strain of rats. These findings indicated that
self-reactive T cells with the capacity to elicit autoimmune
thyroiditis are neither deleted nor rendered anergic in these
animals. Thymectomy combined with a series of sublethal
irradiations has been suggested to cause a selectivt=. depletion
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of requlatory T cells involved in the suppression of
pathogenic thyroid autoimmunity. It has been directly
dellonstrated that (Tx-X) -induced EAT can be prevented by
reconstitution of Tx-X rats with lymphocytes fro. healthy.
syngeneic rats (Penhale et aI, 1976). These data further
supported that a role for a subset of T cells in tho
suppression ot pathogenic autoi1llllunlty. Later it was
demonstrated that irradiation ~ and irradiation
sensitivity of the thyroid are not responsible for the thyroid
lesions in this animal model (Ahmed and Penhale, 1981). Theso
conclusions stem from the experimental datil in Which post-
irradiation transplantation of syngeneic thyroids under the
renal capsule of Tx-X rats led to the development of
thyroiditis in the grafted thyroids. This was further
supported by recent data showing that high dose irradiation of
the thyroid alone does not lead to lIIononuclear cell
infiltration whereas, whole body irradiation, except for
thyroid, resulted In thyroid lesions (Sakaguchi et aI, 1994).
It should be noted that EAT induced In rats by TX-X
resembles HT in several important respects. The disease is of
a chronic nature and persists for at least 18 months. The
lesion develops spontaneously without necessity for
immunization with autoantigens in eFA. However, germinal
centres have not been observed in the thyroids of TX-X rats.
The mechanisms of illll1lunorequlation in the (TX-X) -induced rat
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EAT model were not investigated. 'fhe immune regulatory
mechanisms in this EAT model can be investigated by performing
experimonts similar to those that were demonstrated in PVG/c
rats that develop diabetes following Tx-X. Injection of CD4+
CD45RcI.... T cells that secrete IL-2. IL-4 and IL-IO, but not
IFN-y prevented the development of diabetes in these animals
(Fowell and Mason. 1993). Thus, the delicate balance between
pathogenic and regUlatory T cells appears to determine the
tolerance status of host to self-antigens responsible for
these autoimmune dlseases.
By adopting a different experimental approach, Sugihara
at al (1988) have induced EAT in T-cell-depleted B-cell-
present mice (referred to as B mice). In this study, the
authors have demonstrated that adoptive transfer of normal
syngeneic CDSOJll CD4" T cells, obtained by pretreatment of
lymphoid cells with anti-CDS MAb plus complement, into
syngeneic "8 mice" readily induced EAT. These results
indicate that thyroiditis-inducing T cells are present in the
peripheral lymphoid tissues of normal healthy mice. By
immunohistochemical studies, it has been shown that the
thyroid lesions contain both CD4· and CDS" T cells. These
results raise the possibility that both of these T cell
popUlations may act as effector cells in mediating thyroid
damage (Sugihara et aI, 1989). Interestingly, both CD4" and
CDS" (CTL) T cell clones, that recognize Tg and some other
21
unknown 'thyroid antigen, have been isolated from thyroid
lesions of these mice. Moreover, fractionated CDSbrlOIlt CD4' T
cells but not unfractionated T cells prevented the induction
of EAT (sugihara et aI, 1990), showing the coexistence of both
regulatory and disease causing T lymphocytes in the normal
peripheral lymphoid cell population. EAT induction by
depletion of regulatory T cell subsets has furthered
understanding of the illlmunoregulation in AlTO.
1.2. J spontaneous Autoillllllune Thyroid! till (SAT)
SAT has been reported in Non-Obese diabetic (NOD) mice,
Bio-Breeding (B8) and Buffalo (8UF) rats and Obese strain (OS)
chicken. A few of the studies performed on such spontaneous
thyroiditis models are described belo.....
1.2.3.1 'J.'hll NOD lIIice
As cited in the literature. NOD mice have been sho....n to
develop SAT, but ....ith some variability in percentage of
incidence with age of the animals. However, the severity of
thyroiditis did not vary with the age of the animals (Bernard
et al, 1992). Thyroiditis and Abs to TPO have been
demonstrated in these NOD mice at 1 month of age.
1.2.3.2 'l'he DB lind Bcr rata
silverman and Rose (1971) reported a low incidence of
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spontaneous thyroiditis in 9-12 week old female BUffalo (BUP)
rats and the incidence rose to 4U in eX-breeders. Disease
prevalence was shown to be increased in both males and females
by neonatal thyaoctolllY (NTx) (Silverman and Rose, 1974a), by
imllunization with Tg In various adjuvants (silverman and Rose,
1975b). and by sUbcarcinogenic doses of 3-1llethylcholanthrene
(Silverman and Rose, 19758). In these animals, an important
MHC influence on susceptibility to thyroiditis
demonstrated. Animals with the RTlblb genotype had the highest
risk of developing thyroiditis and those with tt'.e RTlII/u
genotype had the lowest risk (Colle et aI, 1985). In contrast
to the report of Silverman and Rose (1911), Cohen and Weetllan
(1987) did not observe SAT in their colony of SUF rats. but
they were able to induce EAT following NTx. The inability to
develop SAT was attributed to environmental influence on the
immune system.
1.2.3.3 The 08 chickon
OS chicken, among which over 95' develop SAT, were
selected from Cornell strain chickens on the basis of
phenotypic symptoms of hypothyroidism. SAT in os chickens
occurs during the first 3 ....eeks after hatching and is
characterized by massive lYldPhoid cell infiltration of the
thyroid gland with hypothyroidism and cirCUlating AAba to Tq
after 4 'oleeks of age. The SAT in os chicken has been a
2J
particularly useful animal -.odel to study the b,.uno-
pathoqenesis of liT for two reasons (Wick et aI, 1982) _ First,
gertllinal centres rep~ace the functional thyroid tissue and
result in fibrosis of the thyroid glands. Second, autologous
C3 and IgG deposita foraing illlMune coaplexes consisting of 'I'q
and anti-T9 Aba are present in the basal lamina of thyroid
glands in newly hatched birds (Katz et aI, 1981). These Abs
have been shown to precipitate the thyroid disease (Katz ct
aI, 1986). Three groups of genes are believed to control
susceptibility of OS chickens to SAT: (1) MHe, (2) an Immuno-
regulatory locus outside the MMe, (J) genes for target organ
abnonality (Wick et al, 1989). These findings suggested thlllt
autoluune thyroid disease is IlIUlt1ractoirial in origin.
1.3 I_unoqenetica or £AT in aice .1Id r.t.
1.3~1 me control of .oua. BAr
classic studies in thyroid ll.utoilUlunity demonstrated that
DOuse susceptibility to Tq-induced EAT was closely l.inked to
the MaC i.e., H-2 complex (Vladutiu and Rose, 1971a). In that
stUdy, the authors used 35 different strains of mice
representing eleven different 11-2 hllplotypes. Dased on the
susceptibility to Tg-induced EAT, mouse strains wcrlJ
classified as good (H-2 I , t, q haplotypes), fairl.y good (II-2 ft )
lind poor (H_2b, d hllplotypes) responders. Using Fl anirnala (H-
21, d) I these authors further dellonstrated that lIouse
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susceptibility to Tg-!nduced EAT was a dominant trait. Using
an 1n...YJ.,t..t:Q proliferative response to mTq and omploying intra-
H-2 recombinant strains of mice, the Tq-rr gene controlling
the susceptibility to EAT vas more precisely mapped to the K
and/or I-f. reqions of the H-2 complex (Tomade et aI, 1974).
using Intra-H2 recombinant mouse strains (derived from
recombination events between the good responder k haplotype
and poor responder b haplotype), in was shown that the I-A
subregion within the H-2 complex controls the susceptibility
of mice to Tq-induced EAT (Beisel at aI, 1982a). The T cell
proliferative response was also shown to be under the control
of genes located within the I-A SUbregion (Salamero and
Charreire, 1983b). TOJll!lzic et a1 (1974) suggested that
besides Ir-Tg gene (I-A) control, the O-end a.lso exerts an
influence on the severity of thyroiditis. Moreover, Kong et
al (1979), using H-2 recombinant mice, demonstrate.d that HHC
class I at the O-end may also influence the incidence and/or
severity of thyroiditis. It was found that animals carrying
Ok have the highest degree of thyroid pathology, while those
bearing Od have markedly reduced infiltrations. It is
apparent from these investigations that the I-A gene products
determine a good or poor response to Tg as such, whereas the
o region gene prOducts modify the soverity of the disGase
possibly through governing the effector mechanisms necessary
for thyroid inflammation. It is possible that these HHC class
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I and cl.ass II alleles frolll low responders may favour the
generation of regulatory cells (Th2 or cos' T cells) similar
to those results that have been shown in myelin basic protein
(MBP) peptide (G3-S81-induced experiJ:lental autoimmune
encephalomyelitis (EAE) in intra-MHC recombinant rat strains
(Mustafa at al; 1994).
Like the D-end, the J(-end has also been shown to
influence the penetrance of the Ir-Tg by modifying the
severity of the disease. Experiments performed using B6 (11-
2b) and B6.C_Hw 2MI demonstrated a higher incidence of
thyroiditis in B6.C_H_2t.t than 86 (H-2bl mice (Maron and
Cohen, 1.979); B6.C-H-2bo1 has a point mutation in tho H-21<
molecule (Brown and Natheson, 1977). A second line of
evi.dence implicating the K-end in regulating the severity of
thyroid lesions comes from the studies of intra-H-2
recombinant mice (Beisel et aI, 1982b). In these studies, it
was shown that the presence of Kk reduces, whereas K'l or Kh
increases the incidence of thyroiditis in mice to mTg but the
mechanisms by which these MHC class I molecules influence the
severity of thyroiditis have not yet been clarified. This
would be possible by performing EAT studies with defined
pathoqenic Tg peptldes in intra-H2 recombinant mice.
The susceptibility of mice to mTg-induced EAT controlled
by HHC also extends to heterologous Tg-induced EAT (Tomazic
and Rose, 1976; Maron at aI, 1983; Simon et aI, 1986; Romball
"
l'Ind weigle, 1984). In contrast to homologous Tg (mTg) , thesa
heterologous Tgs are poor inducers of EAT by active
immunization, although strong Tq-specific Ab titers were
induced (Kong, 1986). In contrast to Tq-induced EAT, Kotan!
et al (1990) deJP.onstrated that for Tro-induced murine EAT, H-
2b ..,1ce are good responders, whereas H_21,d,k,....:I' mice are poor
responders. using congeneic and reCOmbinant !:louse strains,
the authors further demonstrated that the I-A sUbregion had a
weak association with the induction of thyroiditis and at
least one non-H-2~link.,d gene controls the development of
thyroid lesionsl Ab production to TPO did not correlate with
the incidence of thyroiditis in any given strain.
1.3.2 }(HC control ot rat EAT
Genetic control of EAT in rat strains was studied by two
different investiqators (Rose, 19151 Penhale et aI, 1975a).
In these studies, a wide diverqence in response to hOllologous
Tg in different rat strains both in the extent of thyroid
lesions and in the level of Mbs to Tg, was been demonstrated.
These stUdies suqqested a linkage between EAT susceptibility
and the MHC type. However, definitive experimental evidence to
show the role for rat MHC in EAT has not been
demonstrated.
Susceptibility of inbred rat strains to homoloqous Tg-
induced EAT has also been classified into three categories:
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high, inte~ediate, and low (Penhale et aI, 1975b: Rose, 1975;
Lillehoj and Rose, 1982). The classification was done b.1sed
on the strain susceptibility to the induction ot thyroiditis,
AAb and we proliferative responses. The results obtained in
these three studies are pooled and are snovn here. High
responder rat strains include F344 (RTll), AO (RTIWI, WF
(RTl"), AUG (RTIC ) and LH (RTIC). Intermediate re!lponder rat
strains include AS (RTl1l, LEW (RT!I), HL (RTl l ), IlVF (R'\'ll) ,
and WKY (RTlt ). Low responder rat strains include CAM (RTIWj,
61 (RTIn). DA (RTl' ). ACl (RTl'), HO (RTle ), PVG/c (RTl~l, and
SRR (RTII). The studies ot Penhale et al (1915a) sugg~sted
a relationship betlleen the RTl complex (rat MHe cOllplex) and
susceptibility of rats to thyroiditis. These authors observed
that strains with the RTle (,I,q85) haplotype were the I:ost
susceptible. whereu strains with the RTlw (Ag82) haplotype
vere least susceptible. However,:'Io linkage studies were done
to confh"ll\ this relationship between RTl complex and tAT.
Penhale et al (l915b) further demonstrated that, usinq a
thymectollly-induced rat EAT model, rat strains were graded as
high (AUG and PVG/c). intennediate (WAG and LIS), and low
(CAM) responders. The incidence of Mba to Tg correlated
closely with the strain incidence of thyroiditis. Therefore,
the classification of rat strains into high and low responders
depends on the method of EAT induction. Subsequently,
Lillehoj lit al (1981) have investigated whether or not the
2.
genetic factors (HHC) influence the susceptibility of inbred
rat strains to rTg-induced EAT. The authors demonstrated that
ID1n'1une response to rTg is under polyqenic control. The Itain
factor controlling illlllune response to Tq is associated with X-
chromosome. No evidence of linkage between the rat HaC (RTl)
and imr.:une response to Tg was documented. In contrllst to the
findings reported by Lillehoj at al (1981), a subsequent study
strongly implicated a p\ltative role for rat KlIC in Tg-induced
EAT (de Assis-Paiva et aI, 1989). In the latter study, the
authors employed both inbred (AOG and AO) and congenic PVG
(RT-IC , RT-l·, and RT-IU ) rat strains. The results indicated
that animals with RT-lc haplotype being high responders,
....hereas animals of RT-lu and R'l'-l· haplotypes were poor
responders. It should be noted that this study has employed
only few congeneic rat strains and needs a reinvestigation by
employing a larger number ot congeneic rat strains to
definitely demonstrate that HHC influences the susceptibility
of rat strains to hOllologous Tg-induced EAT.
1.3.3 Intrinsic abnormalities ot tb. tbyroitl. gland
Several investigations have been made to address Whether
or not intrinsic abnormalities or sensitivity of the target
orqan contributes to susceptibility of mouse or rat strains to
thyroiditis.
"
The genetic susceptibility of mouse strains to Tg-!nduced
EAT has been shown to depend on both the effective interaction
of the immune system with the thyroid and intrinsic features
(genetic background) of the target tissue (Ben-Nun at al,
1.980; Okayasu and Hatakeyama, 1983). Ben-Nun at at (1980)
examined the susceptibility to Tg-induced EAT of thyroid
tissue from EAT-resistant (H_Zb) and -susceptible (H_Zkj mice
grafted to histocompatible, but EAT-susceptible scmi-
allogeneic (H_Zkb) Fl hybrid mice [(susceptible (H-2"1 )(
resistant (H-2 b) )Fl mice]. These authors found that thyroids
from the donors of the resistant genotype was relatively
resistant, whereas +-.hyroids from susceptible strains were
relatively susceptible to the deVelopment of thyroiditis.
Similar results were reported when LPS + Tg was used to induce
EAT (Okayasu an,J Hatakeyama, 1983).
The respective contributions of the immune system and the
target organ to EAT development were reexamined in rat EAT by
employing fully allogeneic, but immunologically tolerant rats
(Eisht and McCullagh, 1998a). It was found that thyroid
tissue transplanted from the donors of resistant genotype
(PVG/c rats) to tully allogeneic, tolerant recipients of
susceptible genotype (DA rats) invariably developed
thyroiditis similar in severity to that of the host's thyroid.
These findings indicllte that varilltion in the genetically
determined susceptibility or resistance to EAT is determined
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by the effective interaction of tha immune s:,.-stem with the
target tissue but not by the intrinsic features of the thyroid
gland. The cellular and molecular basis for the observed
results are not understood. However, it is possible that,
following 'l'g-priming, specific CD4+ T cello; elicited in the
allogeneic, tolerant rats might be HHC-dependent but MHC-
unrestricted and these T cells might have destroyed the
transplanted thyroid from genetically EAT-resistant rats.
Evider:r-,,_ for the existence of MHC-unrestricted rat CD4+ T
cells specific for acetylcholine receptor (AChR) has been
documented in rats (Tami et a1, 1987).
~ experiments performed by Lahat at a1 (1989)
demonstrated a strain effect on IFN-y induced class II
C!xpression on thyn:.·:;ytes. In that study it was shown that
IFN-y treatment of thyroid monolayers from aUF (high
responder) but not from F344 (loW respo~,der) rats resulted in
a consistent and a greater degree of class II MHC expression.
These authors failed to give a molecular explanation for the
observed results, but proposed and supported the hypothesis
that end-organ sensitivity to, or abnormality in MHC class II
1\q expression, may be an important contributing factor in the
pathogenesis of AlTO. Previous studies performed in murine
mo"el~ of multiple sclerosis have indicated that inducibility
of MHC class II on astrocytes but not on macrophages from
susceptible and resistant strains of rats or mice differed
II
drastically when cultured in the presence of IFN-y (Massa at
aI, 198','). Hence, strain-specific susceptibility to MBP-
induced EAE has been linked to hyper-inducibility or MHe
class lIon astrocytes.
Kotani at a1 (1981) proposed that radiation sensitivity
of the thyroid gland contributes to the sllscept.ibilH:.y or
various rat strains to (Tx-Xl-induced EAT. These authors
observed a decrease in serum levels of TJ and T4 in
susceptible (X/8F!) but not in resistant (K/AFl) strain of
rats. The thyroid morphology remained normal in both the high
and 10101 responder rat strains. These studies
contradicted recently by sakaguc~i at al (1994) who
demonstrated that high dose (42.5 Gy) fractionated (2.5 Gy 17
times) total IYllphoid irradiation (TLI) caused thyroiditis
including other organ-specific autoimmune diseases in various
mouse strains. They further showed that irradiation of the
target organ alone did not result in thyroiditis development,
whereas irradiation of peripheral lymphoid organs or thymus
induced various aut.oilMlune diseases including thyroiditis.
These results indicate that radiation sensitivity of the
target organ may not determine the murine susceptibility to
thyroiditis.
Sospedra et al (1995) provided a direct evidence that
intrinsic abnormalities of the target organ may influence
sU3ceptibility of individuals to thyroid disease. The authors
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demonstrated that IFN-y hyperinduces HLA. class II expression
on thyrocytes tronl Graves' disease (GO) but not troft
.ultinodular goitre (MNG) patients, These results are
specific to thyrocytes only because they did not observe any
differences in the sensitivity of lIlacrophaqes (from GO and KNG
patients) to IFN-y-induced class II expression. The higher
inducibil i ty was parallel to a faster and stronger induction
of HLA class II mRNA in GD thyrocytes but did not correlate
....ith the levels ot HLA class II or class I originallY
expressed by thyrocytes. These findings indicated that
intrinsic abnormalities in the target organ contributes to the
susceptibility of individuals to human thyroid disease. This
differential class II hyperinducibility seems to be attributed
to allelic polymorphisms in the upper regulatory regions of
HLA class II genes as has been shewn for DQB (Anderson et aI,
1991) and ORB (Louis et aI, 1993) genes. In both of these
studies, the authors suggested such polYJIorphisDl may conter
allelic differences in expression, inducibility, and/or tissue
specificity or class II moleCUles. In conclusion, the
findings reported in animal models and in patients with AlTO
favor the concept that genetic differences between anim8ls or
humans in the expression of MHC at level of the target organ
contribute to susceptibility to AlTO.
))
The importance of genes outside the H-2 region of micc in
responsiveness to Tg. as assessed by Ab titers and thyroid
pathology. has been demonstrated. By examining a large panel
of independent H-2 haplotypes on 810, BALB/c, C3H. and A/J
background for their responsiveness to Tg using LPS as
adjuvant, it was found that non-MHC genes innuencc the Ab
titer and the incidence and severity of thyroiditis in mice
(Beisel, 1982b). Till now, the putative non-MHC genes thilt
influence the induction of EAT have not been characterized.
1.4.1 T cell r ••pons••
1." .1.1 Thyroid Aq-speoific T cell response.
using lymph node cell (~C) proliferative assays, Okayasu
et III (1981) have demonstrated that EAT susceptible (11-2·. -"
but not EAT resistant (H-2b, d) mice can be distinguished by
the capacity ot their T cells to proliferate in response to
IIITg~. The proliferative response to Tg clearly does
not reflect T-helper (Th) function in aiding Ab production
because Tg-priminq elicits Ab responses in both susceptible
and resistant mice. The authors suggested that Tg-spocific
proliferative T cells from EAT susceptible strains of mice
contain both Th and Te (T effector) cells. similar results
were obtained either with homologous (mTg) or with
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heterologous (hTg) -primed LHe in that we from C3A (H-2k) but
not from BALB/c (H-2d) mice prolihrate to respective Tg used
for prbling. The results of Okayasu at al (1981) were
confined later by Rolllball and Weigle (1984) by using bovine
and porcine Tg5 to prime the mice. Tho T cell proliferative
responses of Tq-primed LNC from CBA mice were inhibited by the
addition of I-Ak- but not by I-Ad-specific (control) KAbs
(Beisel at aI, 1982a) indicating that specific T cells
recognize T9 epitopes in the context or I_A" class II MHC.
These results confirmed that that I-A subregion of the H-2
complex controls the Tg-induced EAT in mice.
1 .... 1.2 Shared 'lg .pitope. :!.J..lEI.I. EAT induction
okayasu at al (1981) have shown that lllTg-primed we from
EAT susceptible mice proliferate to hTg and have indicated
that specific T cells recognize shared T cell epitopes C't Tg.
These results were further conflrned by studies frOID various
investigators. Simon et al (1985) demonstrated that the hTg-
pri'llled LNC proliferate in response to hTg as well as to lllTg in
Yi.t.l:Q. Similarly, Romball and weigle (1984) also demonstrated
that bTg-primed LNC proliferate in response to bTg as well as
to mTg. Simlar to mouse EAT, a role for shared Tg epitopes
has been demonstrated in rat EAT (Jones and Raitt, 1961). In
that study, it was shown that challenge of rats either with
homologous (rat) or heterologous (human and sheep) Tg(s)
J5
readily induced thyroid lesions. HO\olever, higher thyroiditis
score was observed in rats that received homologous Tg only.
overall, these data in both mice and rats demonstrated that
Tgs of various species contain shared epitopes recognized by
T cells.
The role of shared Tg determinants in causing EAT was
addressed eithar by direct or adoptive transfer EAT
experiments. It has been shown that the direct transfer of
spleen cells from mTg + LPS primed, EAT susceptible mice does
not induce thyroid lesions in recipient syngeneic mice (Simon
et aI, 1986). Adoptive transfer experiments employing mTg-
primed me that ....ere first boosted in....Y.itr.Q for 3 days either
with mTg (specific) (Simon et aI, 1986) or with Con 1\
(polyclonal activator) readily induced thyroid lesions in
recipient mice (Maron et aI, 1983; okayasu, 1985; Simon et ai,
1986). A role for shared pathogenic Tg T cell epitopes was
demonstrated with mTg-primed (.iILY.iY2) and hTg-boosted (in
~) LNC by adoptive transfer of thyroiditis in mice (Simon
et aI, 1986). Similarly, hTg-primed LNe or sple~,l cells upon
an~ boost with mTg or hTg, readily transferred
autoimmune thyroiditis to recipient mice. These data further
highlighted a pathogenic role for shared Tg T cell epitopes in
EAT. However, the precise location and nature of theGc
putative T cell epitopes remain unknown.
J6
1.4.1.3 Bvidence for {!lovolv_ent of thyroid anti;ens in AI'I'D
In order to address whether thyroid Ags are involved in
AlTD in humans, lymph<)cyte prollfer.,tive assays have been
perfonned to stimulate peripheral blood lymphocytes (PBLs) .in
ili1;:Q by driving them with putative autoantigcns such as Tg,
TPO or TSHR. Although there were occasional reports of a
positive response to Tg (Ehrenfeld et aI, 1971; Delespesse et
aI, 1972), the consensus has been that Tg does not give
proliferative responses in autoimmune thyroiditis (Calder and
Irvine, 1975). subsequent studies have corroborated these
negative findings (Fukuma at aI, 1990). The reasons for
unresponsiveness or weak proliferative responses to Tg arQ not
clear but warrant further investigation.
In ordor to idontify the T cell specificity, computerized
algorithms were used to map T cell epitopes on TPO (Fukuma at
l'l, 1990; Tandon et aI, 1991b). It was found that three TPO
peptides (415-432, 439-457, and 463-481) significantly
stimulated the PBLs from HT patients but not healthy
individuals. However, proliferative responses to some other
TPO epitopes were observed in both HT patients and heal thy
individuals. More interestingly, a heterogenous response to
TPO peptides with PBLs from different HT patients was
observed, Le. different TPO epitopes were recognized by T
cells of diverse HT patients. Thus, it is likely that T cells
from HT patients and healthy individuals recognize distinct
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epitopes (Tandon et aI, 1991b).
The finding that weak T cell proliferative responses to
thyroid Ags was observed in PBIS of both thyroid disease
patients and healthy individuals makes it difficult to
determine whether the T cells identified are ever activated at
the site of disease and involved in its pathogenesis or are
simply a part of the normal precursor pool and activated 1n
Yit.J.:2. Moreover, a recent study indicated a clear reduction
in circulating CDS' T cells in active HT, with a slight
increase in the number of double positive T cells (CD4+, COS')
(Iwatan! et aI, 1992). The infiltrating T cells are mainly
CD4+ and MHe class II' indicating that the cells arc in an
activated state. About 20% of the mononuclear cells
infiltrating the thyroid are monocytes or macrophages; the
rest are roughly equal numbers of T and B cells (Totterman,
1978). In conclusion, the immuno-histochemistry studies have
indicated that thyroid infiltrates of HT patients contain
activated T cells raising the possibility that they may
recognize thyroid 11.1]'5.
Cloning of thyroid Ag-specific T cells from diseased
thyroid tissue and the demonstration of their reactivity to
Tg, TPO and thyroid epithelium have directly demonstrated that
thyroid Ags are involved in the pathogenesis of AlTO (Landei
et aI, 1985; Dayan et aI, 1991). Dayan et al (1991) made use
of an antigen-independent T cell cloning technique to
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establish T cell clones~ from thyroid tissue of a GO
patient and demonstrated in conventional T cell proliferative
assays that these T cell clones recognize Tg, Tro, and TEe.
Recently, Hartin at al (1993) established an~ model
system in which hTPO eDNA transfected EBV-transformed
autologous B lymphoblastoid cell lines (EBVL) were used to
present endogenous Ag and to stimulate PBLs from a GO patient.
By this approach the authors were succp.ssful in isolating
hTPO-specific T cell clones .in.....Y.i.t.I from the thyroid of this
GO patient. These results clearly indicated that thyroid Ag-
specific T cells do exist in the PBLS of GO patients. The
specificity of the clones was not assessed and so no
correlation could be drawn between the T cell clones in the
target organ and in the periphery (Dayan et aI, 1991).
Mullins et al (1994) utilized the above screening protocol to
analyze the specificity of intrathyr."idal T cell clones from
GD patients. The authors established a panel of T cell clones
established 1..!LYit.l:2 from the thyroid gland by an antigen-
independent T cell cloning technique and then tested the
specificity of these T cell clones against either TPO- or
TSHR-transfected EBVL. The TPO- but not the TSHR-transfected
EBVL could stimulate four out of five T cell clones tested
indicate that TPO rather than TSHR is the major autoantigen
recognized by autoreactive T cells in GD. However, followIng
a similar methodology, the same group (MUllins et aI, 1995)
,.
demonstrated that lOt of the CD4+ T cell clones isolated fro.
the thyroid of a different GO patient were TSHR-specUlc and
belonged to either the ThO or the Th2 tlubsets. In conclusion,
these data indicate that thyroid Ags are directly involved in
the activation of illutoreactive T cells in AlTO patients.
1.4.1.4 T cell epitop•••ppil1g: thyroid antig.nCe)
1.4.1.4.1 EAT atu41ea in .ice
It is well established that a T- or e -cell response
usually is limited to a small proportion of the potential
epitopes/determlnants on a protein Ag. T cell determinants
are classified into dOlllinant, subdominlllnt and cryptic epitopes
(See review Sercarz et aI, 1993). By definition, a dominant
determinant induces a strong .in....Y.i.t.I: T cell response with we
obtained from animals iuunized with a native Ag in adjuvant.
The T cell response induced~ by the dominant
determinant can also readily be recalled ..I..n......Y.. with the
native Ag. On the other h.and, a cryptic determinant readily
induces a strong T cell response to itself but not to the
intact Ag: priming with the native A9 in adjuvant does not
elicit T cell responses to the cryptic peptide. The cryptic
deteterminants are further classified into "absolute" and
"facultative" cryptic epitopes. The T cell responses induced
by "absolute" cryptic T epitopes cannot be recalled ..in.~
by its native Ag. On the other hand, T cell responses induced
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by the "facultative" cryptic determinants can be recalled at
hiqh doses of native Ags. T colI responses to "facultative"
cryptic determinants are also induced~ under special
circumstances only. Intermediate determinants inducing a weak
response are referred to as IOsuhdomlnant" determinants.
SUbdominant determinants induce a strong response when
injected in the peptide form, a response which can be recalled
in......Y.1.t.1 by the peptide or by the protein itself.
Investigators from different laboratories have focused
their research on identifying pathogenic, immunodominant Tg
epitopes within the large Tg molecule. Raitt and his group
(Champion at aI, 1987b) have demonstrated that iodination-
dependent T cell epitopes may be important in the induction
and/or perpetuation of autoimmune thyroiditis. Two
clonotypically distinct I-Ak-restricted Tg-specific T cell
hybridomas (derived from T cell line MTg12B and clone MTg9B3,
respectively) responded to normal, but not thyroxine lacking
Tg peptides. In a different stUdy, Champion et al (1987a)
have also sho....n that these T cell hybridomas have closely
similar but not identical epitope specificities since the
hybridomas exhibited differential responsiveness to a panel of
Tgs of diverse species. Later, Champion et al (1991), using
a spectrum of synthetic T4-containing truncated peptides
(corresponding to four hormonogenic domains of Tg) and the
above Tq-specific T cell hybrldomas, identified a nonameric
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sequence (2551-2559) containing thyroxine (T4) at position
2553. Moreover. an absolute requirement tor T4 at post tion
2553 was demonstrated for its recognition: replacement of
thyroxine with its precursor residue Tyr (or any other a.a.)
produced a non-stimulatory sequence. Hutchings et al (1992)
demonstrated the rele\lJlnce of this epitope to pathogenic
thyroid autoimmunity by adoptive transfer experiments in which
peptide-primed (in Y1x2l and peptide-boosted (J..n.......Y.i. LNC
adoptively transferred severe thyroiditis to naive syngeneic
mice. These elegant stUdies, apart from identifying an
lrnmunodominant and pathogenic Tg sequence, directly
demonstrated that the iodination of Tg influences its
IlllJDunoqenicity and also confirmed the results shown previously
in os chickens (Bag-chi et aI, 1985a) and 8B/W rats (Allen et
a1, 1986).
Subsequently, Kotani et a1 (1992), following a
traditional biochemical approach, idtmtitied an i_unodo_!nant
15J1ler T cell epitope (774-788) within the pTPO (926 a.a.1
molecule that can readily induce specific LNC proliferative
and Ab responses and causes thyroiditis in C57BL/6 (H_2b)
mice. Although this 15mer TPO peptide is pathogenic, it does
not contain characteristic features of T cell epitopes such as
amphipathic a-helical structure (Margalit et aI, 1987) and/or
the tetramer motif (Rothbard and Taylor, 1988). Thus, if one
uses the above computerized algorithms, this iJlUllunopathogenic
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TPO sequence "'ould not have been identified. Subsequently,
Texier at a1 (19921. using a Tq-specit'ic .urine cytotoxic T
cell (C'I'L) hybridoma identified a 40mer (1672-1711) (4.5 kOa)
illllunopathogenic peptide within the hTg' molecule. However,
further truncation of t.he peptide was not attempted to
localize the minimal T cell epitope within this 40mer peptide.
More recently, Hoshioka et 011I1 (1993 1 demonstrated the
pathogenic potential of II common T cell epitope of hTg (2730-
2743) and hTPO (11S-131). that was predicted earlier by
McLachlan and Rapoport (1989), by its ability to stimulate
mTg-primed we that can transfer thyroiditis in naive CBA
mice. In conclusion. the Tg or TPO epitopes that are
thyroiditogenlc are Immunodomlnant and have been examined in
heterologous species. However, the role of these T cell
epitopes in a homologous species remains unexplored. In
addition, the Tq epitopes recognized by T cells from thyroid
tissue of patients SUffering from human AlTO have not yet been
identified.
1.4.1.4.2 AI'tD studi•• in bWian
Fisfalen et al (1988) described hTPO-reactive T cell
lines with low stimulation index (5.1). They could not
exclude the possibility of T cell reactivity to Tg because a
pure TPO preparation was not used. Using recombinant hTPO,
hTPO-specific T cell clones from the thyroid of a GD pationt
43
were established by Dayan et 811 (1991). This study utIized an
antigen-independent T-cell cloning technique that involves the
stimulation of T cells with anti-CDJ KAb and IL-2 in the
presence of syngeneic PBMes as APC. In addition, SOIllI:! of
these T cell clones recognized an unknown thyroid Ago and one
clone recognized Tq. Further epitope analysis revealed that
the TPO-reactiv8 T cell clones recognized two distinct
opitopes (535-551 and 632-645) in the context of DP2 or DQ6
and DQ2, respectively. It. third TPO epitope has not yet been
localized. These tindings demonstrated a marked heterogeneity
of autoantigen recognition by T cells at the active sitt! of
disease with respect to nUmber of epitopes on a single protein
involved and the number of HLA restriction elelllents used.
The TPO peptide (SJS-S51)-specific T cell clones derived frolll
the diseased thyroid were found to be resistant to tolerance
induction introduced by 9upraoptimal concentrations of the
peptide or superantigen (SAg) (Staphylococcus enterotoxin p)
J.~ in the absence of APe. This further indicates a role
for thyroid Ags in driving T cell autoreactlvity in.....YiY..2
(Dayan et aI, 1993).
In conclusion, the advent of 'r cell cloning tec..hniques
and the availability of r3combinant thyroid Ags have
dramatically increased the progress in the analysis of
epitopes within thyroid Aqs (in partiCUlar TPO) important in
GO. However, similar progress has not yet been made with
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respect to the generation of T cell clones from thyroid gland
and their epitope specificities in HT patients.
1.5 Antigen-pre.entation in thyroid autoiJlUllunity
various types of APe, such as dendritic cells and B
cel Is, t.ave been shown to playa crucial role in the induction
and/or maintenance of thyroid autoimmunity (Knight et aI,
1988; Hutchings et aI, 1987). Transfer of quite small numbers
(lOS) of dendritic cells from the spleens of mice with EAT has
been shown to induce both thyroiditis and Tg-specific Abs in
more than 50% of the recipients. Similarly, dendritic cells
pulsed exogenously with Tg and adoptively transferred, could
also induce thyroiditis in recipient mice (Knight et aI,
1988). Tg-primed B cells from mice hnve been shown to present
Tg at very low concentrations to specific T cell hybridomas
suggesting that specific autoreactive B cells may playa role
in maintenance of T cell autoreactivity (Hutchings et aI,
1987) .
The observation that MHC class II Ags were expressed on
thyrocytes in patients with AITD led to the hypothesis that
these cells could function as APes, capable of triggering
autoreactive T cells by presentation of T cell epitopes of
endogenous thyroid Ags and contributing perhaps to the
initiation or propagation of thyroid destruction (Botazzo et
aI, 1983). Demonstration of the activation of T cell lines
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and clones isolated fro. thyroids of HT and GD patients by
class II' thyrocytes (Londe! et aI, 19851 Daya;, et aI, 1991)
provided support for this hypothesis. However, the role of
class II' thyrocytes as APe remains controversial because the
primary thyroid cell cultures used to activate T cells were
contaminated with APe such as dendritic cells and it has been
suggested that these dendritic cells either assisted
thyrocytes or presented autoantigens by themselves leading to
the activation or specific T cells.
1.5.1 Faotor. tbat induce or .odify KHC class II antigen
expr.ssion on thyrocyt••
Extensive studies in thyroid autoimmunity have been aimed
at delineating the factors that can induce or modify class II
expression on thyrocytes. A characteristic feature of class
II expression on thyrocytes is its induction by nUlllerous
factors that are described belovo Pujol-Borrell et al (19831
demonstrated the induction of class II expression on
thyrocytes after the addition of phytohema9qlutinin (PHlI) to
thyrocyte culture. IFN-y was shown to be the most potent
class II inducer dE'!9cribed to date (Todd et al, 1985), and
incubation of human thyrocytes ..In.....Y.J... with IFN-y has been
shown to result in the hierarChial expression of class II (OR
> OP » DQ), a finding similar to the one that was observed in
thyroids of patients afflicted with AlTO (Todd et aI, 1987b).
••
Various other agents have also been used as inducers of class
II Ags on murine or human thyrocytes such as leuJtoagglutinin
(Iwatan! et aI, 1986). culture supernatants from syngeneic
(Salall.ero et aI, 1985b) or allogeneic stimulated T cells
(Iwatani et aI, 1986), thyrotropin (Todd et aI, 1987a) and
dibutyryl cyclic.: AMP (Todd et aI, 1987a), tumor necrosis
factor (TNF) (Todd et al 1987c), and Abs to TSH receptor
(Bodolay et aI, 1987; Ropars et aI, 1994). TSH and TSA.b
(thyroid stimulating Ab) can also enhlllnce IFN-y-induced class
II expression (Ropars et aI, 1994). Methimazole at very low
concentrations caused inhibition of IFN-y induced HLA-DR
expression on thyracytee and that this inhibition could be
abrogated by the addition of TJ and T4 suggesting that
methimazole interferes with the synthesis of TJ and T4 (Atta
et aI, 1995).
MHC class II Ag expression, therefore, seems to be a
result of T cell infiltration and IFH-y release, but other
factors may modify this. TNF-a is produced by the mononuclear
cell infiltrate in autoimmune thyroiditis and it may synergize
with IFN-y and increase class II Ag expression on thyrocytes,
although it does not induce class II Ag expression by itself.
Both cytokines individually increase constitutive class I Ag
expression (Weetman and Rees, 1988; Bucasema et aI, 1989). In
contrast to TNF-a, epidermal growth factor (EGF), which is
structurally related to TNF-a, stillulates thyroid growth in
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culture and suppresses 'l'SH-stimulated processes, causes a 50%
decrease in class II Ag expression in TEe cultured with IFN-y
in the presence or absence of TSH. Trans(urming growth
factor-a (TGF-a) has also been shown to partially suppress
IFN-y-induced class II Ag expression (Todd at ai, 1989).
Recently, Takorabet et al (1995) demonstrated induction of
class II Ags on human and murine thyrocytes upon treatment
with a neuroleptic and anti-depressant drug, alimemazine.
Previous studies using indirect immunofluorescence, have also
shown that teoviruses type-l and type-2 can enhance the class
II Ag expression on mouse (Gaulton at aI, 1989) and rat
(Neufeld at aI, 1989) thyrocytes indicating a direct role for
these viruses in the modulation of class II Ag on thyrocytcs.
The viruses were less effective in inducing class II Ag on
human thyrocytes than on !!Iurine thyrocytes (Attll et aI, 1995).
The reoviruses can also hyper induce class I Ag expression on
human thyrocytes. This class I expression was shown to be
dependent on the cytokines (IFN-cz and lFN-B) released after
the infection of thyrocytcs. In conclusison, these various
investigations suggest that expression and modulation of Hile
class II and class I on thyrocytes may aid in amplification
rather than initiation of autoreactivity.
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1.5.2 Thyrocyt.. a. APe
The concept that aberrant MHC class II Aq expression on
thyrocytes is the initiating event in autoillUllune thyroiditis
has been a sUbject of various investigations and controversial
results. The following reports do not support the concept
that class II Aq expression on thyrocytes initiate thyroid
autoimmunity but rather that class II expression on thyrocytes
is a secondary event and is dependent on thyroid-infiltrating
T cells and the cytokines they secrete. First, in kinetic
studies of EAT in rats, it lUIS demonstrated that the
appearance of the lymphocytic infiltrate in thyroids always
precedes class II Ag expression on thyrocytes (Cohen at ai,
1988a). Immuno-histochemical analysis has revealed that the
distribution of class 11+ thyrocytes in autoimmune thyroid
disease is strongly correlated with the presence of nearby
IFN-y containing T cells (Margolick et aI, 1988; Hamilton et
a1, 1991). MHC class II Ag expression, therefore, seems to be
a result of T cell infiltration and IFN-y release, but other
factors may modify this (see Section 1.5.1).
It has been shown that IFN-y treated (class 11°) mouse
and rat thyrocytes failed to present a variety of Ags
inclUding T9 to appropriate T cells, and this was not improved
by the addition of IL-l or phorbol esters (Ebner et aI, 1987;
Minami et aI, 1987). The class II' mouse TEe line (MS) also
failed to activate T cells but this cell line readily does so
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upon treatment with phorbol ester but not upon exogenous
addit-.ion of IL-1 (stein and Stadecker, 1987). However, the
same 1'15 line acquires: allostilllulatory function after a two-
step procedure of irradiation and class II induction,
suggesting that irradiation of thyrocytes induces the
expression of costimulatory molecules (Czirjak et aI, 19901.
The abnormal expression of class I and class II Ags on
target cells~ may not be sufficient to induce T
lymphocyte activation, and other signals or factors may be
required to initiate an autoimmune attack on a target cell.
Thyrocytes have been shown to express leAM-I, Which is
responsible for enhanced T cell binding to thyrocytes (Weetman
et aI, 1989b). However. two other groups failed to detect
ICAK-l Qxpression on thyrocytes from CD patients (Bagnasco et
aI, 1991), thus the role of ICAK-l in activation of thyroid
Ag-spccific T cells remains undefined. The expression of 87,
a .ajor costilllulatory signal in T cell activation, on
thyrocytes. even after their incubation with IFN-y, has not
been demonstrated (Tandon ct aI, 1994). However, phorbol ester
treated thyrocytes from patients with AlTO have been shololn to
trigger T cell alloroactivity (Tandon et aI, 1992a). Overall,
the !indings presented in this section suggest that thyrocytes
by themselves can activate paticular subset of T cells and in
association with other APe /Day activate another subset of T
cells in the target organ.
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1.6 lltiolOqy of autoiuune tbyroid di •••••
It has been suggested that both genetic and non-qenetic
factors contribute to the etiopathogenesis of AlTO in humans.
1.6.1 Genetio rectors
1.6.1.1 Major histocollpatibility coaplex (MBCl
The MHC products in humans, encoded by genes within human
leukocyte antigen (HLA) complex, have been shown to control in
part the immune responsiveness to a variety of Ags. In many
autoimmune diseases, associations hl'ove been reported with
certain MHC alleles encoded by either class I (HLA-A, -B, and
-C) or class II (HLA-DR, -OP, and -00). Most analyses of HLA
in thyroiditis to date have used serologically defined
specificities in which a single DR or DO serological
specificity represents a broad pUblic specificity, present on
mUltiple DRBl or OQBl genes. Using serological typing, an
association of HLA-DR5 with goitrous HT has been demonstrated
(Farid et aI, 1981). HT was associated with DR4 or DRS in one
study from Newfoundland (Farid et aI, 1981; Thomson and Farid,
1985), with DRS in patients from Toronto (Vargas et aI, 1988)
and with DR3 in Hungarian patients (Thomsen et aI, 1983).
Using the RFLP method of DR typing, an association between DR3
and HT was demononstrated in British patients (Tandon at aI,
1991a), Although associations appear to be strongest with DR,
other HLA-D genes such as DO and DP, might increase the
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susceptibility of individuals to HT. Thus, while it appear"
that genetic variation in the HLA-D region confers
susceptibility to AlTD, it is unclear which qene(s) carries
the primary genetic predisposition. Using allele-specific
oligonucleotide probes, an association between 007 (DQBl.030l)
and HT was demonstrated in a population trom Toronto and
London (Badenhoop et aI, 1990). In an RFLP study, using a
Caucasian population in Chicago, it was demonstrated that HLI\-
DR) in association with HLA-DQ2 was significantly increased in
GD patients. In contrast, another stUdy showed no association
of HLA-DR or DO with HT (Manqklabruks et aI, 1991).
Transracial studies have been useful in determining
susceptibility genes in some autoimmune disorders but have not
yet bep-n conducted in sUffic1.ent detail to clarify the H1lI.
associations in autoimmune thyroiditis. HlA-Bw46 and DR9 are
increased in Chinese HT patients (Hawkins et al, 1987; Wang et
aI, 1988), whereas 816 is increased and DR2 is decreased in
Japanese HT patients (Nakao et a1, 1978; Sakurami et aI,
1982). In a more recent report, an association with HT was
reported for "LA-DRSJ (encoded by the DRB4 gene) which is
present only on a restricted nUmber of hap10types (OR4, 7 and
9) . The association of HT with DR9 being the weakest (llonda at
al, 1989).
An increase in DQAl*OSOl has been reported in HT and GO
patients (Badenhoop et al. 1995). In this study, the alleles
52
....ere defined by hybridization ....ith sequence-specific.
oligonucleotides (SSO) and single strand conforutional
polYllorph!slI (SSCP). DQAl'*0501 is found on OR)- and DR-S
positive haplotypes. DRS is associated with HT (Farid and
Balazs, 1988) and GO (Fa-rid and Stenszky, 1988) patients. Both
DRJ (associated ",!th GO) and DRS (associated with HT) are
increased in falilly Illellbers with AITO, although no formal
linJl:aqe hl:ls been demonstrated (Roman et aI, 1992). Yanaqawa
et al (199J) recently described a positive association of GO
with DQAI-0501. which is in linkage disequilibrium with
[>QBl.0201 (OR52 • Ow25) in Cauc8liian DR) haplotypes. These
findings suggested a role for DQ genC!:s in GO susceptibility.
In HT-affected patients, both DR4 and DRS are in positive
linkage disequilibrium with DQB1*O)OI, but not with DQBI*0302
{DQ8}. This is compatible with II. role for DQ genes (or
closely linked genes) in susceptibility to HT, as previously
suggested (Jenkins et al, 1992; Shi et aI, 1992; Tandon et aI,
1991a; Badenhoop et aI, 1990). Interestingly, it has been
shown in falli Iy studie~ that the risk for AlTO in l:OOM
patients was conferred by the presence of DQBl*02Ql (002).
Among the subjects with DQB1.0201, there was II. weak negative
association between the presence of 0081.0302 on the second
haplotype and HT. On the other hand, this {,.1~ Ide favoured GO
development (Santamaria et aI, 1994). The f.J.ndings in this
stUdy suggested that in families, certain alleles
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haplotypes in some 100M patients may produce a risk for
developing AlTO, whereas other 100M patients may lack that
susceptibility. Thus, in families with rOOM and AlTO, the liLA.
polymorphism modulates the susceptibility to each disease in
a complex fashion, with each haplotype playing a complementary
role. Interestingly, Badenhoop et al (1995) have shown that
100M-affected subjects are at risk for AlTO, especially those
carrying OQAl*0501 and arginine at position at 52 of DQAl
alleles, and protection against 100M and GO is conferred by
DQBl*0602 (DQ6).
1.6.2 Non-genetio factorll
These may be endogenous (age and sex honnones) or
exogenous (chemicals, novel immunotherapeutic agents or drugs,
iodine intake, and infection).
1.6.2.1. Age
It has been shown that the incidence of AITD clcllrly
increases with age probably due to chronic exposure to
environmental factors and to possible changes in
immunoregulation. Phillips et al (1993) showed a relationship
between fetal growth and the later (adUlt) appearance of anti-
thyroid Abs. The proportion of women with elevated anti-Tg
and anti-TPO Ab titers correlates with their lower birth
weight. The prevalence of these Abs rose with increasing
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adult body mass particularly in those individuals who did not
have a central pattern of fat deposition. These effects were
modest and unrelated to clinically overt HT. These results
suggest that early nutritional factors and possibly hormonal
consequences of body composition may influence susceptibility.
In this regard, in mouse EAT, it has been shown that old mice
(20 to 30 months) have an increased susceptibility to Tg-
induced EAT ....ith a concomitant decrease in the titer of T9 Aba
(Romball and Weigle, 1987).
1.6.2.2 Sex horaones
There is a strong female to male predominance (5-20 : 1)
for AlTD in the adult population and a peak incidence between
30 and 50 years of age. This may be an effect of sex
hormones. Several reports have documented the influence of
sex hormones on the development of AlTD: Hyperprolactemia
has been shown to increase the risk ot individuals of
developing thyroid Abs (Ferrari et al, 1983). It has also
been shown that women with postpartum thyroiditis go on to
develop permanent hypothyroidism (Oathman et aI, 1990).
However, whether postpartum thyroiditis serves as a permissive
factor for development of HT is unknown. The role of sex
hormones has been verified in a rat model of SAT (Ahmed and
Penhale, 1982). These authors demonstrated that prepUbertal
orchidectomy potentiated the development of (Tx-X)-!nduced
"
EAT in male P'lG/c strain rats (this strain is normally
resistant to EAT development it prepubertal orchidectomy is
not perfone"l). The authors also showed that adlllinistration
of testostero.'8 to these rats completely suppressed the
development of thyroiditis as well as anti-Tg-Ab titers.
Usil1lJ thyroid grafting and extirpation techniques. Ahllod and
Penhale (1986) have deJlonstrated the therapeutic potential of
testosterone by reversing the establ ished thyroiditis in (Tx-
X) -PVG/c rats without altering the Tg Ab titers.
1.6.2.3 Io4i.ne
Adverse effects of dietary iodine on the development or
AlTO has been a topic ot several investigations both in humans
and in various experi.ental animal models. Early studies in
humans indicated a lin)t between iodine intake and development
of AlTO {Beirwalters, 19691. In this &tudy, the authors
demonstrated that keeping hypothyroid-patients on an iodina-
restricted diet has an aJlleliorative effect on the disease
state with patients becorllinq euthyroid. When iodine was
reintroduced, several of these patients relapsed to a
hypothyroid state.
In the rat EAT model, it has been shown that excess
dietary iodine enhances the severity or incidence of disease
in genetically predisposed BB and BUr rat strains, whereas low
iodine intake results in amelioration (Allen et aI, 1986:
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Cohen and W'eetman. 1988b). This effect of iodine seems to be
related to the iodine content of Tg (de PaivlI-Assis et aI,
1988; Ebner et aI, 1992). High dietary iodine intake has also
been shown to exacerbate thyroiditis in the OS chicken and
also seems to be due in part to the iodination state of T9
(Bagchi at aI, 1985al Sundick at aI, 1987). These results
contrast with the findings reported by Allen et a1 (1986) in
which, it has been sholrln that high dietary iodine intake did
not result in hypothyroidism and the rats remained euthyroid.
The findings of Allen et a1 (1986) were confirmed by the
studies of Voorby at al (1990) in Which the authors showed
that a similar regimen induced only minor signs of thyrocyte
d.estruction. Though the initial experiments suggested that
iodine was not essential for the development of thyroiditis,
SUbsequent experiments involving radical iodine depletion,
begining in ovo, revealed that uptake or metabolism of iodine,
in fact, is essential for the development of SAT (Brown et aI,
1991) •
It is believed th.at iodination of Tg results in the
generation of neoantigenic epitopes. In that regard, an
iodinated but not non-iodinated synthetic Tg peptide (2546-
2571) has been shown to induce thyroiditis (Hoshioka et aI,
1994). Interestingly, both forms of the Tg peptide readily
induced T cell responses, but only iodinated Tg peptide
induced Ab responses. Thus synthesis of llono- and di-
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lodotyrosine residues, is neces1iary for the induction of
thyroiditis and Ab responses. These findings are in contrast
to the report of Hutchings et a1 (1992) in which the authors
demonstrated that only T4 containing peptides induce
pathogenic T cell responses. In addition to altering the
immunogenlcity Clf Tg, iodine has been shown to have additional
effects on thyroiditis, e.g., by interacting. with oxygen
radicals to produce highly reactive oxidized iodine forms
capable of tissue injury (Bagchi et aI, 1990).
1.6.2.4 J:n~.otion and inU_aUon
1.6.2.'.1 KechanisII.8 at' intectionw II.8diated &utoillDune dise.s.
As in the majority of autoillll1lune diseases, viruses have
also been implicated in the development of autoimmune
thyroiditis (Tomer and Davies, 1993). but no clear correlation
has been found in human thyroid disease. Such viruses could
affect either the immune system or the tai:"get organ. It has
been delllonstrated that viruses can induce autoimmunity by a
process called "molecular mimicry" as a result of structural
or primary a.a. sequence similarities between autoantigens and
viruses (Oldstone, 1987). However, to date, no sequence
similarities have been reported between Tg, TPO and infectious
agents that are associated with AlTO.
Infection can induce autoimmunity through the induction
of MHC class II expression on target cells and subsequent
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presentation of T cell epitopes from autoantigens. The
regUlation of MHe gene products by viruses that infect thyroid
tissue (directly or indirectly) represents a significant
immunological phenomenon becaus~ of the central role of the
MHC in Ag-presentation. The increased expression of MHC class
II on thyrocytes by IFN-y released by T cells (Bottazzo et aI,
1983) may aid in the presentation of novel (cryptic or oon-
dominant) peptides above the critical threshold level required
for recognition by T cells (Sercarz at aI, 1993). In
ilddition, the proteases released during the inflammatory
process may also alter Aq processing and presenti3tion
(Opdcnakker and Van Damme, 1994). It is possible that
cytakines (IFN-y, TNF-a. IL-I, and IL-8) released during the
inflammatory response induced by infection can augment the
expression of accessory and/or costimulatory molecules such as
ICAH-l and 67, thereby enhancing the presentation of thyroid
Ags. This upregulation of adhesion molecules may lead to
increased leukocyte adhesion, release of nitric oxide and
oxygen radicals, thereby resulting in tissue destruction, and
exposure of intracellular proteins.
The inflammatory process can also increase the expression
of heat shock proteins (hsp) which can alter the presenta"cion
of self-antigens by modulating the transport and processing of
intracellular peptides (Michalek et aI, 1992). ThUS, during
infection abnormal processing and presentation of autoantigens
..
can take place leading to the induction or propagation of'
autoaggression.
1.6.2.4.2 ~a.oci.tiol1 of viral infections witb AlTO in
huaan.
The role ot infectious agents in the pathogenesis or AITD
remains purely hypothetical and has been reviewed recently by
Tomer and Davies (1993). Different viruses such as mCilslcs,
influenza, adena, epstein-barr, lind coxsackie have bccn
reported to be associated with subacute thyroiditis CST)
(Volpe. 1979). The presenco! of Abs to coxackie, adene,
influenza, and mumps viruses was demonstrated in ST patients.
llithough these patients had no specific viral disease. The
pres( nee of anti-TPO and anti-Tg Abs were also detected in 42-
64·' of ST patients (Volpe et aI, 1967). In contrast, Wcet.an
et a1 (1987) demonstrated in ST patients the persistent levels
of Abs that are polyclonal in nature, to several
uncharacterized thyroid antigenic dotorJIinants. Thecc fobs
are believed to be secondary to the thyroid damage (endogenous
priming) caused by viral infection. Apart from Abs to thyroid
Ags, transitory prAsence of autoreactive T calls to thyroid
Aqs was demonstrated (Wall et aI, 1976: Totterman at aI,
1978). These tindings were attribut::=d to the inflilmmatory
release of I\g rt\ther than to specific autoimmune diccaso
induced through molecular mimicry induced by viral infection
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(Volpe, 1978).
An association between congenital rUbella virus infection
and thyroid dysfunction has been demonstrated. The mechanisms
responsible for thyroid dysfunction in these patients are
poorly understood. Anti-TPO or anti-Tg Abs were found in 34%
of the patients (Ginsberg-Fellner et aI, 1984). A recen'c
bacterial or viral infection has been demonstrated in HT
patients by Tonooka et a1 (1978). It was suggested that
retroviral infection may be a triggering factor leading to the
development of thyroid autoimmunity (Josephson et a1, 1989).
Using western blotting, these authors demonstrated the
presence of Abs to non-HIV retroviruses that cross-reacted
with HIV proteins. However, restricted antigenic responses by
T lymphocytes from HT patients led to the suggestion that
these autoreactive T cells might have been triggered by a
specific Ag stimulus such as infection (Katzin et aI, 1989).
Ciampolillo et al (1989) reported the presence of HIV-related
genomes in thyrocytes from patients with GO. More
interestingly, a homology between a 161-base pair region of
the gena encoding TSHR to the gene encoding the HIV regUlatory
protein Nef has been documented (Burch et aI, 1991). Rabbit
Abs to a peptide representing part of this TSHR sequence
showed cross-reactivity with the recombinant Nef protein; sera
from patients with GO also appear to recognize Nef weakly
(Burch et aI, 1991). These findings have sparked speculation
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regarding retroviral involvellent in the pathogenesis of GO.
In a recent study. a higher prevalence of HT in patients with
human T-lymphotrop!c virus type 1 (HTLV-l) infection than 1n
the general population was delllOnstrated (Kawai et aI, 1992).
Thus, it is tempting to speculate that the HTLV-l virus
infects thyrocytes and elicits autoreactivity leading to lIT.
Isolation of either infecting organism from thyroid tissue or
isolation of T cells to viral mimics of thyroid Ags have not
been made but such studies will clarify the role of viral
infections in the etiopathogenesis of HT. In one study, it
was demonstrated that 20", of patients (women) with Chronic
hepatitis C infection had high titers of thyroid Abs and some
of the patients developed hypothyroidism and HT (Tran et a1,
1993). However, the cause and effect relationship between the
viral infection and HT is not understood.
A large proporti<'n of patients with GO and autoi••unc
thyroiditis have Abs to Versin!a enterocoUtica (Shenkman and
Rottone, 1976). Further, weiss et a1 (198J) demonstrated a
saturable binding site for TSH on veninla enterocolitica and
such binding was shown to be inhibited by Abs present In
patients with GO (Heyma et a1, 1986). Murine Abs to
extracellular TSHR react with .X!ll:§inia enterocol jtica and
vice-versa (LUo et 31, 199J) and these authors have identified
two low m. w (5.5 kDll lind ekOa) envelope proteins of~
that are cross-reactive with TSHR (Luo et a1, 1994).
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l.fi.2.4.3 Ani••l .ode18 to study tbe role of infection in
thyroid di•••••
Direct evidence for viral involvement in the etiology of
AlTO comes from animal models in various species such as rats,
mice, and chicken. Penhale at al (1988) have demonstrated
that the composition of the gut microbial flora influences the
susceptibility of female PVG/c strain rats to thyroiditis
induced by Tx-X. Rats maintained under specific pathogen-
free condi tians until weaning were found to be significantly
less susceptible to induction of thyroiditis than
conventionally reared rats of the same strain. It is unclear
at present how intestinal bacterial flora influence the
susceptibility of rats to thyroiditis but a role for antigenic
cross-reactivity with thyroid tissue has been suggested.
Differences in the susceptibility to thyroiditis of BUF rats
from different sources or from different colonies have been
reported and have been attributed to environmental changes,
including possibly viral infection (Silverman and Rose, 1971;
Cohen and Weetman, 1987).
lUavinskis et a1 (1988) have demonstrated that in the
absence of apparent thyroid cell destruction, there is a drop
in the cirCUlating levels of thyroid hormone following a
neonatal viral infection of mice with lymphocytic
choriomeningitis virus (LeMV). The virus has been shown to
persist mainly in the thyrocytes, but signs of either necrosis
6'
or inflammation ....ere not demonstrated. In another study,
srinivasappa et al (1988) demonstrated that mice infected with
reovirus develop thyroiditis characterized by lymphocytic
infiltration, and anti-Tg and anti-TPO Abs, in the absence of
alteration in thyroid function. Onodcra and Awaya (1990) have
shown that a polypeptide encoded by the 51 segment of reovirus
type-l but not type-3 was responsible for induction ot anti-Tg
and anti-TPO Abs.
Ziemiecl'.l et al (1988) by employing southern blotting
technique, demonstrated the presence of an endogenous
retrovirus (ev 22) in os chicken with SAT but not in healthy
normal inbred strains. Ev 22 therefore was considered a very
likely causative agent in SAT. Elaborate classical genetic
studies on F1 hybrids of 05B15 and the higly inbred normnl CIl
(B12) strain, F12 and backcross generations showed that the
only correlation with the presence of the ev 22 locus was
found with altered immunoendocrine feedback regUlation, but
not the absolute degree of SAT or the frequency and titer of
anti-Tg Abs (Kroemer et aI, 1988). Therefore, ev 22 has only
a modulatory, effect, if any, on the course of the SA'!-
pathogenesis. In contrast, a report by Carter and Smith
(1983) implicated retroviral infection in the development of
thyroiditis in chickens. These authors have demonstrated that
inoculation of 1o-day old chicken embryos with avian leukosis
virus (ALV) strain RAV7 resultec\ in hypothyroidism within 3
••
weeks of hatching. Histoloqical analysis of thyroids from
these birds revealed an extensive lymphocytic infiltration.
The hypothyroidism was Wlanifested by marked stunting of gro....th
and hyperlipidemia.
1.6.2 • .5 Druq8 and Clb••ical.
1.'.2.5.1 blod.roDA
Other exogenous factors that are associated with thyroid
autoimmunity includes drugs and chemicals. It has been shown
that ingestion of amiodarone (an iodinated derivative
containing two iodine ato!ns/molecule of drug).
antiarrythmic and antianginal drug. by patients suffering fro.
heart failure resulted in either hyper- or hypothyroidista with
Abs to Tg. TPO and occasionally to TSHR (Singh, 1983).
Similarly. an increase in thyroid Abs was reported after
amiodarone treatment in people on low-iodine intake in UK
(Monteiro et aI, 1986). It is believed that the iodine
released from udC'darone (a 200 mg oral dose generates 6 mg of
free iodine/day) is partly responsible for the precipitation
of the autoimmune response. Recently, Takorabet et al (1995)
have demonstrated that drugs can modulate the autoimmune
response by their effect on target cells. The authors in that
study have shown that CUlturing thyrocytes in the presence of
alimemazine, a neuroleptic and anti-depressant drug, results
in the induction of MHC class II Ag on thyrocytes and these
.s
class II· murine thyrocytes triggered an IIT9-specific UlC
proliferative T cell response. However, the significance of
the proliferative T cell response to the induction of
thyroiditis vas not demonstrated.
1.'.2.5.2 Litbiua
Development ot both thyroiditis and thyrotoxicosis has
been assocIated wIth lithium therapy (Calabrese et 011, 1985).
In this stduy, it has been demonstrated that some patients on
lithium therapy exhibited baselir.'! thyroid Abs or thyroid
disease, whereas those patients with pre-existing thyroid
disease all developed an increase in the autoimmune response
to the thyroid Ags as seen by increased Ab titer or overt
hypothyroidisll. The mechanisms by which lithium mediates its
effect are unknown, but it is believed that lithium affects
illlllluno-regulatory .echanisms by interfering with the function
of Ts cells (Shenk.an et aI, 1981).
1.45.2.5.3 other ch••icab
Various exogenous factors have been shown to modify the
expression of SAT in rats. Trypan blue, and anthracene
derivatives have been shown to enhance the low incidence of
SAT in BUF rats, thereby producing an extensive dendritic cell
and macrophage infiltration within the thyroid gland as well
as the production of anti-Tg Abs (Bernard et aI, 1992).
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1. Ii. 2. Ii CytotiD"
Several reports in humans and expert.ental animals have
indicated that an iatrogenic cause of AlTO is the long term
administration of various cytokines. It was demonstrated
earlier that 10n9 tera treatment with IFN-(I: of patients
sUffering from breast cancer (Fentiman et aI, 1985; Burman et
al 1986) or from myelo-proliferative and lIlyeloplastlc
syndromes (Gisslinger et aI, 1992) resulted 1n development of
thyroid dysfunction and clinical hypothyroidism. In some of
these patients, thyroid dysfunction was suggested to be due to
contamination of the leucocyte-derived IFN-Q preparation with
IFN-y (Burman et aI, 1986). However, this speculation seems
unlikely because similar effects were observed when patients
were treated with recombinant IFN-cr (Gisslinger et aI, 1992)"
Interestingly, IFN-y given to patients afflicted with a
lIlalignant disease or chronic active hepatitis, who had
thyroid-specific Abs prior to treatllent, did not result in
thyroid dysfunction and autoimmunity (Kung et aI, 1990).
It has a"lso been shown that administration of recombinant
IL-2 and granUlocyte macrophage-colony stimUlating factor (GM-
CSF) to cancer patients with pre-existing thyroid Abs
precipitates thyroid dysfunction (Atkins ct aI, 1988; Van
Liessum et aI, 1989; Hoekman et aI, 1991). Ho....ever, the
thyroid dysfunction induced by GM-CSF was reported to be
reversible (Hoekman et aI, 1991). In some of these stUdies,
.7
the results suggest that thyroid dysfunction is mediated by
the combination ot both 1[,-2 and LAK colls "'fth no effect by
either of these alone (Atkins et aI, 1988). Plchert et al
(1990) also shoved that when cancer patients were treated with
IL-2 and INF-a, the patients developed transient mononuclear
infiltration of the thyroid, hypothyroidism and an increase in
class II expression on thyrocytes.
In contrast to the iatrogenic effects of various
cytokines on thyroid function in cancer patients, a pathogenic
effect of IFN-y has been demonstrated in mice. Injection of
recombir.ant IFN-y into the thyroids of CBA mice has been shown
to induce thyroiditis and anti-Tg Abs (Remy at aI, 19871.
These results were further supported by transplantation
studies in which grafting under the kidney capsule of
in....Yi.1m IFN-y treated but not control thyroids into syngeneic
uaice resulted in mononuclear infiltration of the grafted
thyroid (Frohman et aI, 1991). ThUS, these results suggest
that local concentrations of IFN-y co_pared to its circulating
concentration lIIay have different effects.
Injection of a high dose of IL-IB (8. O#A9/ml/kg/d) in BB
rats increased the severity of insulitis and. lymphocytic
thyroiditis (Vertrees et al, 1991). Thus, administn:ltion of
large dose of cytokines exacerbates preexisting thyroiditis.
studies to demonstrate the immune mechanisms by which thF.!se
cytokines mediate their effects were not done.
.8
1.7 Pathogeb!C ••ohani_. ID a.:ITD
The precise cellular and hu.oral Illechanlsas leading to
the manifestation of hu.an thyroid disease are not completely
understood (Weetllan, 1992) although an autoimmune pathogenesis
of thyroid disease is supported by (1) the production of Mbs
to thyroid Ags. (2) the presence of lymphc.cytic infiltration
in the thyroid, and (3) the association of the disease with
liLA class II gono products. A diversity of mechanisms
contr ibuting to the tissue injury in thyroid disease in human
and experimental animals have been shown and will be discussed
in this section.
1.7.1 T cell-••dieted injury
Intil traUon of the thyroid gland by lymphocytes is a
hall-mark of AlTO; it is particularly evident in fIT but it is
also seen in most of the GO patients (Charreire, 1989). It
has been suggested that both CD4· Th cells and CD8· CTLs have
a pathogenic role and that these cells nay destroy the target
thyrocytes through DTH and cytotoxicity mechanisms,
respectively. No definitive evidence ot T lymphocyte-mediated
thyroid damage in HT is available to date. Attempts have been
made to establish CTL clones from HT thyroids using IL-2, but
these experiments led to the generation ot cos· T cells that
exhibited non-specific cytotoxic functions (Canonica et aI,
1ge5; MacKenzie et aI, 1987a; del Prete et aI, 1986; del Prete
••
et aI, 1987). These cytotoxic CDS' T cells were not specific
to Tg or other thyroid Ags, and exhibited natural killer (NK)
activity (del Prete et aI, 1986) or lectin-dependent
cytotoxicity (Bagnasco et aI, 19871. Their role in the
pathogenesis of thyroid disease remains unknown. only one
thyroid-specific T cell clone, derived fro", an HT patient, has
so far been described: the nature of the autoantigen
recognized by the T cell clone has not been elucidated
(MacKenzie at aI, 198ib). Recently, WU at 211 (1994) using
immunofluorescence staining demonstrated that HT thyroids were
infiltrated with perforin containing CD4' and CDS' T cells.
These findings raise the possibility for a perforin-mediated
cytotoxic mechanism in the pathogenesis of HT.
The strongest arguments favouring CD4· T cells playing a
role in thyroiditis induction have come from adoptive transfer
studies in EAT, in which disease has been transferred wlth
CD4' T cell lines and clones (Maron et aI, 1983; Rolllball and
Weigle, 1987; Sugihara et aI, 1993). The precise mechanisllIs
by which these T cells lItediate thyroid patholoqy remain
unknown. Recently, biased TCR VB gene usage has been reported
in the intrathyroidal infiltrate of hTg-immunhed CB"/mlco
(Matsuoka et aI, 1993). Of the 17 TCR VB gene families
examined by PCR, 6 families (VB 1, 2, 4, 8, 13 and 16) were
utilized by the hTg-specific T cell 1 ines. The relative
importance of each of these TCR VB bearing T cells was not
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addressed by adoptive EAT (Matsuoka et aI, 1994). However, it
has been shown that TCR VBS· T cells do not playa major role
in Tg-induced EAT since depletion of VB 8' T cells from mTg-
primed we does not abrogate the adoptive transfer of
thyroiditis in mice (Fuller et aI, 1994).
The role of CTLs in thyroid destruction was first
suggested by the H-2··restricted damage of thyrocytes (Creemers
et aI, 1983). In these studies, the protocols used were
similar: after .in...Yll2 priming with mTg and~ boosting
either with mTg or with TEe, respectively, stimulated T cells
were deposited on labelled, syngeneic TEe targets. These CTLs
(COS·) medhlted the lysis of TEe targets and were shown to be
specifically directed against Tg epltope(s) of the TEe
cultures and to be class I-restricted. These data were
further supported by the demonstration of cytotoxicity against
labelled syngeneic but not allogeneic TEe with rnTg-specific
cos' CTL hybridorna (Remy et aI, 1989) and CTL clones (Sugihara
et ai, 1995).
T cells, by virtue of the cytokines they secrete, can
mediate thyroid damage indirectly and thereby affect thyroid
function. Direct injury of thyrocytes in a primary culture
is difficult to prove, but, cytokines could alter functional
responses thus contributing to the development of
hypothyroidism. A large proportion of CD4+ and CDS' T cell
clones derived from thyroids nf HT patients has been shown to
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release IFN-y~ (del Prete et aI, 1987) and C04' clones
established~ from the thyroids of both GO and liT
patients produce most or all of the following- cytokincs: IL-2,
lPN-y, IL-6. TGF-B. TNF-Q; and lyaphotoxin (Grubeck-Loebenstcin
at al, 1989) suggesting the lack of clear distincticn of
clones into Thl and Th2 subsets. In contrast, Paschke at ... 1
(1993) failed to detect THF-a in the thyroids of GO patients.
It has been shown that THF-a is cytotoxic for rilt
thyrocytes~ and its effects are potentiated by pre-
incubation with IFN-y (Taverne et aI, 1987), whereas U'N-y
exhibits inconsistent inhibitory effects on thyrocyte survival
(McLachlan et aI, 1990). However, IFN-y (N"gayaIll8 at aI,
1987) and IL-6 (Weetlllan et aI, 1990a: Tominaga et al, 1991)
have been shown to inhibit the TJ and Tg release in response
to TSH. Wilson et al (1990) have shown the pathogenic
potential of XL-lB, as demonstrated by its ability to enhance
the severity of thyroiditis in BB rats. If the~e findings are
confirmed in NT, then 1IIacrophages lIlay be important effoctor
cells in thyroid damage as the major producers of IL-l and
TNF-Q. Both IFN-y and TNF-Q will also modulate Mile class I
and class II expression and contribute to the autoantigen
presentation and T cell reactivity (Seotion 1.5). Moreover,
the potential role of pro inflammatory molecules released by
macrophages, such as oxygen metabolites, prostaglandins, and
leukotrienes, nee~s to be investigdted.
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1.7.2 JUlHbody-••lIiated ti••ue injury
The presence of Tg-specific Abs is a hallmark of E'.T in
anilolals and HT in hu.ans. The role of these anti-Tg Aba in
thyroid disease is not completely understood. Both TPO- and
TSHR-specific Aba are also found in HT patients (Weetman and
McGregor, 1994). It is likely that these Tg- and TPO-speclflc
Aba may mediate complement-mediated tissue injury, and
antibody-dependent cell-mediated cytotoxicity (ADCe) , whereas
TSHR-specific Abs may mediato their pathogenic effoct by
blocldng the binding of TSH to TSIIR.
1.7.2.1 Role of Tg-apecitic Aba
Tg-specific Abs Ilay differ in affinity, ability to
activate the complpJDent system or to cooperate with effector
cells in l!n ADCC &ystem. Jones and Roitt (1961) have
demonstrated, usinq a tanned red cell hemaqglutination (HAl
technique, the existence of low Tg-specific Ab titers in rato
with severe thyroid lesions. Later, Lillehoj and Rose (1982)
confirmed these findings and demonstrated that the titer of 1'g
Abs, as measured by the chromium chloride red cel~ JI"
tecl:.,ique, does not significantly correlate with the severity
or thyroiditis. In contrast, a close correlation was shown
between the titer of anti-Tg Abs and the severity of thyroid
lesions in rats in which autoimmune thyroiditis was induced by
TX-X (Ahme" and Penhale, 1981). using the same rat model of
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thyroiditis, Kotan! et al (1981) showed a dissociation b:!tween
the titer of Tg Abe and the extent of thyroid lesions in
backcrosses of FI hybrids (of high- and lO\<l-responder parental
strains) to either parental strain. Overall, these
experiments suggest that Tq Abs may comprise both pathogenic
and non-pathogenic Abs since Tg Ab titers correlated with
sever! ty of thyroid lesions in some but not in other
experiments. Furthermore, the passive injection of high titer
homologous Tg Abs did not produce thyroid lesions in rats
(Rose et aI, 1973a). A role for anti-Tg Abs was further
excluded by adoptive transfer experiments in rats in which the
transfer of rTg-primed LNC to naive syngeneic rats induced
thyroiditis without concomitant appearance of anti-Tg Abs
(Rose and Molotchnikoff, 1973b).
Similarly, in the mouse EAT model using high responder
mouse strains, a lack of correlation between the titer of Tg
Abs and severity of thyroid lesions has been demonstrated
(Vladutiu and Rose, 1972; Esquivel et aI, 1977).
Interestingly, Vladutiu (1982) showed that cyclophosphamide
treated low-responder C578L/6 mice compared to untreated
control mice had suppressed Tg l\b titers with a concomitant
increase in the severity of thyroid lesions. In contrast to
the serum transfer experiments in rats (Rose et aI, 1973a),
passive immunization of mice with anti-Tg antiserum (Vladutiu
and Rose, 1971b; clagget et aI, 1974a; Tomazic et aI, 1975)
7'
induced thyroid lesions. These data indicate that this organ
is accessible to anti-Tg Abs and aut~antibodies to Tg playa
role in the induction of th}'roid lesions.
It has been shown in Tg-induced mouse EAT that 63\ of
anti-1gM treated (B-cell depleted) mice had moderate tc? severe
thyroid lesions when compared to 88\ of irrelevant Ab-treated
control mice (Vladutiu, 1989). These a-cell depleted mice
showed a reduction in Ab titers. These data suggested that Tg
Abs are not necessary for the dovelopment of thyroid leGions
and further raised doubts about the pathogenic role for Tg
Abs. However, it should be noted that B cell depletion in
these mice was not complete. In contrast, Rayfield et a1
(1989) has induced a full B-cell deficiency in two CBA mice by
injecting anti-IgM serum from birth. These mice developed
less severe thyroiditis without concomitant induction of '1'g
Abs after immunization with Tg. These results suggested that
thyroid lesions can be induced in the absence of B cells.
However, B cells may playa role in lnct'easing the severity of
the disease. Another possibility is that Tg Abs may cooperate
wIth 'tg-primed WC and enhance/potentiate the severity of
thyroiditis in rats and mice.
More recently, a slight reduction in the severity of
lymphocytic EAT has been shown by adoptive injection either of
B cell depleted mTg-primed WC cultures or of mTg-primed LNC
into mice that were pretreated with anti-I-Ak Abs. In
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contrast, the same approach drastically reduced the severity
and incidence of granulollatous EAT in recipient mice. In the
sallIc study. it has been shown that challcnqe of .ice that were
treated with anti-I-At Abs developed lowered Tg Ab titers and
) eSB severe granulomlltous thyroid lesions. These data
suggested that anti-Tg Abs having unique
function/specificity or thyroid-infiltrating B cells lire
required tor the development ot granulomatous but not
lymphocytic EAT (Brll1ey-Hullen et aI, 1994b). In that regard,
recently it has been shown that anti-Tg Aba from HT pBtients
possess catalytic activity as assessed in 50S electrophoresis
gels by their ability to lyse radio labelled Tg into several
smaller sized fragments. Thus, by virtue of catalytic
activity. these Abs lIay affect the generation of thyroid
hormones (Li et aI, 199~).
1..7.2.2 ThyroU cytotallic antibo4i•• : ca.pI•••nt-••diatecS
injury
One potential mechanism far thyroid cell damage is Ab-
mediated complement activation. It is thought to be a
particular property of TPO-specific Abs (Khoury at aI, 1981).
In expert.ental ani.ala: It should be noted that
cytotoxic Tg Abs have not been demonstrated in AlTO, and in
fact, only cytotoxic thyroid Abs specific for TPO have been
demonstrated (Pulvertaft et aI, 1959). ThUS, whether or not
7.
compleaent plays ill role in Tg-induced EAT 1a controversial.
Nakamura and Weigle (1968) shO\oled that coltplellent deficient
Ilice developed EAT after immunization with a mixture of
heterologous Tq without adjuvant, suggesting that complelllent
was not necessary for the development of EAT. In contrast,
the absence of Tg-specific Abs in recipient rats that were
injected with Tg-primed LNC has been demonstrated by adoptive
transfer experiments (Rose et aI, 197Jb). However, the
complement level in the recipient rats decreased 7 days post-
transfer, but this decrease wa!! not observed after transfer o(
albumin-primed LNC. suggesting that a complement-mediated
cytotoxic mechanism may be invoved in thyroid destruction.
clagget et al (1974a) demonstrated a correlation of amount and
temporal appearancQ of Tg Mbs with the occurrence of irRlllune
complexes at the basal area of thyrocytes in A/J mice that
received a mixture of heterologous Tq without adjuvant.
Histological exaainlltion of the thyroids revealed neutrophil
and mononuclear cell infiltration. Recently, Inoue et al
(1993) demonstrated the importance of late complement
components in Tg-!nduced EAT in rabbits. Rabbits deficient
in sixth complement component did not develop severo
thyroiditis, whereas normocomplementic rabbIts developed
severe thyroiditis subsequent to Tg + croll. challenge.
In 8T and OD patients I Several lines of evidence
sU9g-est a major role for complement-rixing Abs against TPO in
mediating thyrocyte damilge.
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Anti-Tg Abs do not fix
complement, probably due to widely spaced epitopes on the Ag
which prevent IgG cross-linking (Adler et aI, 1984). The
complement fixing properties of TSAbs are unknown. The
presence of immune complexes associated with complement
deposition has beAn observed on the thyroid follicular
basement membrane (Werner et aI, 1972) and has been confirmed
by Weetman et al (1989a). The latter authors also
demonstrated elevated lovels of serum terminal complemont
component (TCC) concentrations, a factor associated with
disease activity. Chiovato et al (1993) using slCr-release
assay in which rabbit serum was used as a complement source,
demonstrated that TPO h the target for thyroid-cytotoxic Abs
and suggested the involve.ment of other thyroid Ags because
preadsorption of HT patients' sera with TPO did not completely
abrogate the cytotoxic activity.
It should be noted that, like most nucleated cells,
thyrocytes are resistant to homologous complement-mediated
lysis (Morgan, 1989). This was shown to be mediated in part
due to the expression of CD59 and the membrane attack complex
(MAC) inhibitory protein/homologous restriction factor (HRF)
by thyrocytes which prevent the insertion or the !inal
complement components into the cell membrane. Blocking CDS9
greatly increased thyrocyte killing by complement .1n....Y.1..tI:
(Tandon et ai, I992b). In contrast, the release of cytokines
"
such as IL-l, IFN-y and TNF-CI can increase the expression of
CD59 and HRF in HT patients and, by preventing MAC formation,
may render the thyrocytes resistant to complement-mediated
cell lysis. However, nonlethal MAC formation (sublethal
complement attack) has been shown to inhibit thyrocyte
function, causing the suppression of the cAMP response to
stimuli such as TSH and TSAb (Weetman et aI, 1990b). This
sublethal complement attack on thyrocytes causes them to
release a range of pro!nflammatory molecules such as H.-I, IL-
6, prostaglandins E2 , and oxygen radicals. These may be
important in causing injury to thyrocytes leading to further
infiltration by and activation ot: lymphocytes. It is possible
that scavenging of such oxygen radicals by antithyroid drugs
and by antioxidants administered experimentally explains the
amelioration of thyroiditis observed with these agents
(weetman et aI, 1984b; Bagchi et al, 1990).
1.7.2.3
(ADCC)
Antibody-dependent cell-IlU!ldiated cytotoxicity
1I.bs may also participate in 1I.DCC by binding to cell
surface 1I.g9, thereby allowing N'K cells to kill target cella
via Fe receptor interaction with the bound Ab. 1I.DCC is
measured by 51cr-release assay. There are conflicting results
regarding the role of 1I.DCC in the pathogenesis of AlTO.
Bogner et al (1984) demonstrated that normal lymphocytes,
7'
incubated with thyrocytes and HT patient sera Jdlled
thyrocytes at least two times more effectively than control
The authors also have shown a strong positive
correlation between the degree of lysis produced and the anti-
TPO Ab titer and that anti-Tg Abs do not participate in ADec.
In contrast, subsequent studies from the same research group
did not demonstrate a correlation between the degree of lysis
and anti-TPO Ab titers suggesting that Aba specific for
unknown thyroid Ags also contribute to ADec in a high
proportion of patients (Bogner et aI, 1990). In one study,
39\ of HT patients contained thyroid cytotoxic Abs in their
sera (Bogner at aI, 1995) I ",hereas others have failed to
detect ADeC using HT patient sera (Sacks et aI, 1986). Thus,
it is likely that differences in 1\DCC observed by different
research groups might be attributed to variation in the degree
of thyroid 1\9 expression by the thyrocytes used in the assays.
Therefore, the exact role at the ADCC mechanism in the
pathogenesis of HT is uncertain.
1.1.2.4 Thyroid stimulating blocking antibodies (TSBAba) or
Thyroid StimUlating Antibodies (TBAbs)
The third mechanism by which AAbs can participate in the
thyroid disease pathogenesis is to directly modify cell
function. Anti-TPO Abs have been shown to inhibit the
biological activity of TPO by binding to a catalytic site
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(Weetman et aI, 1987). Blocking the T5H binding site on TSHR
by T5Mb is another notable mechanis.. The existence of these
Abs in 1fT patients has been documented (Tamal et aI, 1991).
Anti-Gal, a natu.ral Ab, may contribute to the pathogenesis of
GO by its lIibility to bind a-galactosyl moities on the TSHR and
to chronically sti.ulate thyrocytes froll GO patients. These
Abe cannot stimulate the thyrocytes from thyrotoxicosis
patients or healthy individuals because the a-galacosyl
moitles are absent on TSHR in these individuals (Winilnd at aI,
1994) •
1.7.3 'l'hyrocyt.. and cytokinea
It is likely that thyrocytes, by their ability to secrete
various inflammatory and proinflammatory cytokines, may either
stimulate T- and/or B- cells or exacerbate the mononuclear
cell infiltration of the thyroid. These calls .ay participato
more actively in the pathogenesis ot thyroid disease than
previously thou9ht. It has been de.onstrated by~
hybridization of IIlRNA that thyrocytes from HT and GO patients
secrete IL-Io: and IL-6, although the IL-lo: synthesis by CD
thyrocytes is not eo constant feature (Miyazaki ct aI, 1989:
Zheng et aI, 1991). Cytokines such as IFN-y and TNF-Q have
been shown to increase the IL-6 production .in...:iJ.t.J:: (Kennedy
and Jones, 1990). Thus, the local release of IL-6 by
thyrocytes seems likely to stimulate both T and B cells.
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Thyrocytes produce IL-a and the production of IL-8 is
stimulated by IL-l and 1s inhibited by IFN-y (W~etman at aI,
1992). At low concentrations, IL-a is a chemoattractant for
lymphocytes, and its local release by thyrocytes may aid in
exacerbating mononuclear cell infiltration of the thyroid.
1.7.4 Thyrooyt•• and Adbesion 1I018cule.
Lymphocytic infiltration of the thyroid gland in
autoimmune thyroid disorders requires, as a first step,
attachment of lymphocytes to endothelial cells (EC) and,
subsequently, their interaction with thyrocytes and
extracellular proteins. cytokines (IL-I, IFN-y, and TNF-aj
secreted by thyrocytes as well as by infiltrating mononuclear
cells aid in the induction of adhesion molecules such as ICAM-
1, which serves as a ligand for LFA-l (Weetman et aI, 1989b).
This ICAM-l expression is absent on thyrocytes under normal
conditions but is induced in thyroid disease (Weetman et al,
1989b: Bagnasco et aI, 1991; Tandon et aI, 1992a). In
contrast, the ICAM-l expression on thyrocytes in GO patients
has not been deloonstrated (Bagnasco et al, 1991). The
functional consequence of ICAM-1 expression by thyrocytes has
been demonstrated by increased binding of lymphocytes to ICAM-
1+ thyrocytes (Weetman et aI, 1989b) and increased NK and T
cell-mediated cytoxicity against such targets (Weetman et aI,
1990c). These data raise the possibility that thyroid cells
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may be killed by cell-mediated cytotoxicity. Interact:l.on of
thyroid cell ICAM-l with LFA-l on lymphocytel'l will also lead
to activation of the latter. Recently. it has been
demonstrated by flow cytometry and immunohistochemical
techniques, that TEe express ICAM-l and VCAM-l, suggesting
that the LFA-l/ICAM-l, and ICAH-J and VLh-4/VCl\M-l pathways
could playa relev::.nt role in localizing and perpetuating the
autoimmune response in autoimmune thyroid disorderfJ
(Marazuela at aI, 1994). The expression of these adhesion
molecules on thyrocytes and on endothelium will aid in
migration and homing of autoreactive lymphocytes to the target
organ.
1.7.5 'l'hyrooyt1ll8 and hea.t shook proteinll (hap)
In addition to the secretion of cytokines and expression
of adhesion molecules, thyrocytes in human thyroid disease (HT
and GD) also express hsp-72 (Keufelder et aI, 1991). In that
study, it has been sho'Wn that hsp-60 and hsp-70 do not playa
role in autoimmunization, since T cell reactivity to hsp-60
and hsp-10 on TEe does not appear to occur.
In conclusion, it appears that the pathogenesis of tiT and
GO is a complex interaction of several mechanisms and needs
further extensive investigation.
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1.8 llIUllunotherapy ot AlTD
Various attempts, thyroid Ag-specific and non-specific,
nave been made to modulate the host' 5 inunune response in order
to treat thyroid disease in susceptible animals and in humans.
Specific methods of EAT prevention include injection, before
active imlllunization or adaptive transfer, of soluble thyroid
Ag5, irradiated Tg-specific T cells, or anti-idiotypic lobs
(anti-Id ."hs) specific to the TCR of Tg-specific T cells or to
Tg Abs, or anti-TCR VB Abs. Non-specific methods include the
usa of anti-class II MHC Aba, anti-thyroid drugs, cytokines or
;:\nti-cytokine Abs, sex hornlones. anti-CD4 and anti-adhesion
molecule Abs. Therapies that inhibit the hormonal secretion
of the target organs, and/or modulate immunity by therapy with
isohormone, have also been attempted in the suppression of
AlTO.
1.8.1 specific lIUIuno8uppre38ion
1.8.1.1 'l'hyroilS Aqs as illlllunotberapeuticl!J
This approach entails the use of organ-specific Ags such
as Tg or thyroid extract. An initial set of experiments
revealed that injection of guinea pigs with soluble thyroid
extract in saline before or after immunization with thyroid
extract in CFA delayed the onset of thyroiditis but did not
influence its incidence or severity (Jankovic and Flax, 1963).
The efficiency of this approach has been reexamined by
8'
Silverman and Rose (1974b) who demonstrated that i.
injection of soluble thyroid extract suppressed the
development of SAT in aUF rats. These authors suggested that
suppression might have been due to the induction of either
tolerance or immune deviation. Later, Whitmore and Irvine
(1977) were also able to prevent the development of Tx-X-
induced EAT by L p. injection of a crude thyroid extra-:..:t 1n
saline in PVG/c rats. The protection was Aq-speclflc because
rats that were injected with liver extract as the tolerogen
developed thyroid disease SUbsequent to 'fg challenge. The
treatment was effective only when rats "'ere injected with
soluble Tg extract during the course of irradiation or before
but not after the onset of thyroiditis. These authors
suggested that this immunization might have evoked suppressor
(Ts) T cells. The differences observed in the results
reported in guinea pigs and rats may be attriLutcd to the dose
or route of Ag or variations in the immunization schedules
followed.
EAT prevention with soluble Tg has also been achieved in
geneticallY susceptible strains of mice through augmentation
of cirCUlatory Tg by L v. injection of deaggregated exogenous
mTg (}(ong et aI, 1932) or through physiological stimulation of
the thyroid gland by infusing with TSH or thyrotropin-
releasing hormone (TRH) before immunization with Tg (I.,awis ct
aI, 1987; }(ong et aI, 151851). The suppression was shown to be
'5
linked to a ~ 2-J day increase in circulatory Tg levels and
wa=- transferred by CD4' but not COS· T cells of tolerant
anillals since pretreat.ant of splenic cells with anti-CD4 but
not anti-CDS Aba could abrogate the adoptive transfer of this
suppressor function of spIan!.:: cells (Parish at .11.1, 1988 ~ Kong
et aI, 1989). Interestingly, Tg- and TSH-induced suppression
was effective in preventing the afferAnt- (EAT induced by
direct challenge with mTg in CFA) but not the efferent-· (E1r.T
induced by adoptive transfer of mTg-primed spleen cells) phase
of EAT (Fuller et aI, 1993). These findings support the
prevailing contention in thyroid autoimmunity that circulatory
mTq serves It physiologic role in maintaining self-tolerance by
:.ustaining low levels of Ts activation and that additional
elevation above baseline increases and prolongs resistance to
EAT induction. It is unclear, whether the disease prevention
by elevated Tg levels in the cirCUlation occurs via the
generation of the Th2 cells that secrete suppressive/anti-
inflammatory cytokines such as IL-IO/IL-4 (Burstein et aI,
1991) or regulatory/suppressor T cells that secrete TGF-B, or
through the induction of clonal anergy Le., the tolerization
of Thl cells that secrete IL-2/IFN-y (Dewit et aI, 1992;
Burstein et aI, 1991). For that matter, it is not
established whether EAT in mice or rats is a Thl- or Th2-
mediatec1. disease. The disease is transferrable by IL-2
secreting T c~lls (Hutchings et al, 1992; Sugihara et aI,
8.
1993). On the other hand, the disease is aggravated by anti-
IL-2 receptor MAb (Braley-Mullen at ai, 1991) or anti-IFN-y
MAb (Stull at aI, 1992). Interestingly, Zerubavel-Weiss et ill
(1992) demonstrated that Tg-specific Th2 cell lines can
adoptively trllonsfer EAT to naive recipient mice. Though these
methods have not yet been applied to other thyroid Ags such as
TPO and TSHR, it is possible that induction of tolerance to
autoantigen may others through bystander
suppression, a finding observed in the EAE model. If this is
correct, this approach might even be successful in a disease
in which the exact autoantigen is unknown if another protein
from the target tissue is administered (AI-Sabbagh et aI,
1994). Moreover, it solves a major conceptual problem related
to designing 1\g- or T-cell specific therapy of inflammatory
autoimmune diseases such as human thyroid disease in which
autoreactivity is directed to multiple Ags (Tg, TPO, TSIlRj in
the target tissue. More recently, it has been demonstrated
that oral administration of Tg prior to challenge "'ith Tg in
CFA reduced the intensity of both humoral and cellular immune
responses and severity of thyroiditis but did not completely
protect the mice from thyroiditis (Guimaraes et aI, 1995).
However, the mechanisms of immunosuppression were not studied.
It was suggested that THO cells might have been tolerized.
It has also been shown that EAT suppression could be
induced by pretreatment of animals either with guinea pig Tg
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(gpTq) in IPA (Braley-Mullen et aI, 1978) or with Lv.
injection of Tg-coated syngeneic spleen cells (Braley-Mullen
at aI, 1980). The mechanism(s) by which these regimens confer
protection in mice has not been investigated, but the
lovalvement of T cell anergy analogous to the one reported in
the MBP-induced EAE model has been suggested (Gaur et aI,
1992; Kennedy et aI, 19908 and 1990b). The efficiency of
these various methods remains to be tested in patients with
AlTO.
1.8. 1. 2 Monoclonal antibodies (MAba I to CD.
Stull at al (1988) have shown by adoptive transfer
experiments that EAT in suscoptible strains of mice can be
abrogated by injecting depleting anti-CD4 MAb either at the
time of or 19 days after the transfer of mTg-primed LoNe to
recipient mice (only two time points were studied). More
recently I Hutchings et al (1993) using the llIurine EAT model,
demonstrated that injection of non-depleting anti-C04 MAb at
the time of immunization with Tg and adjuvant prevented the
induction of both thyroiditis and AAb response. This
protection was transfera~le and appeared to be both Ag-
specific and Ag-dependent. This regimen did not affect the
immune response to exogenous Ags. The kinetics and
immunobiology of the therapy suggest that this approach has
great therapeutic potential for AlTO. It would be interesting
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to use a synthetic analogue of the CD4 protein surface to
inhibit EAT development since such a regimen has been shown to
suppress EAE in mice effectively without depletion of the CD4°
subset and without inherent inununogenicity of an Ab (Jameson
at aI, 1994).
1.8.1.3 TCR-baud 8trategi••
It has been shown that rats can be vaccinated against
subsequent induction of active EAE (Ben-Nun at aI, 1981) or
adjuvant arthritis (AA) (Holoshitz et aI, 1983) by injecting
them with irradiated autoreactive pathogenic T cell lines
under suitable conditions. SUbsequently, Maron et al (19B3)
have extended these findings to prevent Tg-lnduced EAT in
mice. In that stUdy, it has been demonstrated that injectir.:n
of mice with irradiated, activat.ed mTg-specific CD4', CDS' T
cell clones/lines can protect them from subsequent EA'l'
development produced either by active immunization with Tg or
by adoptive transfer of a Tg-specific pathogenic T cell line.
However. anti-Tg Ab levels in vaccinated mice were not
altered. demonstrating the lack of a correlation between EAT
and anti -Tg AD levels. The mechanisms of resistance tnat are
activated by vaccination have not been elucidated fully,
although, III role either for anti-clonotypic Mba directed
against the TCR or for Ts cells has been suggested (Maron et
aI, 1983).
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Remy et a1 (1989) have employed a cloned MHC class 1-
restricted Tg-speciflc CTL hybridoma that recognizes
determinants within a 40mer path09'enic Tg peptide as therapy
in mice (Texier et aI, 1992). Vaccination of mice with
irradiationM attenuated CTLs was shown to prevent development
of EAT, through the induction of anti-idiotypic Ab (Ab2B) that
recognizes the paratope of an anti-Tg MAb (Abl) specific to
the pathogenic epitope of the Tg molecule or through the
generation of anti-clonotyp!c Abs (Roubaty et aI, 1990). In
contrast, Flynn and Kong (1991) demonstrated that the T-cell
vaccination induced protection to Tg-!nduced EAT in mice
operates through the generation of both suppressor/regulatory
CD4' and CDS' T cells. Recently, Charrierets group has
described one anti-clonotypic Ab that reacts with the TCR of
the class I-restricted Tg-specific CTL hybridoma and is able
to protect mice against the development of EAT When given
parenterally one day before immunization with tryptic
fragments of Tg (Texier et aI, 1992). These data indicate
that induction of anti-clonotypic A1:Is to Tq-specific T cells
is one of the potential Jlechanisms of the protective immunity
against EAT. Analogous Abs directed against specific v
regions are protective in EAE, and this may be a potential
approach to immunotherapy in situations such as human thyroid
disease although the feasibility of this approach has been a
matter of debate (Davies et aI, 1991: Davies et aI, 1992). It
should also be noted that irradiated thyroiditogenic Tg-
specific T cells failed to protect C57BL/6 mice against
SUbsequent challenge with Tg + CFA (Zerubavel-Weiss et aI,
1992) thus further raising the questions regarding the
feasibility of T cell vaccination as an approach to treat
thyroid disease.
1.8.2 cytokine-directed iDmunotherapy
Some recombinant cytokines, by virtue of their
immunosuppressive properties, may provide an alternative to
specific imrr.unotherapy of autoimmune diseases. It has not been
established which cytoldnes are of prime importance either in
human or in animal models of thyroid disease, although various
t}'pes of cytokines have been shown to playa crucial role in
the immunopathogenesis of autoimmune thyroiditis (reviewed in
Weetman and McGregor, 1994). Several reports have addressed
the immunotherapeutic potential of cytokines in AlTO.
Injection of neutralidng MAb to U'N-y has been shown to
prevent Tg-induced EAT by decreasing the number of Tg-specific
coa+ T cells (Tang et aI, 1993). These findings are an
extension of earlier studies where l1L...YiY2 treatment with
anti-IFNy MAb exerted beneficial effects on the development or
course of autoimmune diseases in animal models of type-1
diabetes (Cockfield et aI, 1989) and of systemic lupus
erythematosus (SLE) (Jacob et aI, 1987). In contrast, anti-
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IFNy MAb treatment exacerbated the symptoms of MBP-induced El.F.
(Biliau et aI, 1988) and heterogeneously modulated the course
of adjuvant-induced arthritis eM) (Jacob et aI, 1989;
Bolssier et aI, 1995).
Th2 cytokines, IL-4 and IL-IO, under identical
experimental conditions exhibit diverse effects by
exacerbating or weakening of cytotoxic mTg-specific T cell
reactivity and maintenance or attenuation of sUbsequent
transferred EAT (Mignon-Godfrey et aI, 1995a). The
immunotherapeutic potential of IL-IO has been demonstrated by
its ability to treat both early-phase and established-phase
EAT in mice (Mignon-Goefroy et aI, 1995b). These findings are
extensions of previous results reported in various animal
models of autoimmune diseases such as EAE in rats (Rott et aI,
1994), and diabetes in NOD mice (pennline et aI, 1994). The
therapeutic effect of IL-lO was reported to be through
enhanced T cell death (apoptosis), since a reduction of up to
40 to 50% in CD4' and COS· lYl'i'lphoblastoid spleen cells was
observed in IL-lo-treated mice (Mignon-Goefroy et al, 1995b).
In contrast, no reduction in Tg-specific Ab levels was
reported in either experimental or control groups indicating
that the Th cell compartment at least was not affected. These
findings contrast with the results obtained in anti-IFNy
treated mice wherain Tg-specific Ab titers were reduced (Tang
et aI, 1993) indicating differences in the cyto)t!ne-mediated
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immunoprotection mechanislis.
In contrast to the studies of Tang et a1 (1993), it has
been shown that culture of IllTg-primed CD4· splenic T cells 1n
the presence of lllTg and anti-IFNy or anti-IL-2 receptor MAb
augmented the development of thyroiditis and anti-rnTg Ab
responses in mice on adoptive transfer, although this
treatment had been anticipated to neutralize Thl cytokine and
there by exert protective effects (Braley-Mullen et aI, 1991:
Stull et aI, 1992). These various studies indicate that IFN-y
possesses either pathogenic or protective role. Thus, the
effects of cytokine therapy may not be as siJlple as predicted
and the observed capac!ties of cytokines to exacerbate disease
limits their use as immunotherapeutics for human thyroid
disease. In thyroid autoinununity, Widder et al (1991) have
shown that TGF-6 suppresses the ..In.....Yi..t. proliferation of
intrathyroidal T cells from GO patients in response to lectin,
IL-2, or autoloqous thyrocytes. TGF-B has been sho....n to exert
a direct inhibitory effect on autoantigen and class II
expression by thyrocytes. However, its utility as
immunotherapeutic agent has not been tried~ in HT
patients or in animal models of AlTO.
1.8.3 MHe-band st.rateqies
Based on the findings that the I-A SUbregion of the H-2
complex has a major influence on Tg-induced EAT (section
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1.3.1), Vladutiu and steinman (1987) have demonstrated that
injection of anti-I-A MAbs of appropriate MHC specificity
before antigenic challenge with Tg and CFA, results in the
total prevention of the development of thyrof,l.' lesions and
anti-Tg Mbs. When mice were injected with anti-class II MHC
Aba after Tg challenge, the severity of EAT and the titers of
anti-Tg Mbs were decreased but not completely suppressed.
These findings were attributed to B cell depletion since these
Abs seem to exert cytotoxic effects on B cells (Vladutiu and
steinman, 1987).
1.8." sex hOnlone (a}-based strategiea
Based on the findings that sex hormones influence the
susceptibility of various animal species to thyroiditis
(reviewed in section 1.6.2.:1:), their capacity to treat thyroid
disease has been tested. Ahmed et al (1986) demonstrated the
beneficial effect of testosterone injected into PVG/c rats
with chronic thyroiditis. There was a reduction in the
severity and incidence of thyroiditis but not in the anti-Tg
Ab titers.
1.8.5 IIIohorJIol1al tberapy
Therapeutic approaches directed at modulating the
feedback regUlation of target cell activity have been
reported. Takasu et al (1990) reported that those patients
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with HT treated with thyroxine (which lowers T5K levels)
remained euthyroid for 1·8 years after the thyroxine treatment
was stopped. Over 20% of the patients with hypothyroidism
after HT may recover satisfactory thyroid function, and can be
identified during thyroxine treatment by their thyroid
response to T5K in a TRH test. Kampe at al (1990) also
reported that administration of L-thyroxine in women with
postpartum thyroiditis (positive for anti-TPO Abs) prevented
hypothyroid symptoms I but did not a1 tar the course of
postpartum thyroiditIs. It has further been shown that
supranormal serum T4 concentration l,as a significant
suppressive effect on peripheral blood NK cell activity, and
on IL-2 production by T cells to PHA in humans (papic et ai,
1987). Excess T4 interfered with the release of lytic factors
from NK cells in mice (Stein-strellein et aI, 1987).
convincing data on the immunosuppressive effect of T4 has
also been demonstrated in BB rats that are known to develop
SAT. Treatment of BB rats with thyroxine for 3-4 months
resulted in a reduction in Ab titers to Tg and TPO, and
significantlY lowered the frequency of lymphocytic thyroiditis
(13%~ 45t in treated~ untreated controls) (Banovac
et aI, 1988). However, treatment of 5B rats with T4 and
iodide has been shown not to significantly change the
incidence of lymphocytic t.hyroiditis (Reinhardt et aI, 1987).
These results are in contrast with the previous findings
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reported by weetman et al (1982) wherein the authors
demonstrated the absence of any therapeutic effect of T4 on Tg
+ CFA induced EAT in AUG rats except that TSH levels were
brought to normal levels. This suggested that pathogenesis of
autoimmune thyroiditis is independent of thyrC':.\.d hormone
secretion.
1.8.' Konoclonal antibodies (HAbel to adbesion _al.oules as
illllllunotherapeuticlI
Accumulating evidence suggests that cytokine-induced
expression of adhesion molecules on endothelium and thyrocytes
is an essential step in the migration and homing of
autoreactive T cells to the target organ of autoimmune attack
(reviewed in Weetman and McGregor, 1994). Metcalfe at al
(1993) demonstrated the efficacy of MAbs with specificity for
ICAH-l and LFA-l. In that study, the authors sho....ed that
administration of either of these MAbs significantly reduced
the severity of lymphocytic infiltration in Tg-induced EAT in
rats suggesting that these MAbs appear to inhibit cell-
mediated autoimmunity ~.
1.8.7 Global i_l,lDOauppr••sive regimeD
Recently, it has been shown that treatment of CBA mice
with a novel immunosuppressive drug from day -2 to day +28
after immunization with Tg suppressed the development of
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thyroiditis and Tgw5~ecific Ab titers in a dose-dependent
manner (Nicoletti et aI, 1994). The immunosuppressive effects
of FK 506 was shown by Tamura et 81 (1993) in Tx-X-induced EA.T
in PVG/c rats and was suggested to be due to its capacity to
interfere with CD4+ T lymphocyte function and adhesion
molecule-dependent cytotoxic effector mechanisms.
Overall, the Ag-driven peripherl..l tolerance may serve as
an effective Immunotherapeutjc appro..:ch to treat EA.T. This
model subsequently may provide the basis for immunotherapy of
human autoimmune thyroid disease.
1.' su-ary and .tate••nt or object.iv..
1.9.1 Buaaary
Major achievements have been made in the mo~ecular
characterization ot the three major autoantigens that may be
invo~ved in autoi1'lUllune thyroid disease and this in turn has
facilitated the identification of T- and B-cell. epitopes of
these three thyroid Ags. specific data on T cell epitope
mapping .... i thin Tg so far have come from mouse EAT studies,
whereas Tg opitopes recognized by intrathyroidal T colIs from
AT paticnts have not been identified. In contrast to the.
progress made in Tg-induced EAT, little progress has been made
in identifying the epitopes recognized by autoreactive T- and
B-cells in the animal models of spontaneous thyroid disease.
some progress has been made with respect to T- and e-c<!ll.
epitopt~ mapping within TPO in both human thyroid disease lind
animal models of EAT. After cloning of TSHR, rapid progress
has been made in delineation of both T- and B-cell l:!pitopes
within TSHR associated with Graves I disease and animal models.
Heterologous epitopes of either human, porcine or rat Tg
origin have been used to induce EAT in mice because the
molecular structure ot mouse Tg is not known. It is not clear
if the disease induction was due either to the true
recognition of the conservad Tg determinants or to the
presence of xenogeneic determinants. Attempts have not been
made to address thl:! immunopathogenicity of these Tg epitopes
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in a homologous species, for example in rat EAT. Though it
has been shown that Tg contains dominant B epitopes, their
nature and location remain mostly undefined. Moreover, the
factors that influence Tgs to elicit IgG responses to distinct
epitopes are unknown, although iodination of Tg has been shown
to influence the T cell autoreactivity. Tg-specific CD4' and
COS+ T cells have been shown to playa major role as mediators
of thyroid disease in mice. However, it has not yet been
clearly established in Tg-induced rat EAT whether the disease
can be mediated by C04' or CDS' T cells alone or in
combination. In addition, the role of these T cells in the
immunopathogenesis of human thyroid disease is unknown and
needs further extensive investigation. The role for Tg~
specific Aba in thyroid disease remains controversial but
their contribution towards the thyroid pathology warrants
further investigation.
The etiopathogenesis of human thyroid disease rell'la ins
elusive. Despite molecular developments in HLA analysis,
there have been no really major improvements in our
understanding of the immunogenetics of thyroid autoimmunity.
The existing data suggest that non-MHC genes play an important
role in susceptibility. In addition, the importance of
environmental and endogenous factors in modulating the thyroid
disease is recognized, and the role of viruses in thyroid
pathology is circumstantial.
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Several studies have demonstrated that thyrocytes
activate autoreactive T cells. It is not known whether class
II' thyrocytes by themselves or in association with dendritic
cells by presenting endogenous T cell epitopes of thyroid Aqs
can activate specific CD4+ CDS- ToR a/B+ T cells. Presentation
af Immunodominant Tg epitopes by primary thyroid culture
(thyrocyte::.) has been reported, but little is known on the
presentation of non-dominant or cryptic Tg epitopes.
Antigen-presentation studies have been hampered by the lack of
knowledge on the nature and location of pathogenic:: Tg epitapes
and by the lack of availability of appropriate tools such as
T cell hybridomas or clones specific for these pathogenic
epitopes and pure thyrocyte populations.
It is now known that TCR VB usage, as demonstrated in
induced and spontaneous models of thyroid disease, by
lntrathyroidal T ceUs specific for Tg or other thyroid 1\gs is
highly heterogenous. These findings indicate that therapeutic
approaches using peptide analogs or anti-TCR VB Abs are
unlikely to be helpfUl in the treatment of AlTO. Oral
tolerance has been recently considered as a potential
immunotherapeutic approach based on the knowledge that T cell
suppression is likely to be mediated by distinct T cell
subsets that secrete different pattern of cytokines.
continued basic and applied research in human thyroid disease
and in animal models in all of the aspects discussed above
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will help in our undarstanding of the etiopathogenesis of AlTO
and of appropriate intervention.
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1.9.2 st.st•••nt of objacU.v••
The project origlnat.!'Id with the general aim of inducing
experimental autoimmune thyroiditis (EAT) with homologous Tg
in mice in the absence of oil-based adjuvants (sllch as CFA),
in order to avoid the adverse effects on the immune system of
these adjuvants. Meanwhile, work was in progress in this
laboratory on inducing EAT with rat 1'9 peptldes in
heterologous species (mice). since knowledge of the
immunopo'lthogenlcity of these Tg peptides in rats is unknown,
I focused my research on the induction of EAT with these rat
Tg peptidcs in homologous species (rats). Based on the
findings during the course of EAT studies in rats, I
subsequently focused on the delineation of inununodomlnant B-
cell epitopes among Tgs of various species, and finally
examined the ability of class II· thyrocytes to activate the
Tg peptide-specific T cells in rats.
The particular aims or Objectives of the studies reported in
this thesis are:
A. To reexamine the adjuvant free-induction of EAT in mice by
targeting soluble Tg -Dnto antigen-presenting cells (APe) using
monoclonal antibodies (MAbs), as delivery vehicles, specific
for M'HC class II molecules expressed on APC.
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B. To investigate the Immunopathogenlcity in rats of It 17mer
homologous Tg peptide (2495 -2511) that has been previoUsly
shown to cause EAT in heterologous species (mice)
(Chronopoulou and carayanniotis, 1992).
c. To examine the Immunopathogenicity in rats of an lamer
homologous Tg peptide (2695-2713) (with respect to its ability
to induce thyroiditis and T- and Brl.:ell responses, and to
determine if rat EAT is a CD4· T cell disease) that has
recently been shown to cause EAT in mice (carayanniotis et a],
1994) •
D. To identify the nature and location of immunodominant Tg:
epitopes associated with thyroid disease in rats and to
examine the factors contributing to variation in relative
immunodominance of these epltopes among heterologous Tg of
various species,
B. To reexamine the original concept proposed by Botazzo et
al (1983) that class II' thyrocytes trigger thyroid antigen-
specific T cells Le" to examine specifically whetheI' class
II" thyrocytes, in the absence of professional APe, can
present an endogenous Tg epitope of a pathoqenic Tg peptide
(2695-2713) to specific rat T cells.
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CHAPTER :2
Material. aDd M.ethods
2.1 Ani••la
Female CBA!J (H_2kj. and C57B6/6J (H_2bj inbred mice were
purchased from The Jackson Laboratory (Bar Harbor, ME) and
were used for immunizations at the age of 6-10 weeks. Female
F344 CRT-It), wr (RT-IU), and WKY CRT-Ik) inbred rats were
purchased from The Harlan Sprague Dawley Inc. (Indianapolis,
IN) and were used for immunizations at the age of 6-7 weeks.
Animals were acclimatized to the animal holding facilities at
least for a week before immunization. All animal care
procedures were carried out according to institutional
regUlations.
2.2 Cell cul~ur•••dia, call lin••, in_truDo.ate, monoolODal
antibodie., and other r._qonts
Cell culture ••dia RPMI-1640 medium (Flow Labs),
Oulbecco's modified Eagle's medium (OMEH) (GIBCO BRL,
Burlington, Ontario, Canada), Ham's modified F-12 medium
(GIBCO BRL) , RPMI-IO (RPMI-1640 medium supplemented with 10\
heat inactivated fetal bovine serum (FBS), 20 mM HEPES, 2 mM
L-glutamine, 100 V/ml p~micillin, 100 ~g/ml streptomycin and
5 x 10-5 M 2-mercaptoethanoll, OMEM-IO is similar to RPMI-IO
except that it contains DMEM instead of RPMI 1640, DHEM-20 is
similar to OMEM-IO except that it contains 20t FBS instead of
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lot PBS, Expansion mediUlII (DMEM-IO containing lOt of filtered
supernatant of Concanavalin A activated F344 rat splenocytes).
Cell lin.. C'I'LL-2 cell line (TIS 214) (Gillis et al,
1977). FRTL-5 cells (CRL 8305) (Ambesi-Impiolllbato at aI,
1980). HB 64 [(M2-1C6-4RJ clone secreting IgGl MAb specific
for matrix protein of the influenza type A virus) (Yewdell at
aI, 1981)]. HB 65 «H16-LIO-4R5 clone secreting IgG2a MAb
specific for nucleoprotein oC influenza type A virus) (Yewdell
et aI, 19B1)]. and TIB 92 [(10-3.6.2 clone secreting IgG2a Ml\b
specific for detertl'llnants expressed on I_Ak) (01 et aI, 1978) l
were obtained from American Type CUlture Collection (ATee
Rockville, MO). BW5147 a'-/S- variant (White et aI, 1989)
a kind gift of Dr. P. Marrack (National Jewish Centre for
Immunology and Respiratory Medicine, Denver, CO).
:Inatruaenta 6 scintillation counter (BeckJD.an Instruments
Inc., Mississauga, Ontario, Canada), BrinkJD.an homogenizer
(Brinkman Instrument, Westbury, NY), FACStar Plus analyzer
(Becton Dickinson, Mountain view, CA), Microplate reader
(Biorad Model 3550), Se1li-automated cell harvester (Skatron
Inc., sterling, VA), TSK 4000SW size-exclusion column (Beckman
Instruments, Toronto, Canada) were used.
Monoclonal alltibo4i•• (MAbs) The following mouse HAbs
(IgGl) specific for various rat T lymphocyte surface markers
were purchased from Serotec Ltd., Toronto, Canada: OX-6 (MeA
461 specific for monomorphic determinants on RTI-B antigens
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(I-A equivalent). OX-17 (HeA 50) specific for monomorphic
determinants on RTI-D antigens (I-E equivalent), W3/25
(specific for CD4 determinants), OX-IS (MeA 51) specific for
monomorphic determinants on RTI-A antigens (MHC class I
equivalent), DX-19 (MCA 52) specific for CD5 antigen expressed
on all T cells, MRC DX-S (MCA 48) specific for CDS
determinants, OX-22 (MeA 53) specific for CD45RcII lgh expressed
on Band T cells, and R73 (MeA 453) specific for constant
determinant of rat TcR VB.
other r.agents The followIng reagents were used.
Alkaline phosphatase-conjugated goat anti-rat IgG (Fc
specific) (Sigma Chemical Company, st. Louis, MO), alkaline
phosphatase-conjugated goat anti-mouse IgG (FC specific)
(Sigma), heat-killed Bordetella pertussis organisms (Ditco
Laboratories, Detroit, Michigan), bovine serum albumin
Fraction V (BSA) (Sigma), complete Freund's adjuvant (CFA)
(containing Mycobacterium butyricum) (oitco, Detroit,
Michigan), concanavalin A (Can A) (Boehringer Mannheim, Laval,
Quebec, Canada), diethanolamine (BDH Chemical Ltd., England),
EDTA (GIBCO BRL), fetal bovine serum (FBS) (Bioproducts for
science, Indianapolis, IN.), ficoll-paque (Pharmacia LKB
Biotechnology, Baie d'Urfe', Quebec, Canada), F(ab'h
fragment (Fab specific) of goat anti-mouse IgG-FITC conjugate
(sigma), fungizone (GIBCO BRL), glycine (Fisher scientific,
Toronto, Canada), glutaraldehyde (sigma), hypoxanthine,
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aminopterin, thymidine (HAT) (s!qma). Hank's balanced salt
solution (RSSS) (GISCO BRL). HEPES (GIBCO BRL). hypoxanthine,
thymidine (HT) (sigma), incollplete Freund's adjuvant (IFA)
COHea). polyethylene glycol 1500 (PEG 1500) (Boehringer
MannheitD, Indianapolis, IN). 24-well. Uat-bottoJlled cell
culture plates (Nunc, Denmark), 96 w well, flat-bottomed
polyvinyl chloride (PVC) IIIleroUter plates (Dynatech
Laboratories, Chantilly, VA), 96-well, flat-bottomed
microt!ter plates (Nunc), L-glutamine (GISCO BRL) , 2-
Mercaptoethanol (Sigma). ovalbumin (Sigma), penicillin (GlOCO
BRL), purified protein derivative (PPD) (statens
Serullinstitute, Copenhagen, Denmark). propldium iodido
(Slqma) , protein G sepharose 4 Fast flow affinity
chromatography columns (PharJllacia), recombinant rat lPN-V
(sigma), sepharose CL 4B (PharJllacial, sodiutl azide (8oH
Chemical Ltd, England), streptomycin (GIBCO BRL) , 3H-thymidlne
(6.7 Ci/lUllol, ICN Radlocheldcals, Misslsauga, Canada), ICR
Douse or Sprague-DaWley rat thyroid glands (Bioproducts tor
Science, Inc., Indianapolis, IN), bovine thyroglobulin (bTg)
and porcine thyroglobulin (pTq) purchased in lyophilized form
(Sigma), trypsin (GIBCO 8RL), and tween-20 (DOH).
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2.3 Thyroglobulin ('1'g) peptide.
Tg peptide
Rat TgPl (rTgPl)
Ra t Tg peptide
Rat TgP2 (t'TgP2)
N-terminal 12mer
Amino acid sequence Sequence position
(AC-GLINRAKAVKQFEESQG-amide) 2495-2511
(Ac-TODYASFSRALENATRDY-amide) 2550-2567
(AC-CSFWSKYIQTLKDADGAK-amide) 2695-2713
(Ac-CSFWSKYIQTLK-amide) 2695-2706
c-terminal 12mer (Ac-YIQTLKDADGAK-amlde) 2702-2713
Human TgP2 (hTqP2) (AC-CSFWSKYISSLKTSADGAK-amide) 2695-2713
The peptides were synthesized at :>70\ purity at the
Alberta peptide Institute on an Applied Blosystems (Foster
City, CA, USA) 4301'. synthesizer as described earlier
(Chronopoulou and Carayanniotis, 1992; Carayanniotis et aI,
1994). These peptides were used for .in.....Y.i..Y. or .i:l......Y.i.:
experiments without further purification. For descriptive
purposes, amino acid positions within rat TgPl or TgP2 are
identified by the hTg sequence nUmbering, since the complete
rat Tg (rTq) sequence is unknown (Oi Lauro et aI, 1985).
2.4 PUritication or 1Il0noclonal antibodies an4 thyroglobulin.
Monoclonl:ll antibodies (MAbs) were purified on protein G-
sepharose affinity chromatography columns from cult~lre
supernatants of the hybridoma cell lines TIB 92, HB 64, and HB
'0'
65. The details of the hybridoma cell lines were given under
section 2.2. After extensive dialysis against double-
distilled water, KAbs were lyophilized and storetl at -20°C
until further use. The protein (Ab) concentration was
estimated spectrophotometrically at 280 nm as 1.4 0.0. units
= 1.0 mg/ml.
Mouse thyroglobUlin (mTgl, rat thyroglobulin (rTg) , and
human thyroglobulin (hTg) were purified from frozen thyroids
of outbred ICR mice, Sprague-Oawley rats, and humans,
respectively as described (Chronopoulou and carayanniotis,
1992) (the iodination status of Tgs were not assessed). The
thyroids were homogenized in phosphate bUffer, pH 7.0 and the
supernatant was centrifuged three times at 16,000 X g. After
extensive dialysis against double-distilled water, the 1'9s
were lyophilized and stored at -20°C until further use.
Bovine thyroglobulin (bTg) and porcine thyroglobulin (pTg)
were purchased in lyophilized form (Sigma). The protein (Tg)
concentration was estitnat.ed spectrophotometrically at 280 nm
as I 0.0. unit .. 1 mg/ml.
2.5 preparatioD and pUrifioation of thyroglObulin-monoclonal
antibody (Tg-NAb) ilmunoconjugates
The Tg-MAb immunoconjugateo were prepared as follows.
0.5 mg of mTg was mixed with MAb at 1:8 lIlo~.ar ratio (this
ratio found to be optimal) in 1 ml PBS (pH 7.4). Later, an
10.
equal volume of freshly made 0.3\ (W!V) glutaraldehyde was
added drop wise to the protein solution. This was followed by
gentle stirring for 2 hr at room temperature. The reaction was
stopped by the addition of 0.25 ml of 2 M glycine. Later, the
reaction mixture was extensively dialysed against PBS at 4°C,
and centrifuged at 16,000 X 9 for 5 min to remove possible
aggregates. Conjugates were purified by HPLC gel filtration
on a 7.5 x 600 rnm TSI< 4000SW size-exclusion column and were
stored at 4DC until further use.
2.6 I_unia.ticn ot aioe
Priming of female CBA or 86 mice (GIg-roup) was done by
subcu1:aneous (s.c.) injection at the base of the tail of 0.1
ml PBS containing 5 ~~g of the appropriate mTg-MAb conjugate.
In addition, a group of mice (2/group) were injected with 0.1
ml of complete Freund's adjuvant (CFA) : PBS (1:1) emulsion
containing 50 IJg flITg. After J weeks, these mice received
booster injection intraper!toneally (Lp.) with 50 PrJ free mTg
in 0.1 ml PBS. Two weeks after the second injection, mice
were bled from the retrobulbar sinus and their sera were
collected and stored in 0.05\ NaN] at -20°C until further
analysis by enzyme-linked immunosorbent assay (ELISA). The
serological analysis of the mice sera for.' mTg-speciric IgG was
done by ELISA as described (Chronopoulou and carayanniotis,
1992) .
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2.7 LJllpbooyta proliferation ••••y
Rats were injected into one hind footpad with 100 pI of
CFA:PBS (1:1) emulsion containing TgPl (200 nmol .. 380 ltg) or
TgP2 (200 nmol "" 420 pg) or Tg (200 J.lg). Fourteen days later,
the animals were sacrificed and popliteal lymph node cells
(LNe) were collected aseptically, washed with RPMI-IO (culture
medium) (section 2.2). After two rounds of washing, " x lOS
cel1s/200 jJi/well were cultured with or without antigen in 96-
well, flat-bottomed microculture plates for 4 days at 37°C in
a 5% CO2, 95% air humidified incubator. Eighteen hours before
harvesting, 1 pC! of 3H-thYJ\lidine eH-TdR) was added to each
well in 25 pI of medium. The cells were harvested onto glass
fibre filters using a semi-automated cell harvester. The
incorporated 'H-TdR was counted in a B scintillation counter.
Proliferation data were expressed in 11 cpm +/- 50 or
stimUlation index (5I) +/- SO. 6cpm was defined 4S (mean cpm
in the presence of antigen minus mean cpm in the absenc"! of
antigen). Stimulation index (5I) was defined as (mean cpm in
the presence of antigen / mean cpm in the absence of antigen).
2.8 AntibOl1y blockin9 atul1i ...
TgPl-primed LNe ....ere obtained by priming ot' different rat
strains with 12.5 nmol TgPl. The method of immunizations and
lymphocyte proliferation assays were as described under
Section 2.7. TgP2-specific T line cells were obtained after
>11
12 days of second .i.n....Y.i..t. boosting with TgP2 as described
under Section 2.12. To inhibit the rat LNC proliferative
response, HAbs such as MRC OX-6, NRC OX-17 and W3!25 were
used. As a control, HB 65 or HB 64 MAb were used. The details
of the /!lAbs were given under section 2.2. All Saratee MAbs
were used at nontoxic concentrations derived from MAb
titration curves on inhibition of Con A stimulation of rat
splenocytes. Inhibition of proliferation by specific blocking
M1I.bs was expressed as \ inhibition or A cpm +/- SO. The \
inhibition was defined as (l-(cpm in the presence of MAb)
(cpm in the absence of MAb» x 100.
2.9 BAT induction with Tg peptid8s ('1'9P1 and TqP2)
Rats were injected SUbcutaneously (s.c.) with 0.2 ml
CFA:PBS (1:1) emulsion containing either 200 nmol pao J.lg)
TgPl or 200 nmol (420 tJg) TgP2. This 0.2 ml emulsion was
divided equally and 100 #1 emulsion was injected at the base
of the tail and the rest of the 100 1.11 emulsion was injected
into one hind footpad. Immediately, these rats were injected
intravenouslY (Lv.) with 3 x 10" Bordetella pertussis
organisms in 0.5 ml PBS since the addit.ional injection of rats
with Bordetella pertussis has been reported to enhance the
severity of EAT caused by Tg plus eFA (Eishi and Mccullagh,
1986b). One week later, the rats were boosted s.c. in the
right flank with 100 nmol (190 J.lg) TgPl or TgP2 in 100 #1
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IFA:PBS emulsion. Three weeks after the second challenge,
rats were ether anaesthtized and bled (2-3 mIs) by cardiac
puncture. The sera were collected and stored in 0.05\ NaN} at
_20oe until further use. Later, the rats were sacrificed and
thyroids were removed and fixed in 10\ buffered formalin for
histopathological examination.
2.10 Histological .x..in.tion of thyroids
Serial sections (JOQ-Soo/thyroid) of rat thyroids were
stained with hematoxylin and eosin by Ed Eve1.'.y (Department of
Anatomy, Faculty of Medicine at this institute). The sections
were scored by the author for mononuclear infiltration
according to a modified method of Twarog and Rose (1970).
Scoring of mouse thyroids for mononuclear infiltration W8E
performed as described (Chronopoulou and carayanniotis, 1992).
The slides were coded as unknowns until the results were
tabulated. The scoring for mononuclear infiltration
expressed as inf.iltration index and was as follows.
Infiltration
index
!Ii area of thyroid infiltrated
with mononuclear cells
No infiltration
0.5 Interstitial accumulation of inflammatory cells
distributed between t~o or more foIl icles
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One or two foc! of inflauatory cells at least the
size of one follicle
ElCtensive Intlltration, 10-40\ of total area
Exten&ivp. inUltration, 40-80\ of total area
Extensive infiltration, >80\ of total area
2. 11 I..uniut1on with thyroglobulin and T9 peptidlls to
IItudy the urological iuunodoainallo8 of 'l'q peptU••
F344 rats (2/groUp) were primed by injecting s.c. with
200 nJlOl (324 pg) If-terminal (2695-2706) or 200 Mol (280 pg)
C-t8nainal (2102-2713) 121ller peptides of r'1'qP2 or with 200
hlllOl (438 1'9) 19ur hTqP2 (2695-2713) or with 1 IIICJ Tq in 0.2
III of CFA:PBS (1:1) eaulslon. 100 pI of o. Z..l en.ulsion was
injected at the base of the tail and the rest vas into one
hind footpad. A week later, the rats were boosted s.c. in the
right flank with 100 pI IF'A:PBS (1:1) e!lulsion containing 100
nlaol of respective peptide or 0.5 ..::j of respective Tg. Three
weeks after the second chalh!nqe, the animals were
anaesthetized and were bled by cardiac puncture. The sera
wet'e collected and stored in O. 5l NaN1 at -20°C until further
2.12 Generation of a 'l'lJP2-.pecific '1' cell lin.
The protocol for the generation of a rT9P2-specific T
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r:ell line(s) was established and was as follows. The T cell
line was generated from draining popliteal LNe of rTgP1,-primed
rats. Briefly, FJ44 rats (2/group) ....ere injected into one
hind footpad with 100 IJI of CFA:PBS (1:1) emulsion containing
100 mnol (210 j.lq) TgP2. Fourteen days later, the popliteal
LNe from these rats were collected and washed thrice with
OMEM-IO medium (Section 2.2). The LNe were boosted~
by culturing 4 x 106 cells/ml with 10 /-I9/ml TgP2 in 24-well
flat-bottomed cell culture plates for 9 days at 37°C in a 10%
COl' 95% air humidified incubator. After the first~
boost, the viable T cells were separated from cell debris by
Ficoll-paque density gradient centrifugation (400g for 30
min). These FlcoH-cut T cells were washed three times with
DMEM-IO and boosted (2nd round) again~ by incubating
T cells at 2.5 x 105/ml with 8 x 106/ml to 10 x l06/ml of
irradiated (2000 rads) syngeneic ·,hymocytes as antigen-
presenting cells (APe) and 10 pg/ml TgP2 in 24-well, flat-
bottomed plates for 4 days. Later, the cell population was
expanded at 1:4 ratio in expansion medium (section 2.2).
After 8-10 days of expansion, the viable T cells were
separated from cell debris by Ficoll-Paque density gradient
centrifugation and washed J times with DMEH-lO. Stimulation
and expansion cycles were followed as above. Ficoll-cut T
cells were SUbjected to specificity and MHC-restriction
assays.
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2.U rAC' ualyd.
The T cell line or 8~UOb 2.12 was stillUlated with TqP2
for 96 hr. then centrifuged over Ficoll-Paque to reaove APC
debris. The T cells were washed three times and stai!1ed by
indirect illlllluno!luorescence technique using aouse PfAbs
specific for COS (pan or cells) (OX-19), CD4 (W3/25). CDS (('X-
8), TCR-a/J! (R7J), RTI-B (I-.\ equivalent) (OX-6), RTI-O (I-E
equiValent) (OX-I?, RTI-A (OX-IS) lind OX-22 (CD45RCIol-1
according to a modified protocol o! C!!Ispi et &1 (1986).
Briefly. B x lOs T cells were washed once with sterile PAB
(phosphate buffer with 0.5' BSA and o.n sodiUll azide).
suspended in 50 ul of 2\ goat serull in PAB (to avoid
SUbsequent non-specific binding of goat anti-JIOuse IgG-PITC
conjugate) and incubated on ice for 30 .in. Later, the cells
vue washed twice lind incubated with the above K.\bs at 1/100
dilution in PAS tor 30 .in on ice. A control group consists
of T line cells incubated with isotype (IqGll-aatched MAb (HB
64). The cells were washed twice and incubated with 50 ~l of
1/80 diluted F(ab l )2 fragment of FITC-conjuqated goat anti-
mouse IgG on ice for JO min. Atter giving two washes, the
cells were suspended in 0.5 ml ot cacodylate butter (pH 7.2)
containing n paraformaldehyde. A similar protocol was
followed for surface phenotyping of T cell hybrldomas. The
cells were then subjected to flow cytolletric analysis ot a
FACStar plus analyzer. A minimum of 10,,,,,0 cells were
11.
counted. The results were expressed as histograllls of relative
cells number YenWi log fluorescence intensity (L. F. I).
2.14 'l'be T Clell liD. apeciflClity a114 MKc-r••triotion ••••y.
The T cell line specificity assay ....as performed as
described elsewhere. (Fling et aI, 1991). Bl"iefly, 104 T
cells/50 III (after 12 days of stimulation) were incubated with
irradiated (2000 rads) syngeneic (F344) or allogeneic (WKY or
WF) rat thymocytes as APe at 106 cells/50 1-11 in the presence
or absence of rTgP2 or hTgP2 peptides or 12mer overlapping
peptides of rTgP2 (section 2.3) or intact rTg in a final
volume of 200 Jjl/well in 96-well. flat-bottomed microculture
plates. The culture medium used was DMEM-IO (Section 2.12).
Later, the cultures were incubated at 37oC/I0\ CO2/95\
humidified air for 72 hr. The cells were pulsed during the
last 18 hr of culture with 1 pCi of 3H- TdR/well in a total
volume of 25 1J.l OHEM medium. The cultures were harvested onto
glass fibre filters and 3H-TdR uptake was assessed in a B
scintillation counter. Proliferative responses were
expressed as SI +/ SO or lIean cpm +/- SO of triplicate
cultures.
2.15 Adoptiv. tranllrer 01' thyroiditis
For adoptive induction of thyroiditis in rats, a protocol
was established. Adoptive EAT was induced by l.p. injection
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of viable rTqP2-primed and rTgP2pboosted LNC at 10' LNCjml
HBSS/rat. These cells were obtained froll F344 rats after 14
days of in.....Ylli2 priming with 100 ~l of CFA:FBS emulsion
containing 100 nllo1 (210 pg) TgP2 and sUbsequent~
boosting with 10 1!9'/ml TgP2 for 3.5 to 4 days. As a control,
F344 rats were primed with 100 ~l eFA: PBS emulsion alone or
containing 200 119 ovalbumin (OVA). Fourteen days later,
pritted LNC were .1n.....YllI2. boosted with 10 119/1111 Con A or 2S
1l9/ml OVA, respectivelY.
In addition, rTqP2-specific T line cells (section 2.12)
were J.n...:illm boosted for 3.5 days at 37°C in a 10\ CO2' 95\
humidified air incubator with 10 1J9/1I1 TgP2 in the presence of
irradiated (2000 rads) syngeneic th.ymocytes as APe. The
viable T cells were separated from dead cells by Ficoll-Pague
density gradient centrifugation and washed three tilles with
HSSS before injected at 10' cells/rat. Rats were sacrificed
10 days post-transfer and thyroids were collected in 10\
buffered formalin for histoloqical examination.
2: .16 Generation of T ot11 hybrido... froa peptL4e-prillled LIC
The T cell hybridollas were generated following a lIOdified
method of Perkins et al (1991). Rats were iWlIllunized by
injecting into one hind footpad 100 nmol (210 Jig) rTgP2 in 100
~l of CFA:PBS (1:1) emulsion. Fourteen to fifteen days later,
the popliteal LNC were collected aseptically and single cell
U8
suspensions were prepared in DMEH-IO culture medium. After
washing thrice with DMEM-IO. 4 x 106 cells/tnl/well were
cultured in a 24-we11, flatMbottomed plates (5) in the presence
of 10 Jig/ml TgP2 at J70c/IO\ CO2/95\ humidified air. Four days
after the first~ boosting with the peptide, viable T
cells were fused with BW5147 Q"/8" at 1:2 ratio (lymphocytes:
tumor cells) by adding 1 ml of PEG 1500. This was followed by
a slow add!ticn of DMEM without FBS and 40 mis DMEM-2 O. The
preparation was incubated for 2 hr at nOe/IO\ COz/95%
humidified air. Subsequently, 40 mis of DMEM-20 containing IX
fungizone (as per specifications) was added. The cell
suspension was plated gently at 100 1J.1/well in 96-wel1, flat-
bottomed microculture p1ates. The cultures were incubated at
J7oe/lo, CO2/9S' humidified air. After 24 hr of incubation,
100 JJ.l of 2X HAT (hypoxanthine, aminopterin, thymidine) was
added/well. Gradually, the cells were changed from HAT to
medium containing hypoxanthine and thymidine and finally to
DMEM-20. Hybridomas usually appeared in micrc'IIells after 7-10
days of cUlturing~ The contents of the wells wit.h T cell
hybridomas showing > 50% con fluency were transferred to 24-
well plates and subsequently screened for TgP2-specificity as
descr ibed under SectioD 2 .18 ~
2.17 Generat.ion and oloninq of If 0.11 hybri4oa.a fro. T Hn.
cells:
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Flcoll-cut cot' rTgP2-specific T line cells were~
boosted with 10 #9/_1 TgP2 in the presence of irradiated
(20001 rad syngeneic thyaic APe for 4 days. The fusion, post-
fusion, ll.nd screening methods were as described under section
2.115. Antiqen-specific T cell hybrldOlll118 were cloned by
limiting dilution at 0.33 cells/lOa #1/....e11 in 96-1Ie11, tlat-
bottomed mlcrocul ture plates using DMEM-20 containing 1\
syngeneic rat RBC suspension. The cultures were incubated at
37oC/IO\ CO2/95' humidified air. The hybridolnll clones started
appearing after 9-10 days of culturing. At this stage, HO ~l
of spent medium was replaced with fresh DMEM-20 and this step
....as repeated 5 days later. When the hybridoaa gro.... th was >50\
confluency, the contents of the welle: froll 96-ve11, flat-
bottomed plates were transferred to 24-well, flat-bottomed
plates and cultured in 1 1111 of DHEM-20. The cells were
subcultured once again and subsequently screened for TgP2-
specificity IllS described under SectioD 2.11.
2.18 'r c.ll b.ybr14oaa .ctivaUoll. aDd. CTLL ••••y.
T cell hybr1dollAs \lere plated at lOs cells/well (in 24 hr
activation assay) or 1.5 x 104/\1811 (1n 48 hr activation
assay) in 96-well, flat-bottomed microculture plates
containing 5 x l.Os/well of irradiated (1500 rad) syngeneic
spleen cells. Live splenocytes froll syngeneic (F344.) or
allogeneic (WKY and tfF) rats were used in the me-restriction
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assay. Glutaraldehyde~fixedcells were prepared according to
the protocol liS described (Shlllonkevitz et aI, 1.983).
preparation of single cell suspensions of thyrocytes (MHC
class II' or MHC class II") was done as described under ••OUOD
2.21. The cultures were incubated with or without antigen
either for 24 hr or 48 hr at J70CjlO% COzl95% humidified all'.
subsequently, 50/.'1 supernatant was transferred from the test
plate to a new plate for IL-2 release assay on the IL-2
dependent CTLL-2 line and frozen for a minimulll of 2 hr at -
?OoC.
CTLL assay was performed in the following manner. After
thawing of the above frozen plates(s), 104 CTLL cells/IOO
/J.ljwell added. The medium used was DMEM-I0. The cUltures
were incubated for 24 hr at 370C/10I CO2/95% humidified air,
pulsed during the last 6 hr of incubation with 1 /-lei/well of
lH-'l'dR. Later, the cells were harvested onto ghss fibre
filters and incorporated lH-TdR was counted in a liquid
scintillation counter. The values were expressed as mean cpm
+/- SO of duplicate or triplicate cultures.
2.19 Dlnot enlya.-linlted. iaaunollorbent ••••y (ELI8".
Serological analysis of peptlde- or rTg-primed rat sera
for peptide- and Tg-specific IgG was performed by a direct
alkaline phosphatase-based ELISA. tfeat denatured Tg was
prepared according to a method of shimojo et a1 (1988) by
boiling an aqueous Tq solution tor 30 ain. '!'tIe wells of 96-
well, rIat-bottaed polyvinyl chloride (PVC) aicrotiter plates
were coated with various antigens (0.2 /£g of 17Jller TgPI or
0.21 ~g of lamer rTgP2 peptide or 8 ~g of the truncated nller
pepti6es of rTgP2 or 0.21 Wi! of hTgP2 or 1. "9 of intact or
heat denatured Tg) in 100 ,,1 of coating bufter (carbonate
buffer, pH 9.6) and incubated at 40C overnight. Ovalbumin was
used as a control antlqen. The plates were v!lahed once with
PBS and ineubatlld with 100 "l/well of serum samples for 1 hr
at roolll temperature (RT). Following three waahes with PBS-
Tween. 100 1£1 or 1/1000 diluted alkaline phosphatase-
conjugated goat anti-rat IqG was 'lashed three times 'lith PBS-
tween and p-phospl\ate liubstrate (1 Jl9/ml in 10'
diethanolalline, 100 pllwelll was added and incubated at RT for
1 hr. The reaction vas ..toppel1 by aMing 25 pI/well of 5N
NaOll. Absorbance of p-nitrophenolato product at 405 nm was
measured using I Microplate reader. The values (experimental
values minus the background values) were expressed as Ilean +/-
SO of duplicate wells. Background values are the values
obtained in the absence of illmunll sera.
2.20 Coap.titiv6 inhibition BLISA
The protocol for cOllpetitive inhibition ELISA was as
follows. The PVC plates were coated. overnight at 40c with 1
~g of intact rTq!well in 100 ,,1 o~ coatil'lC) buffer (carbonate
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buffer, PH 9.6) and then washed once with PBS. The unreactive
sites were blocked with 1\ BSA in PBS tor 2 hr at RT. The
wells were incubated with 50 pI of day 28 TgP-prllDed FJ44 rat
(3/qroup) sera of Table 5.1 at 1/512 dilution per well.
Simultaneously. the plates were incubated vith or without
competitor peptides (TgP2 as specitic competitor; TgPl as non-
specific competitor). The competitor peptides were used at
200 molar excess of rTg coated on the plate. TgP2 (12.6
lAg/mIl or TgPl (11.4 Jj9/ml) or dilution buffer as such 50
/AI/well were added and incubated at RT for 1 hr.
Subsequently, the plates were washed three times with PBS-
Tween and incubated with 100 pI/well ot alkaline phosphatase-
conjugated goat anti-rat IgG at RT tor 1 hr. Later, the
plates were washed three ti.es with PBS-Tween and incubllted
with 100 Jll/vell of substrate solution (s.ction 2.19) at RT
tor 1 hr. The reliction was stopped by adding 25 1-'1/ve11 of 5N
NaOH and O. D. readings at 405 nm were taken. The values
(experimental values minus the lIean background values) WI;.TP
expressed as mean +/- so of triplicate wells.
2.21 Induction and ••••••••Dt ot KH'C 01... II antigen
expression on J'isb.r rat tbyroid .pithelia1 cell line~S (FRTL-
5)
FRTL-S cells were cultured in Ham's modified F-12 medium
supplemented with II six-hormone mix lind 5' F13S (culture
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medium) as described (Ambesi·Impiobato et aI, 1980) .
Induction of HHC class II antigens on FRTL-S cells was
performed following a modified protocol of Platzer et a":'
(1987). Briefly, FRTL-S cells were cultured either in 2S cm2
or in 80 cmz tissue culture flasks and were treated with
recombinant rat interferon-y (IFN-y) at 100 units/ml for 5
days. Later, the cell layer was rinsed once with HBSS and a
cell suspension was prepared by adding 5 to 10 mls of filter
sterilized PEB (PBS containing 0.02' EDTA and U BSA) and
inCUbating- at 37°C for 15 min. The cells were washed
thoroughly with HBSS before use.
MHC class I and II and antigen expression on thyrocytes
waa monitored by immunofluorescence. All washings were done
with washing buffer (PAB) (see section 2.13) at 40C/2500 rpm
for 3 lItin. Briefly, 2.5 x 105 cells were incubated with 50 ~l
of 1/100 diluted 0>:-6 , O>:~17 and OX-IS MADs (SectioD 2.2) on
ice for JO min. As a control, isotype-matched MAb (HB 64) (10
pg/ml stock) was used. The cells were washed three times with
washing buffer and incubated with 50 j.ll of 1180 diluted goat
anti-mouse IgG FITC conjugate on ice for 30 min. Later, the
cells were washed three times as above and resuspended in 0.4
ml of dilution buffer and 100 1-11 (5 I-Ig) ot propidum iodide
solution. The cells were subjected to FACS analysis. Dead
cells were gated out. A minimum of la, 000 cells were counted
by FACStar plus analyzer as mentioned earlier (seotion 2.13).
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CHAn•• J
::r_uDotarqatlnq ot '!brro9'~obUliD OD. AIrotiqan-pn••ntiDCJ Calla
Abroqat•••atural Tolaranca in tba Aba.nca of AlSjuVaDt
3 • 1 Introduatioll
For decades, thyroglobulin (Tgl. the major autoantigen of
the thyroid gland, has been used mostly with complete Fre'Jnd's
adjuvant (CFA) for induction of experimental autoimmune
thyroiditis (EAT) in lIlice (Charreire et aI, 1989)_ Apart from
CFA, several adjuvants such as lipopolysaccharide (LrS)
(Esquivel et aI, 1977), rnurallyl dipeptide (HOP) (Kong- et aI,
1985), poly A:U (Esquivel et aI, 1978). and SGP (a synthetic
copolymer or starch, acrylamide, and sodium acryillte)
(Williams et aI, 19B7) were used to enhancG the immunogenicity
of Tq leading to induction of EAT in mice. Haptenization of Tg
was also shown to enhance its imaunogenicity (Weigle et ai,
1965) _ Previously, adjuvant free induction ot: thyroiditis and
autoantibodies to Tg in mice had been achieved only through
the use of large amounts (several hundred micrograms) of mouse
Tg (mTg) administered in repeated injections over a period of
4 weeks (EIRehewy et aI, 1981)_ Subsequently, it was reportod
that, in the absence of adjuvant, extracorporeally antigon
(Aq)-puised dendritic cells when injected into mice could also
enhance the i1llJlunogenicity of ttlTg (Knight et aI, 1988)_
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several investigators have described that the
immunogenicity of foreign proteins (Rawamura et aI, 1986;
carayanniotis et al, 1987; 1990; Casten and Pierce 1988;
Snider and Segal, 1987 and 1989) or peptides (Carayanniotis et
al, 1988: Casten et aI, 1988, Wyss et a1 1991), or haptens
(Hjaaland and Fossum, 1990 and 1991) is drattlatically enhanced
either .in.....llY..g or .i..n....Yitx2 when such Age are conjugated to
MAbs specific for determinants expressed on the surface of
antigen-presenting cells (APe). The outcome of these findings
was that KAb-medlated delivery of antigen onto APe facilitated
the uptake and further processing of 1.9 by APe leading to
enhanced illlJ:lunoqenicity of Age either ..1n.....ti.Y2 or~.
Taking into account the above reports on immunotargeting,
the adjuvant free induction of EAT in mice was reexamined. In
this chapter, I have asked whether or not the immunogenicity
of mTg would similarly increase .in.....Y...i.Y in the absence of
adjuvant, by iltlll\unotargeting small doses of this autoantigen
onto APC using MAbs specific for MHC class II Ags. To address
this question, I have selected CBAjJ (H-2~) and C57B6j6J (H-
2b) mice that are known to be high and low responders to mTg
when mTg is injected in CFA (Charreire, 1989). Induction of
Tg-specific IgG responses was 1I0nitored by ELISA and
thyroiditis was assessed by concomitant histological
examination of the thyroid glands.
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3.2 R••ults
3.2.1 separation of i_uDooonjuqat•• by BPLC gel filtration
Analysis of a simple mixture of mTg and MAb specific for
MHC class II Ag (I_At) by gel filtration through a TSK-4000SW
size-exclusion colullIn (seotion 2.5) indicated that free MAb
eluted between 20.5 and 21.4 min, and free mTg at 15.6 min.
(Figure J .IA). similar analysis of a conjugate mixture by gel
filtration, obtained after cross-linking of mTg with MAb
(anti-I-At MAb) by glutaraldehyde (Seotion 2.5), revealed a
single high molecular weight peak containing soluble
conjugates at 10.6 min, whereas small amounts of free mTg or
MAb remained in the reaction mixture (Figure 3.18). A similar
HPLe profile was obtained with a simple mixture of mT9 and
control MAb specific for influenza NP (Figure 3. 2A) and after
cross-linking mTg to a MAb specific for influenza NP (Figure
3.2B). HPLC purified protein from each conjugate peak was
SUbsequently used for immunization.
3.2.2 IlIIJIlunotargeting of IllTg-(I-,.' NAb) conjugate in vivo
eliei ts IllTg-speeitic Iqa reapon.e in H-211: but not in H_2b aiee
CBA (H-2') and B6 (H-2b) mice were selected for the
present study since they are known to elicit significant mTg-
specific IgG responses when challenged with mTg in CFA,
although the Ab titer and thyroiditis induction is higher in
C5A than in 56 mice (Vladutiu and Rose 1971). Mice from each
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Fi9ure 3.11\-6 Comparison of HPLC profile of (AI • simple
mixture ot .Tq and anti-I-A' KAb, (D) • supl. following
conjugation with qlutaraldebyde of lIl.'I'q with anti-I-Air. NAb. CAl
50 ~l of simple mixture of mTg and anti-I-A~ MAb or (B) 50 III
of conjugate of mTg with anti-I-AIr. MAb were passed through
TSK-4000SW size-exclusion column using phosphate buffer, pH
7.0, at a flow rate of 1.0 ml/min. Horizontal axis represents
time in minutes, vertical axis represents O. D. at 2S0nm.
IIlTg
1
Mill>
1
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A. (1IlTy+Ml\b)
B. mTg-(anti-I-l\k MAil)
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Figure 3.21.-8 comparison of BPLC profile ot CA) Do simple
mixture of aT9 arad anti-Influen•• nucleoprotein IHP) XAb, (8)
a 81U1lplll following conjugation with glutaraldehyde of mTq with
anti-Innuen•• NP XAb. (Aj 50 /.£1 of simple mixture of mTg and
anti-influenza NP MAb or (8) 50 j.ll of conjugate of mTg with
influenza NP-specific MAb were passed through a TSK-4000SW
size-exclusion column using phosphate buffer. pH 7.0, at a
flow rate of 1.0 ml/min. Horizontal axis represents time in
minutes, vertical axis represents 0.0. at 280nm (as in Figure
3.1).
A.
B.
o
IIITy MAil
1 1
IIITu-(allli-NI' MAil)
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strain (6/group) were primed s.c. at the base of the tail with
5 ",,9 of mTg-(anti-I-Ak MAb) conjugate in 100 1011 PBS on day
zero llnd boosted Lp. with 50 }Jg' of mTg in 100 lil PBS on day
21. Serum samples were collected on day 35 after the priming
injection (SectioD 2.6). Significant IgG responses were
observed only in CBA mice expressing I_Air. (Figure 3.3A) but
not in 86 mice expressing I_Ab (Figure 3.38). These findings
are interpreted to be a result of focusing of mTg onto APe by
the immunotargeting approach during the immunogenic challenge,
because IgG responses were elicited in mice bearing
appropriate MHC class II alleles only.
3.2.3 Priming with control illlllunooonjugate lI'l'q-(anti-NP MAb)
in vivo 40e. Dot elicit an IITg-apaoitic 190 respon•• in H-2 k
aice
To further test the effect/specificity of targeting of
mTg onto APC by the immunotargeting approach, control CBA mice
(2 mice/group) were injected with either 25 ",g of purified
mTg- (anti-NP HAb) conjugate in 100 ",I PBS or 50 ",g of mTg in
CFA (as a positive control) s.c. at the base of the tail and
were boosted with 50 "'9 of free mTg in 100 pI PBS as described
(Section 2.&). Testing of the immune sera 35 days after the
initial (priming) injection failed to reveal the presence of
mTg-specific IgG in CBA mice that received the mTg-(anti-NP
NAb) conjugate (Figure 3.4). In contrast, CBA mice that were
1JO
Pigure 3.31\-8 Det.raInatioD of .Tll-specific seoondary IgG
responsos to i_unotargotad aTg in CPA (A), and 86 ID) ai08.
IgG reactivity to mTg in individual mouse sera (Day 35) from
eBA (6jgroup) but not 86 (6/group) mice primed on Day 0 with
the indicated antigens and boosted on Day 21 with free mTg as
described under section 2.6. 0.0. 405 nm values from an
alkaline phosphatase-based ELISA represent mean +J- SO of
triplicate wells. The assay was performed as described
earlier (Chronopouloll and carayanniotis, 1992).
O. D. 405 nm
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primed with mTg in CFA mounted a strong mTg-specific IqG
response (Figure 3.4). The Ab titers induced after priming of
mice with eFA + mTg were equivalent to those obtained after
immunotargetinq of mTg in the absence of adjuvant 1n CBA mice
(Figure 3.3A). These findings further suggest that the
enhancement of mTg immunogenicity in CBA mice after its
conjugation to the anti-class II MHe MAb is not due to a
possible aggregation effect, chemical modification of mTg, or
non-specific uptake of immunoconjugate. These data are
compatible with the hypothesis that specific delivery of rnTg
by MAb onto APe bearing appropriate MHe class II Ags leads to
the abrogation of natural tolerance to mTg.
J.2.. IlllJIIunotarg_tinq of aTg favors induction ot an Ig0
response but not thyroiditis in CBA .ice
Histological examination of the thyroid glands obtained
from CBA mice that received mTg- (anti-I-Ak MAb) conjugate for.
priming (from the experiment shawn in Figure 3.3A) did not
reveal intiltration with mononuclear cells (0/6). 'l'he data
clearly indicated that, despite the presence of an mTg-
specific IgG response, thyroid infiltration with mononuclear
cells did not occur. The data also indicate that mTg-specific
antibodies raised by this particular procedure were not
pathogenic in mice.
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Figure 3 • .fi Deteraination of IllTg-apacific secondary 190
respODse. in CDA aioe primed. with CPA + 11I'1'0 (A) an41ll'l'q-canti-
NP MAb) conjugata (D). IgG reactivity to mTg in individual
mouse sera collected on day 35 from CBA mice (2 mice/group)
that were primed on Day 0 with the indicated antigens and
boosted on Day 21 with free ml'g as described under Seotion
2.6. 0.0. 405 nm values from an alkaline phosphatase-based
ELISA represent mean +j- SO of triplicate wells. The assay
was performed as described earlier (Chronopoulou and
carayanniotis, 1992).
•O. D. 405 om
;;0t---~---~
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:1.:1 Dbeuadoll.
The results of this study duonstrate tor the first tillle
in EAT that adjuvant·free challenge of aiee with aOUse Tg
(.T91 abrogates natural tolerance to 1ITg. This was achieved
by targeting s.all doses of IllTg onto APC expressing
appropriate MIte class II Ags using MAbs (ant!-HHC class II) as
delivery vehicles.
The precise mechanlsm(s) underlying the observod MAb-
mediated enhancement in the bmunogenicity of conjugated T9 is
(are) not clear. The most plausible reason for the observed
effect may be due to the direct fOCllslnq of or targeting of Tg
onto various APC (dendritic cells, B cells and macrophages)
expressing appropriate MHC clns II detenlnants. This would
lead to internalization, processing and surface expression of
1'9 epitopes in the context of MHC class II J:lOlecules on APe.
The peptide-MHC class II cOllplexes would then be rl!cognized by
T helper (TH) cells, which in turn provide the second signal
to .Tg-specific 8 cells. Subsequently, this would result in
the induction ot a humoral illlJlune response since IgG
responses to Tg are T cell-dependent (Vladutiu and Rose,
1975). In this model, B cells (compared to l!Iacrophages and
dendritic cells) lire expected to act as APC by internalizing
the conjugate either via their MHC class II Ags (specific
path....ay) or IgG receptors (non-specific pathway) expressed on
their surface as suggested earlier (carayanniotis and Barber,
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1987; Skea and Barber, 1993).
Alternatively, the targetea MAb .ay also enhance the
bnmunogenicity of the Ag non-specifically by inducing
lll\lllunogiobulin (anti-I-A~ MAb)-specific TH cells that help
mTg-speciflc 8 cells and promote an mTg-specific IgG response
by a process called "linked recognition". This W1echanlsm of
i1llIllune recognition was described earlier (Janeway, 1983:
Lesserman, 1985). The present findings, however, do not
support the above possibility (linked-recognition mechanism),
because DlTg-spt!ciflc IgG responses were not observed in H-2b
mice immunized with mTg-(anti-I-Ak HAb) conjugate or caA mice
immunized with mTq-(anti-NP MAb) conjuq8te (control).
The mechanism(s) by Which the targeted MAbs specific for
MHC class II Ags confer their adjuvanticity .1.n....Y..1Y2 is/are not
clear. It is possible that during cognate T-B cell
interaction, recognition of MIIC-peptide complexes on B cells
by TcR of Tgwspecific TH cells, leads to induction of
costimulatory lllolecules, such as B1 on naive B cells, and
these B7· B cells may effectively present the autoantigen to
T cells by providing a second signal to T cells, leading to T
cell activation. These activated T cells in turn lllay help Tg-
specific B cells~ analogous to the results obtained .in
illl:2 as shown earlier (Nabavi et aI, 1992). Alternatively,
the adjuvanticity conferred by targeted MAb specific for HHC
class II determinants may also be attributed to the ability of
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targeted !'lAb to activate APC leading to secretion by APC of
endogenous mediators such as interleuk!n-l (IL-l) (placeis,
1985). In that regard, human recolllbinant It-lt:! was shown
earlier to enhance splenic plaque-forming cells to sheep RBC
both in....Yit.I:Q and~ (Reed et aI, 1989). In the murine
system, evidence to support this possibility is not documented
and remains to be established. It is ..-orth noting that
adjuvants such as LPS and HDP (8 component of CPA), that have
been used for induction of EAT, exert their adjuvanticity
through the induction of 1L-1 secretion by APC (Lasfargues et
aI, 1987; Lise and AUdibert, 1989).
In the present stUdy, despite the adjuvant free induction
of an IlTg-speciflc IgG response by imnunotargeting,
concomitant mononuclear cell infiltration of the thyroid ....as
not observed in the responder CBA mice. In EAT studies, it is
known that mTg-specific IgG responses are more easily induced
than thyroid lesions (Charreire, 19891 Rose et aI, 1971) and
do not correlate with disease (thyroiditis) development.
These data suqget:ted that these two autoimmune manifestations
are under different immunoregu1atory control. ThUS, the
possibility that immunotargeting favours an autoantibody (AAb)
response rather than thyroiditis induction cannot be excluded.
Inability to induce thyroiditis in CBA I1ice by thi.. approach
lllay either be due to the low doses of illl1llunoconjugates (5 IJg
of the conjugate/mouse) employed or failure to overcome the
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immune mechanisms that regulate the induction of T cells
associated with pathogenic thyroid autoimmunity.
Adjuvant free induction of EAT in mice by injecting large
doses of mTg in saline at repeated intervals was reported
earlier (EIRehewy at aI, 19811. Similarly, Jermy et al (19931
also reported the adjuvant-free induction of experimental
autoimmune myasthenia gravis (EAMG) in mice by injecting very
small amounts of Ag, equivalent to 1 Jig of affinity purified
mouse AChR, in saline. The present observations that
induction of Ab responses but not thyroid lesIons by
immunotargeting of mTg in mice suggests that the
Imrnunoregulatory mechanlsm(s) involved in the breakdown of
tolerance leading to induction of autoreactive IgG responSJ in
mice is different from those involved in the induction of
mononuclear cell infiltration of thyroid (pathogenic
autoimmune response).
Carayanniotis and Barber (1987) have demonstrated
adjuvant free-induction of IgG responses to avidin by
targeting conjugate onto APe using MHe class II Age as
targets. In that stUdy, the authors have used biotin as a
cross-linker to produce ei:fer:tive Ag-Ab conjugates. In the
present study, I have also demonstrated a targeting effect at
low doses of injected Tg-MAb conjugate (Figure 3.31.-8). In
contrast to the method used in the stUdy by carayanniotis and
Barber (1987), I have used glutaraldehyde as a cross-l inker
137
to produce effective immunoconjugates.
The present findings extend the previous reports
describing the methods for enhancement of immunol1.'micity of
foreign proteins such as avidin (carayanniotis and Barber
1987; 1990; Carayanniotis et aI, 1991), ferritin (Ka....amura and
Berzofsky. 1986), influenza haemagglutinin (Barber and
carayanniotis, 1988), hen egg lysozyme (Snider and segal 1989:
Snider et aI, 1990), pigeon cytochrome C (Casten and
Pierce, 1988), foreign peptides (Carayanniotis et al 1988;
Casten et aI, 1988; Wyss et aI, 1991) and haptens (Mjaaland
and Fossum, 1990 and 1991).
The results described in the present one and other
studies (carayanniotis et aI, 1987; 1988; 1990; 1991., Skea
and Barber, 1993) suggest that professional APe such as
dendritic cells, B cells, and macrophages playa role in the
enhanced immunogenicity of mTg. However, the contribution
towards Ag presentation by each of these APe populations is
unknown. It is worth noting the report of Berg et al (1994)
Wherein the authors show that targeting of FITC onto APC
expressing appropd ate MHC class II Ags induced strong Ag-
specific primary and secondary IgG responses in rats. These
authors also showed that dendritic cells but not B cells or
macrophages initiate the humoral immune response in MHe class
II-mediated Ag delivery. These latter data furthermore
support previous findings, implicating a primary role for
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dendritic cells in the inductlon of immune response, obtained
with a different methodology in which extr3corporeally Ag-
pulsed dendritic cells, when injected in saline into mice,
initiated either humoral (Sornasse et aI, 1990) or cel1-
mediated immune responses (l<night et aI, 1988).
In the present study, MHC class II 1\95 have bee:l
exploited as targets to deliver the autoantigen (mTg) onto
diverse APe popUlations, whereas in other studies Ig0
molecules have been exploited as targets to deliver diverse
Ags such as bovine serum albumin (BSA) and fluorescejn
isothiocyanate (FITC) specifically onto B cells (Lees at aI,
1990, Berg at aI, 1994). Lees et al (1990) have reported the
enhancement of the immunogenicity of eSA, in mice in the
absence of adjuvant, by targeting 5SA (100 ~g conjugate
/llIouse) onto B cells using goat-ant i-mouse IgO MAb. In
contrast, Berg et al (1994) reported recently that targeting
of FITC (25 ~g conjugate/mouse) onto B cells using goat-anti
rat Igo Ml\bs as delivery vehicles induced a weak specific-
primary IgG response in rats. Thus, the efficacy of
immunotargeting at enhancing the immunogenicity of Ag5 might
be influenced by various factors such as the type of "'g
(mUltivalent~ hapten) or the dose of the Ag or the
species (rat ~ mouse) or a combination of these
parameters.
While the results obtained in the present stUdy
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dellonstrate the induction of autoreactivity by targeting self-
antigen onto APe, recent studies have also demonstrated the
potential of the 1.munotargeting approach in suppressing
autoilllJllunity. Day et al (19921 have described the suppression
of experimental autoimmune encephalomyelitis (EAE) by
targeting a pathogenic peptide of myelin basic protein (MBP)
onto B cells with IgD-specific MAbs in LewiG rats. In this
model, although EAt was suppressed, MBP-specific T cells were
not anergized. In another report. Reim at al (1992) have
shown that targeting of AChR on B cells~ normally
enhances its presentation to specific T cells, whereas
targeting follololed by fixation of APe induced specific T cell
anergy. Therefcre, key factors such as the kind of Ag and of
targeting MAb used, the type of targeted APC, the conjugate
dose, and the route of administration can greatly influence
the outCOlle of the iuune response. The relative i.portance of
each of these parameters remains to be established.
The difficulty in eliciting an autoimJIune response with
soluble autoantigen in saline necessitates the use ot potent
adjuvants. Most commonly used CFA is known to present
problems such liB int'lammatory lesions (granulomas and open
sores) at the immunization site (Broderson, 1989; WiedmAn et
al 1991) and exerts poorly understood effects on the immune
system. The value of the immunotargeting approach in the
dtudies of autoillUllunity lies in its capacity to direct
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autoantlqen onto selected APe populations either in......Y.i.t.. or
~ and to avoid initiation of autoreactivity in the
context of simulated infection (Cohen, 1992) provided by CFA.
In conjunction with the use of defined pathogenic epitopes,
immunotargeting can provide new impetus in the study of
regUlatory mechanisms of adjuvant-free activation
suppression of an autoimmune response.
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CBAPTBR ..
Induction of IXp.ri••ntal Autoipun. Thyroiditis in Rats vi th
the synthetic peptide (2495-2511) of Thyroglobul.in
4.1 Introduction
Experimental autoimmune thyroiditis (EAT) in rats,
induced after challenge with rat thyroid extract or rat
thyroglobulin (rTg) in adjuvant (Jones and Raitt, 1961~
Paterson and Droblsh, 1968; Twarog and Rose, 1969, Rose, 1975:
Lillehoj et aI, 1.981: De Assis-Paiva,1989), has served for
decades as a model for Hashimoto's thyroiditis (HT) in humans.
Various inbred rat strains differ in their susceptibility to
EAT and it appears that MHC genes play a major role in
determining the induction of the disease (De Assis Paiva.
1989) as observed in mouse EAT (Charreire, 1989). significant
non-MHC gene effects in rat EAT have also been reported
(Li1lehoj et aI, 19B1). Thyroid lesions induced in rats
following Tg challenge have been found to correlate with
lymph node cell (LNe) proliferative responses to rTg~
or delayed hypersensitivity (OTR) responses to rTg ..i.n....:tJ...
(Lillehoj and Rose, 1982). In contrast, no significant
correlation has been observed between rTg-specific Ab levels
and the degree of thyroid damage (Rose, 1975; Lillehoj and
~ose, 1982).
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Interpretation of genetic analyses and studies at the T-
cell clonal level in EAT have been hampered by the fact that
the autoantigenic determinants on Tg remain unknown, mainly
because of the large size of Tg molecule (dimeric Tg MW '" 660
kDa). Recently, there have been attempts from several
laboratories to delineate T-cell epitopes on Tg. Champion et
al (1991) identified an immunodominant and phylogenetically
conserved 9mer Tg peptide 2551-2559 containing thyroxine at
position 2553 and demonstrated that this peptide could trigger
the activation of murine T-cell hybridomas. Subsequently,
Hutchings at al (1.992) also demonstrated that Tg peptide
(2551-2559) -specific T cells could adoptively transfer
thyroiditis to naive syngeneic mice. In addition, Texier et
a1 (1992) identified an immunodominant and phylogenetically
conserved 40mer human Tg (hT9) peptide that induced mild
thyroiditis in mice. This Tg peptide was recognized by a
cytotoxic T cell hybridoma (CD4", CDS', TcR a/B')in the context
of HHe class I molecules.
Chronopoulou and carayanniotis (1992) have also recently
reported that the l1mer rat Tg (rTg) peptide 2495-2511
(rTgP1) induced thyroiditis in a heterologous species (mice)
and elicited T cell and IgG responses. TgPl-induced IgG
cross-reacted with Tgs from various species. These authors
identified the TqP1 sequence by using algorithms (Margalit et
aI, 1981; Rothbard and Taylor, 1988) that scanned the known
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portion of rTg (01 Lauro et aI, 1985) for putative T cell
epitopes since the primary amino acid se.quence of mouse Tg
(mTg) is unknown. Since TgPl is phylogenetically conserved
among rat, bovine and human Tgs, and causes thyroiditis in
mice, it is possible that TgPl constitutes a self peptide in
mice. However, the lack of data concerning the primary amino
acid sequence of mTg raises the possibility that recognition
of xenogeneic determinants on TgPl contributed to its
immunopathogenicity.
The present study was undertaken to examine EAT induction
with Tgl'l in a homologous system using WKY, FJ44 and WF rat
strains that are known to be EAT-susceptible after Tg
challenge (Lillehoj and Rose, 1982). EAT was monitored by
mononuclear cell infiltration of the thyroid and T~cell or
B-cell autoreactivi ty.
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4.2.1 'l'qPl is tbyroid!toq_niCl in rate
Since the Tg sequence 2495-2511 (TgPl) can induce EAT in
mice, an attempt was made in the present study to determine
whether it could similarly induce thyroiditis in the
EAT-susceptible rat strains WF, F344 , Bnd WK'i. Four rats per
strain were s.c. primed with 200 nmol (380 ~g) TgPl in CFA,
followed immediately by an Lv. challenge with~
~ organisms. All animals were boosted with 100 nmol
(190 J.lg) TgPl in IFA on day 7 as described under Section 2.9.
Twenty eight days after the first challenge, the thyroids were
removed and sUbjected to histologic examination. Rats that
received CFA plus Bordetella pertussis only served as
controls. As shown in Table 4.1, three out of four (75\) WKY
and WF rats and one out of four (25%:) FJ44 rats developed
mononuclear cell infiltration of the thyroid gland after
peptide challenge. Infiltration had the appearance of either
discrete perivascular foci (Figure 4.1) diffuse
interstitial accumulation of mononuclear cells surrounding the
thyroid follicles. On the other hand, thyroids collected from
adjuvant-primed rats did not reveal mononuclear inriltration.
The results revealed the pathogenicity or TgPl in rats of
diverse MHC haplotypes and confirmed that TgPl can induce
thyroiditis in a homologous species.
·"
Table 4.1 EAT induction by TgPl in variousrnt strains3
InRtrration index Rats with Incidence
Strain HaplotYpe 0 0.5 1 Z 3 4 thyroid lesions
WKY k 1 Z 1 3/4 75%
F344 1 3 - 1 - - - 11+ l:,'.
WF u 1 1 1 1 - - 3/+ 75%
a RatS were primed with 200 mnol ofTgPl and B.percussisand one week later, they were boosted
with 100 nmo! of peptide. Three weeks after the second challenge the thyroid glands were removed
and mononuclear cell inBlrrarion of the thyroid was assessed. Immunization and histological analysis
was performed as described in Materials and Methods (Sections z.a and 2.9). No infiltration was
observed in connol animals (2 rats Jgroup) that received CFA and B. penuss'isonly (..ot shown).
J'iqure ~.1 Photo.icroqrephe ahowill; 'I'qPl-illlduced .Ollolluoleer
cell ill.tiltraUoll ill the thyroid. Focal .ononuclear cell
infiltration ot the thyroid waa induced after challellge of WKY
rata with TgPl (intiltration index of 1.0) 1 (A) 100X. (81
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".2.:Z TqPl !D,4ua•••trong ••condary proliferative r ••pon...
ot" lyaph Dode cells (LIte) .i.IL:!.U:u
Th~ relative 11UD.unogenicity of TgPl was examined in WF,
F344 and WKY rat straIns by proliferative assays. Rats were
immunized in one hind footpad on day 0 with 200 Dol (l80 ~gl
TgPl. Fourteen days later, the draining popliteal we were
obtained and cultured in the presence or absence of TgPl. As
shown in Figure 4. 2A, we from WRY rats proliferated most
strongly .1n....Y.1..ttl to TgPl at the peptide concentration range
tested (22,7 - 0.3 /-&H). popliteal InC from FJ44 and WF rats
responded aigni!icantly as well. The responses were specific
since no LNC proliferation was observed in cultures containing
control Ag, ovalbumin (see legend to Figure 4.21.). Analysis
of TqPl-pri.ed sera from tha above rat strains (of Figure
4.21.) by direct ELISA, did not reveal the presence of TqPl-
specific primary IgG responses (Figure 4.28).
Challenge of WRY rats with titrated amounts of peptide
revealed that as little as 5 nmol (9.5 1£9) of TqPl can pri-.e
the rats for a significant popliteal LNC proliferative
response to TgPl ..i..I:lJ1..tt2 (Table 4.2). we from any
individual rat group did not respond to an unrelated Tq
peptide (2550-2561), but proliferated strongly to PPO. The
data indicated that TgPl is strongly immunogenic at the T cell
level, and TqP1-lIpecitic we pr01iferative responses correlato
with susceptibility of rats to thyroiditis.
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riqure ". 2~ TqPl-specHic LIfe prolif.r.~iv. respons•• in rats
of various RTl haplotypu. Rats (2 rats/group) were lnjected
wi th 100 pI of eFA emulsion containing 200 nmol (380 pg) TgPl
into one hind footpad and 14 days later the draining popliteal
I.J{C were removed and incubated with the indicated
concentrations of TgPl for 4 days. 3H- TdR was added during
the last 18 hr of the culture. The assay was performed as
described under section 2.7. The values were expressed as 51
+/- SO of quadruplicate wells. Background mean cpm of
quadruplicate wells were WRY = 6,893, F344 = 11,632, and WF =
3,472. Proliferative responses (mean cpm) of TgPl-primed LNC
to control antigen, ovalbumin (10 pg/ml) as folloW's: F344 =
15, 422; WKY"" 9,762; WF = 5,341.
Pigure ".28 Tqpl-prilllinq don not el.icit spocitic-prillllary
IqG responses in rats. The pooled serum samples of TqPI-
immunized rats that were used in the priming experiment (of
Figure 4. 'lA) were analyzed for TqPI-specific IgG in an
alkaline phosphatase-based ELISA as described under section
2.19. o. D. 405 nm readings were expressed as mean +/- SO of
triplicate wells at the indicated dilutions of the serum.
Stimulallon index
0.0.405 "m
14a 10
Table 4.2 Effect of anriien dose in vivo on TePI itnmunogenicicy
TgPI dose
in vivo (nmol)
J NC proliferation in ";no (Acorn +1- SD) in the presence 0(8 _
TgPI Tg peptide (2550-2567) PPD
25
5
1
0.2
21,305 +/- 2,889
18,480 +/- 4,286
2.287 +/- 1.848
4.915 +/- 436
1,675 +/- 6E
1,056 +/- 2.195
3.655 +/- 3,804
635 +/- 1.796
73.235 +/- 6,386
81,332 +/- 3,483
85.437 +/- 4,231
79.867 +/- 1,989
a Popliteal LNC &om WKY rats primed in vivo with the indicated dose afTgPl were stimulated
for 4 days in vIaowith TgPI (ll.uglml), Tg peptide (2550-2567) (12.pg/ml) or PPD ( 10 pg/ml).
3H-TdR was added during the lasr 18 hr of culture. The assay was done as described under
Marerials and Methods (Section 2.6). Background cpm in the :Jbsence of antigen were: 25
nmol =11,201. 5 nmol = 12.089, I nmol = 25,933 and 0.2. nmol = 8,283.
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4.2.3 TqPl is racoqlli.8d by CD.. • T oells in the conta.t of
both R'l'l-D and RT1-D MHC class II molecules
To address whether TgPl is recognized in the context of
RTI-B (I-A equivalent) or RTI-O (I-E equivalent) MHe class II
molecules, various MAbs were used to block the proliferative
response of Tgpl-prirned rat LNC to TgPl 1n.....Y.i.t..r. As shown in
Table 4.3, peptide-specific proliferation of LN'e from all rat
strains was strongly inhibited (60-88%) in the presence of
WJ/25 (anti-CD4) MAb, suggesting that the response was maJnly
dependent on CD4~ T cells. Addition of QX-6 MAb, specific for
RTl,·B antigens (I-A equivalent), significantly blocked
TgPl-specific proliferation of LN'C from F344 rats (86%), and
to a lesser extent of LNe proliferation from WK':t and WF rats
(57t and J7t respectively). In the pr~sence of OX-17 MAb,
specific for RTI-D antigens (I-E equivalentj, the response of
FJ44 rat LNe was again strongly inhibited (67%) while LNe from
WRY and WF rats were also significantly inhibited (31% and 421;
respectively). No significant blocking was observed by the
control HAb (H16-LIO-4R5) specific for influenza type A virus
nucleoprotein. The data suggested the presence of TgPl
epitope(s) that could be recognized in the context of either
RTI-B or RTI-O gelle produc'";s by CD4' T cells.
4.2.4 TgPl contain. oryptio 'I' oell epitope(ol
The non-imrnunodominant nature of TgPl was demonstrated
iii
Table 4.3 MHC-testrietion ofTgPl-speci£k LNC proliferative Tesponse in virto
B10ckina In viaoprolifl!Jj!rioD (epm +/.$.D.> ofIDPI_primM I NCfrom 8,
MAh WKY F344 WF
18,790 +/- 1,421 (O)b 22,675 +/- 2,027 (0) 12,013 +1- 2,056 (0)
W3/25 7.520 +/- 507 (60) 2,802 +/- 585 (88) 3,372 +/- 375 (72)
OX-6 7,996 +/- I,m (57) 3,091 +/- 935 (86) 7.531 +/- 1,030 (37)
OX-17 13,048 +/- 1,185 (31) 7,581 +/- 2,130 (67) 6.953 +/- 662 (42)
HB-65 N.D. Z5,35'/ +/- 3.543 (-12) 15,149 +/- 3,270 (-26)
a Poplite31 LNC from the indicated rat strains were primed in .1VO with H.5 nmol TgPl in CFA and 14
days later were cultured in virTD with 6.2 )Jg/ml peptide and the indicated MAb. W3!ZS (anri·CD4), OX-6,
(anri-I-A) and HB-65 (H16-LIO-4R5, onti- influenza A nucleoprotein) were used at 3.2 )Jg/ml and OX-I?
(anti-I.E) at 1.6 pg/mt. At these concentrations, the indicated MAbs were non toxic since they did not
inhibit Con A stimulation eftat splenic cells (data not shown). Toe assay was done as described under
Materials ::md Methods (Section 2.7). The background cpm were: WKY = 6,704, F344 =4,110, WF =
2,117.
b Percent in hibition .,f proliferation calculated as described in Marerials and Methods (2.7)
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earlier in a heterologous species (mice) (Chronopoulou and
Carayanniotis, 1992) in the context of homologous (mTgj and
heterologous Tg (rTg). The non-dominance of TgPl on Tg
reported earlier in mice may not apply in rats by virtue of
possible differences in the Ag processing anc. presentation by
lymph node APe of mice and rats. Therefore, it was important
to reexamine the relative ilMlunodomlnan-=" of this peptide in
the context of both homologous (l'at) and heterologous (mouse
and human) Tgs in rats. WKY rats (2/group) were primed by
injection into one hind footpad of rat or mouse or human Tgs
in erA. Fourteen days later, the draining popliteal LNC were
challenged .in..-Yi.tI:2 with the corresponding Tg or equimolar
concentrations of TgPl. The results are shown in Figure 4. J.
The results demonstrated that priming with homologous or
heterologou:j 1'95 induced significant LNC proliferative
responses to the corresponding Tg. However, no response was
detected against TgPl .in....Yi..t.1J (Figure 4. JA-C). Lack of TgPl
reactivity was observed over a wide range of peptide
concentrations in....illl:2 that were clearly stimUlatory to LNC
primed with TgPI..i..n...llYg (Figure 4.2A). Thus, even though TgPl
alone is immunogenic and pathogenic in rats, it cannot prime
the host when it is given in the context of intact Tg,
suggests that TgPl is a cryptic determinant within Tg in rats.
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Figure .... 3 Rat LHC prilll8c! with homologous or heterologous Tg
in vivo do not respond to 'l'gPl ~. WK'i rats (2 rats/
group) were primed in one hind footpad with 200 119 of the
indicated Tg in 100 /.11 eFA emulsion and 14 days later
popliteal loNe were removed and cultured in the presence of the
respective Tg or TgPl for four days. lH-TdR was added during
the last 18 hr of the cUlture. The assay was done as
described under seotion 2.7. The values were expressed as
mean cpm +/- SO of quadruplicate wells. Background mean cpm
of quadruplicate wells were rTg '" 7,109, mTg "" 3,903, and hTg
'" 23,439.
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-"2.5 'rgPl--priainq of rat. do•• Dot elicit strong peptide-
specific 190 re.pona••
On day 28, sera were collected from rats that had been
used in the experiment shown in Table 4.1. Sera were tested
individually for the presence of Abs against the peptide or
rTg by alkaline phosphatase-based ELISA. As shown in Figure
4.4, one out of four WK'i. two out of four WF, and three out of
four FJ44 rats showed a weak but detectable IgG response to
the peptide. Sera from all rat strains showed weak or no
cross-reactivity to rTg. Thus, strong peptide-specific IgG
responses were not detected dasp! te the presence of
thyroiditis in rats.
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Pigure 4.'" Doteraination of Tgpl-opeoific :IgO relliponse. by
ELISA. Individual sera (at 1/32 dilution) from the indicated
rat strains were tested for the presence of IgG specific for
TgPl and for IgG cross-reactive with rTg. Open circles
represent individual rats. Data are obtained from complete
serum titration curves. Dotted lines represent background
O. D. values obtained with sera (at 1/32 dilution) of control
rats (2 rats/strain) challenged with CFA and heat-killed
~~ organisms. St,andard deviation (SO) of
triplicate values did not exceed 20\ of the mean. The assay
was done as described under sllotioD 2.19.
O.D.405nm
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4.3 Discu..sioD
The results of this chapter demonstrate that the
homologolls synthetic 17mer TgPl sequence (2495-2511) induces
thyroiditis, and elicits strong T cell but weak IgG responses
in rats of diverse MHC haplotypes. These data support the
previous findings reported in an heterologous species (mice)
(Chronopoulou and carayanniotis, 1992).
Since TgPl causes thyroiditis in both rats and mice, it
raised the possibility that this cryptic pathogenic sequence
may also be important in the development of autoimmune thyroid
disease (AlTO) in humans. It should be noted that thyroiditis
induction in rats was achieved with a J3-fold molar excess of
peptide (380 119 TgPl) over known thyroiditogenic doses of Tg
(2 mg Tg) (Jones and Roitt, 1961, De Assis-Paiva et ai, 1989).
However, an attempt was not made to determine whether or not
lower immunogenic doses of TgPl such as 5 nmol (9.5 1J.9) (Table
4.2) can also induce lymphocytic infiltration of the thyroid.
It is noteworthy that TgPl contains T cell epitopes that are
restricted in the context of both RTl-B (I-A) and RTI-D (I-E)
KHC class II molecules in various strains, but does not
possess the putative MHC class II binding motif (S-----E) for
RTI-Bl class II HHC (Wegmann et a1, 1994). Analogous
findings whIch confirm the ability of a peptide to induce both
I-A and I-E restricted autoreactive T cell responses in rats
have been made with encephalitogenic T cell clones reacting to
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the peptide 85-99 of myelin basic protein (MBP) (Offner at aI,
1992) •
The capacity of TgPl to induce EAT in different rat
strains and be recognized by T cells in the context of
disparate MHC class II molecules is somewhat unexpected.
These findings may be attributed tb the presence of various
MHC-binding motifs within the TqPl sequence as predicted
earlier (Chronopoulou and carayanniotis, 1992). The capacity
of TgPl to induce EAT in both rats and mice may also be
attributed to a probable identity between the rat and mouse
Tgs at the TgPl sequence and to the extensive homology between
the rat and mouse MHe (Gill at aI, 1987; Diamond et aI,
1989). Nucleotide sequencing of the gene(s) coding for mTg
and establishing its amino acid sequence are necessary to
clarify the degree of homology between the rat and mouse Tgs
at the TgPl site.
Two striking correlates between Tg- and TgPl-mediated EAT
emerge from the present findings in rats and from earlier
findings in mice (Chronopoulou and carayanniotis, 1992) :
First, after TgPl challenge, lYtllPhocytic infiltration of the
thyroid has been observed in all the rat strains that were
tested and in mouse strains (H_2 k and H-2") that are known to
be susceptible to Tg-mediated EAT. Second, following priming
with TgPl ~. all of these strains have exhibited
significant proliferative T-cell responses to TqPl~
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analogous to the findings with Tg in high responder rat
strains (Lillehoj and Rose, 1982). Previously, it
demonstrated that .in....Y1tJ;:g proliferative responses correlated
with the pathogenic potential of TgPl (Chronopoulou and
carayanniotis, 1992). Similarly a correlation was also found
between Tgpl-specific LNC proliferative responses~ and
susceptibility of rat (WKY, Hr, and F344) strains to
thyroiditis.
The recognition of TgPl by proliferative CD4+ T cells in
the context of RTI-B and RTI-D MHC class II molecules in
diverse rat strains (Table 4.3) may suggest that MHe class 11-
restricted T cells play a role in the thyroid disease
development. In a collaborative stUdy, we have recently shown
the existence of MHC class II-restricted TgPl-specific CD4' T
cells in mice and that MHC class II-restricted 9mer epitopes
of TgPl induce thyroiditis (Rao et aI, 1994). However, I have
not attempted to map the minim.tl T cell epitopes within TgPI
and also not addressed the functional role of HHe class 11-
restricted T cells specific for epitopes within TgPI in rats.
It is possible that these T cells may include Th cells that
(a) help B cells in the generation of TgPl-specific IgG, (b)
function as "final effector cells themselves" or "inducers of
final effectors" in mediating thyroid lesions or, (e) play an
effector role as mediators of delayed-type hypersensitivity
(OTH) (Lillehoj and Rose, 1982).
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Despite the similarities between Tg- and TgPl-mediated
EAT in rats, the TgPl-mediated disease may represent a new
EAT model unrelated to the one resulting from Tg use. The
basis for this conclusion stems from the lack of
immunodominance of TgPl in the context of both homologous
(rat) and heterologous (mouse and human) Tgs in rats (Figure
4.3), and in the context of homologous Tg (mTg) and
heterologous (rTg) Tgs as shown earlier in mice (Chronopoulou
and Carayanniotis, 1992). The lack of immunodominance of TgPl
may be explained in various ways: TgPl may not be generated
after Tg processing~ by APe in the peripheral IYJllph
nodes or TgPl may be generated but fail to compete with
higher-affinity Tg peptides for binding to the MHC in a manner
shown earlier with synthetic peptides of a variety of Ags
(Sercarz et aI, 1993). Alternatively. TgPl may be generated
~ after Tg challenge over the course of time, as a
result of spreading of autoreactivity to cryptic T cell
determinants, analogous to the one observed for cryptic
determinants of MBP in MBP-primed or MBP-peptide primed mice
(Lehmann et aI, 1992).
At present, it is not clear, how the priming with the
cryptic TgPl sequence results in the induction of thyroiditis
in rats. It is likely that specific T cells recognize TgPI
that may be expressed on thyrocytes in the context of MHC
class II molecule~ as a product of thyroid prC'teases that
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digest Tg differently from enzymes in lymph node APe.
Thyroidal cat.hepsins are known to generate 27-33 kDa fr"'galonts
of Tg that position TgPl very close to their N-ternd.nus (Dunn
et aI, 1991). It was previously hypothesized that leakage of
such Tg fragments to the periphery may also lead to
generation of TgPl in APe of lymphoid tissues, assuming that
these fragments were processed differently from that of
intact Tg IChronopoulou and carayanniotis, 1992). Yet another
attractive hypothesis is that TgPl-reactivity may be elicited
via "molecular mimicry" of this peptide with peptidic
sequences on proteins derived from various pathogens such as
the reovirus that is known to cause thyroiditis in mice
(Srinivasappa et aI, 1988). The existence of pathogenic T
cells specific to cryptic epitopes exist in the periphery
sl.:qgest that thymic tolerance to TgPl has not been established
in rats. This is possibly due to inability of the APe to
generate cryptic epitopes from intact Ags analogous the
results reported for a cryptic peptide on self-cytochrome C in
mice (Mamula, 1993). It is also possible that the molecular
mimic of cryptic TgPl on infectious agents may become
immunodominant anlaogolls to the results reported for a peptide
on homologous and heterologous lysozymes (Moudgil and Sercarz,
19(3). It is likely that when an individual comes in contact
wi th the infectious !lIgents that harbour these "homologous
mimics", the autoreactive T cells specific for cryptic
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epitopes of autoantigens may be recognized thus contributing
to the triggering of pathogenic thyroid autoimmunity. Tho
fact that. TgP1 at the T cell level remained cryptic or 110n-
dominant after Tg challenge of rats as observed in the present
study and of mice reported previously (Chronopoulou and
carayanniotis, 1992) represents 8 difference between the TgPl
and the previously identified thyroiditis-causing Tg peptides
(Champion et al,1991: Hutchings ~t aI, 1992; Texier et aI,
1992) which are imrnunodominant.
The observation that challenge of rats with TgPI 01 iclted
weak Tgp1-specific IgG responses (Figure 4.4) differs from the
previous finding" in mice where challenge of mice with TgPI
elicited strong peptide-specific IgG responses (Chronopoulou
and carayanniotis, 1992). It should be noted however that
TgPI used throughout the present study did not contain the
extraneous amino acids such as N-terminal cysteine (eys) and
c-terminal tyrosine (Tyr) as opposed to the "Cys-TgPI-Tyr:"
used 1n the earlier studies in mice (Chronopoulou and
Carayanniotis, 1992). Moreover, it would be interesting to
know whether or not challenge of rats with Cys-TgP1-Tyr would
enhance the TgPl-specific IgG response in different rat
~trains. However, the present findings are analogous to those
reporl<:!d earlier on Tg-mediated rat EAT (Rose, 1975 and
Lillehoj and Rose, 1982), where Ab titers did not correlate
with. disease severity in various rat strains. In contrast to
162
the previous findings in mice, TgPl-specific IgG did not
cross-react significantly with rTg (Figure 4.4). Two
possibilities can be entertained for the observed differences
in the pattern of reactivity of TgPl-primed sera to homologous
Tg in rats and mice: It is possible that rat sera recognize
TgPl epitope(sj distinct from the ones recognized by mouse
sera, and the tertiary fOlding or post-translational
modifications of Tg (Charrelre, 1989) may block the binding of
IgG Aba to these epitopes.
EAT induction with TgPl or other defined Tq peptides
(champion at aI, 1991; Hutchings et aI, 1992; Texier et aI,
1992) opens a new field to study immunoregulatory mechanisms
of this disease at the cellular or molecular level. In
addition, it facilitates the easy establishment of phenotypic
or functional profile of 8utoreactive T cell clones with
defined specificity. This may eventually aid in the assessment
and development of various immunotherapeutic strategies for
human autoimmune thyroiditis.
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CHAPTBR 5
Boaologous ThyroglobUlin Peptide (2695-2713)-Xedlata4
espad••ntal Autoruuna Thyroiditis (BAT) in R~t.: Paptida-
specific HIIe-Unre.tricted CD..• '1' Cell Line Adoptively
Transfers Tbyroiditis to Haive 1'344 Rat.
5.1 Introduction
Experimental autoimmune thyroiditis (EAT) is induced in
susceptible strains of rats by injection of homologous
thyroqlobulin (rat Tg) (Lillehoj and Rose 1982) or of II.
synthetic 1711er Tq peptide, TqPl (2495-2511) (Chapter 4) in
adjuvant. EAT in rats can also be induced in naive syngeneic
rats by adoptive transfer of thyroiditis with homologous or
heterologous Tq-prilled lymph node cells (LNC) (Twarog and
Rose, 1970: Jankovic et aI, 1969) but not by serun (Rose ot
aI, 1973a). The stUdies performed in mice clearly indicate
that EAT is a CD'" T cell-mediated disease since Tq-specific
CD'" T cells transferred thyroiditis to high (Maron et aI,
1983; Romball and Weigle, 1987) and low (Zerubavel-Weiss,
1992; Hiyl1ma et aI, 1993; sugihara et aI, 1993) respondor
syngeneic naive mice. This was further supported by
experiments in which the induction of thyroiditis in mice was
prevented witn non-depleting anti-CD4 antibodies (Hutchings
at aI, 1993).
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Previously described Tg-specific T cell lines or clones
recognize Tq detcl1llinants 1n an HHe-restricted fashion but
their fine epitope specificity is not defined (Champion et aI,
1985; Zerubavel-Weiss et aI, 1992; Hiyama et aI, 1993:
sugihara et aI, 1993). Furthertllore, T cells associated with
thyroid disease recognize evolutionarily conserved
determinants on Tgs of various species (Maron et aI, 1983;
Romball and weigle, 1987; Zerubavel-Weiss et aI, 1992; Hiyama
et aI, 1993; Sugihara et a1, 19931 Hutchings et al 1992;
Texier et aI, 1992; Rao at aI, 1994). Recently, it was shown
that an autologous (rllt) homologue of an immunopathogenic
epitope of bovine interphotoreceptor retinoid-binding protein
(IRBP) failed to induce experimental autoimmune uveoretinitis
(EAU) in Lewis rats (Kozhich et aI, 1994). The pathogenic
autoimmune response induced by the heterologous bovine IRBP
peptide (1181-1191) was directed to a "surrogate epitope"
(273-283) but not its homologue (1181-1191) on rat tRBP,
highlighting the molecular mechanism involved in heterologous
peptid<1-mediated autoimmune disease.
Previous I}' it was shown that an 18mer rat Tg peptide,
rTgP2 (2695-2713) causes EAT in an heterologous species (mice)
(Carayillnniotis et aI, 1994). This peptide was identified by
using algorithms (Margalit et aI, 19891 Rothbard and Taylor,
1988) that scanned the known portion of the rTg. The rTgP2-
mediated EAT in mice is characterized by specific T cell and
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IgG responses and mononuclear infiltration of the thyroid
induced by both direct challenge ",ith the peptide and adoptive
transfer with peptide-primed LNC. Since the primary amino
acId sequence of mTg is not known, at preser.t, it is uncertain
whether or not rTgP2 constitutes a self epitape on rnTg. Since
its immunopathogenicity in an homologous species is unknown,
I have addressed whether or not rTgP2 (1) is immunogenic at
the T- and B- cell levels and causes thyroiditis in rats, (2)
contains dominant T cell determinants in the context of
homologous Tg. and (3) generates MliC-restdcted peptidc-
specific CD4· T colls that can transfer thyroiditis to nillvc
syngeneic rats.
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5.2 Results
5.2.1 Priming .itb TqP2 induces IIpecific LNC proliferative
a.nd rqa re.poDse. in different rat strains
To perform EAT studies with rTgP2 in rats, it was
necessary to idE::ntify the responder rat strain in which the
peptide induces we proliferative responses, because Tg-
specific~ LNe proliferative responses correlate with
susceptibility of rats to thyroiditis (Lillehoj and Rose,
1982). Three different rat strains namely F344 CRT-I l ), WK'i
(RT_lk) and WF CRT-I"', that were used in TgPl (2495-2511)-
mediated EAT studies earlier (Chapter .), were injected with
200 nmol TgP2 in CFA in one hind footpad. Fourteen days
later, the proliferative response of primed popliteal LNe was
determined in the presence TgP2 (specific Agj and TgPl
(control Ag). As shown in Figure S.lA, TqP2 could induce
proliferative responses In a dose dependent manner of LNC from
F344 and WKY but not WF rats. The responses are specific
because only background WC proliferative responses were
observed to control peptide, rTgPl (Figure 5.18). These data
indicate the permissive recognition of rTgP2 in different RT-l
haplotypes, and rTgP2 induces LNC proliferative responses in
rats of p<l.rticular MHC haplotype only.
Serological analysis of the Tgp2-primed sera from the
same rats that were used in the priming experiment (of Figure
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rigure 5.1A-8 Proliferative LRC reapon••• in rate of v.rioull
RTl haplotype. to TqP2 (Il) and TgPl (8)~. Rats (2
rats/group) were injected with 100 1-11 of erA emuls.lon
containing 200 nmol TgP2 into one hind footpad. Fourteen days
later, the draining popliteal LNe were removed and incubated
with the indicated doses of TgP2 or TgPl for 4 days. lpi]-TdR
was added during the last 18 hr of the culture. The assay was
done as described (Seotions 2.71. Background I.NC
proliferative rQsponses (mean cpm of quadruplicate wells) in
the absence of antigen were as follows: WKY - 19,340: FJ"4 -
12,178; WF. 6,427.
Figure S.le-I! Reactivity with TqP2 (e), intact r'l'q (D), and
h••t denaturad rTg (2) of day 14 eera fro. '1'qP2-pri••d rats of
4ifferent strain.. Analysis of ~ooled serum samples frail
TgP2-primed rats (2 rats/group) troll different rat strains
obtained 14 days after footpad challenge with 100 Jl.1 of CPA
emulsion containing 200 nmol TgP2 (of Figure S.lA). specific
IgG reactivity against the indicated Ags was measured by an
alkaline phosphatase-based ELISA (section 2.19). 0.0. 405 nm
readings are mean of triplicate wells and arc expressed as
lQean +/- SO. Mean of the background values at 0.0. 405 nm WIlS
0.121. TgPl or ovalbumin was used as a control antigen.
o
o
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S.IA), revealed the presence of TgPz-specific IgG in all three
rat strains. It was observed that, at the serological level,
TgP2 is more immunogenic in F344 and WKY rats than in WF rats.
Subsequent analysis of the reactivity of peptide-primed sera
with rTg revealed that Tgp2-specific IgG of F344 but not WKY
and WF rats reacted with intact rTg (Figure 5.10), although
the same sera from all of the above three rat strai.ns reacted
with heat denatured rTg (Figure S.lC). These data show that
TgP2-specific: IgG of different rat strains recognize distinct
epitopes within the TgP2 site on rTg, and TgP2-specific IgG
recognize linear B cell epitopes. The data clear.ly
demonstrate that the homologous r'TgP2 is immunogenic at both
T- and B- cell levels in rats.
5.2.2 Direct cballenge of P3H rats vit.b TgP2 inducas .ild
thyroiditis
To test whether or not TgP2-induced we proliferative
responses correlate with susceptibility of rats to
thyroiditis, F344 rats were selected for further EAT studies.
Thyroids collected on day 28 from rats (J/group) challenged
with TgP2 (immunization procedure is described under Section
2.9) showed a mild degree of mononuclear infiltration in 2 out
of J rats (664 incidence) (Table 5.1). In contrast, thyrojds
from control group rats (adjuvant-primed) did not show thyroid
lesions. These data indicate that rTgP2 causes thyroiditis in
if
Table 5.1 Direct challenge ofF344 tats with TgPZ induces mild thyroiditis-
Inviro Infjlt[itiQDiDlkx Ratswitb % incidence
0 0.3 1.0 2.0 3.0 4.0 thyroid tezjorn
~
CFA+TSPl 1 2 2J3 66%
CFA 3 0/3 0%
~
CFA+TV'l 1 1 2 3/4 75%
CF:\ 4 0/4 0%
.. Rats \'..ere primed with 200 nmot TgPZ and Bo:=erel1a perrusrisandl week later they were
bccsted with 100 nmol peptide. Connol :::micals were injected with CFA and Borderel1a
~:r'3':SCf'.l'i as de~:ibcdunc.er )'1ateriab and)'lethods (Section 2.5). Three weeks after the
seo:cnd challenge, the :nyroic. slands were rel!:ovcd and mononuclear ceU infiltration of the
thy:oi<h was~ed as des.::ribed I:nder Materia!s2nd Methods (Sterian 2.9).
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rats. specific LNC proliforative responses correlate with
susceptibility of rats to thyroiditis and are in agreement
with earlier data using Tg (Lillehoj and Rose, 1982).
5.2.3 ~ (efficient) but not~ (ineftiel_ntt
processing of hOJDoloqOUB tbyroqlobulin results in activation
of 'l'gP2-apeoiUo proliferative or oella
To address whether or not TgP2 contains dominant T cell
determinants in the context of homologous Tg (rTg) in rats,
F344 rats (2/qroup) werE:: challenged with 100 jJl of emulsion
containing 200 jJg rTg or 100 nmol TgP2 ("r no antigen into one
hind footpad and, 14 days later, LNC proliferative assays were
performed. The results are shown in Table 5.2. The
rTC;;-primed LNC proliferated strongly to rTgP2 but not rTg
itself. Furtharmore, TgP2-primed LNC proliferated strongly to
TgP2 but not rTg at equimolar doses. CPA-primed WC failed
to proliferate in the presence of Tg-peptides. Proliferative
responses were specific, because no responses WE're detected to
the control peptide, rTgPl. These results indicate that (1)
.in......Y.iY.2 processing of rTg leads to generation of the TgP::!
sequence and activation of peptide-specific T cells, (2)
processing of rTg .iILYi.tl:2: is inefficient, and (3) the TgP2
sequence contains non-dominant T cell determinants in rats
since .in...Jl...i... pulsing of TgP2-primed LNC with rTg did not
ii'
Table 5.2 T gP2 contains non-dominant T celt determinants
In vivo In vitro txmlite-al LNC ntolif~rntiveremom~ (51 +/. Sma
T(>PI
9)L\1 lpM
TIIP2
l)JM O.l}JM
,T.
lpM O.lpM
CFA + T,Pl
CFA+rTI
CFA
1.0+'·0.3 0.8+'.0.2 ~ 1.8+'·0.1 0.9+'·0.0 I.2+f-O.3
0.9 +/. 0.1 0.9 +1- 0.1 i..l.±.!=...Q.. .l.6...±.!.:... 1.4 +1· 0.2. 1.5 +'- 0.1
0.9 +'- 0.1 1.0 +/. 0.1 1.1 +1. 0.4 0.5 +1. 0.2 1.0 +,. 0.3 0.9 +,. 0.2.
a F3H f:lts were Injected into one hind footpad with 100 JJI of CFA emulsion containing 200 pg rTg or 100
nmol TIP! (210 ,ue:} or no antigen. FO\,lneen days later I their popliteal LNC Vlefe collected and stimuhned (or
4 days in \';tro with the in2c:ned3fl~igensasshown: 1 )J-\{ TaPI '"' 2.1 PI/ml,l jJM TaPl "" 2.1jJgfml; 1 J.lg
rTg =660 }Jglml. The backg:-ound proiiferative :esponses (mean cpm) in the absence ofantigen for different
I:roupl were 3S follows; C:=A + TeP2 = 5.409; CFA + TTg "" 14,037; CFA '" 11,611. The prolifeTative
Ttsponses (cpm x 10.3) to PPD in vin" for diffe~ent groups were as follows: CFA + TilPZ = 8.3 +1. 0_7; CFA
+ TTg =5.9 +/.0.5; CFA = 3.9 +1. 0.6.
• Unde~Hntod \'ah::~ d\!!!'lote ii~d"iC<int prolue:-ath-e respc•.1e1 (51 > 2.0) to T IIPZ,
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result in TgP2-specific LNe proliferative responses.
5.2." The TgP2-specitic T line cells are of CD"·, CDS', TCR-
a/O·, and CD4SRC' phenotype
To characterize the TgP2-specific T cells in FJ44 rat5,
a short term TgP2-stimulated T cell line was generated and
stained W'ith various MAbs specific for rat lymphocytes, The
resu1ts of the FACS analysis of the T cell line are shown in
Figure 5.2. The T line cells are OX-19' (99.7\). WJ/::!5'
(98t), OX-8' (2%) and R73" (99%:), a phenotype charactf'rbtlc
of rat CD4·, TCR a/B' T helper/inducer cells. Allor t.he 'r
cells were OX-22- (100\), a finding consistent with thO::!
notion that the T cell line predominantly consists of memory
T lymphocytes (Spickett et aI, 1983; Powerle and Mason, 1909).
A minor popUlation of T cells expressed RTI-B (OX-6') (15 %)
and RT1-D (OX-17') (6\' HHC clas~ .- molecules which suggests
that activated rat T cells express MHC class II determinants
(Reizis et aI, 1994).
5.2.5 The TqP2-speoif1c T l1ne cells recognille the peptide in
the context of HRC 0188s II aoleoule.
To further characterize the above TgP2-stimulated T cell
11ne, a proliferative assay was performed. In the specificity
assay (Table 5.3), the T cells responded to rTgP2 but not to
rTgPl (control peptide) or PPD. However, the T cell line
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itiqura 5.2 Plow oyto••tric aDaly.ia of 'I'gP2-apeoiric T oel).
line. Cultured FJ44 rat T line cells (obtained after 4 days
of a third .in..y.J.Y:g boosting with rTgP2) were incubated with
appropriately diluted primary MAb Against rat T cell surface
m~rkers (QX-19. WJ/25, ox-a, R73, OX-6, OX-I7 and OX-IS) or
with an isotype-matched control NAb (HB 64) and then with
rITe-conjugated goat secondary Ab. Flow cytomctric analysis
was performed as described under seotion 2.13 using a FAC5star
plus analyzer (Becton Dickinson, CA). Data are presented as
histograms ot log tluorescence intensity~ relative cell
number. Shaded areas represent T cells incubated ....ith both
pdmary MAl::: s.;>ecitic for rat T cell markers and secondary Abs:
white areas represent T cells incubated with primary control
HAb and secondary Ab.
OX-17I'
/
.r
~ I I
OX·19 W \ OX-22~
~
I' I' I' 1)~"
w/\
R73 L~6~ •ii, I' I' ""lSI,) \I I' I' I' I"
Log fluorescence intensity
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exhibited a weak but significant proliferative response to
heterologous TgP2 (human TgP2 .. hTgP2) that shares 79'
a.a.sequence homology with rTgI"2. These results indicate
that the T cell line is TgP2-speciflc and recognizes conserved
T cell determinants an heterologous hTgP2. Furthermore, the
T cell line failed to recognize rTg itself in the culture, a
finding confirming the earlier data obtained in LNC
proliferative assays Crable 5.2) that ..l..n.....YitJ processing of
rTg does not generate the TgP2 sequence. Furthermore, when
rTg-pulsCd splenic APC were used, no proliferative response of
the T cell line was observed (data not shown).
To test whether or not t"l'qP2 is recognized in the context
of RTI-B or RTI-D MHC class II molecules, antibody blocking
studies were performed. The results are shown in Table 5.3.
Addition of either OX-6 or OX-17 NAb but not the isotype-
matched control MAb (HB 64) (anti-matrix protein of Influenza
type A MAb) to the culture, significantlY inhibited (34%)
TgP2-induced proliferation of spocific T line cells. These
results indicate that TgP2-specific T cell line recognizes
rTgP2 in the context of both RTI-B1 and RTI-O' HHe class II
molecules. The results can also be interpreted as TgP2 is
presented by both RTI-B1 and RTI-01 HHe class II molecules and
the T cell line h,,"5 a mixture ot speciticities.
!:If>
Tllbte 5.3 Specific T cell line recognizes Tr::P2 ill the context (,[ MUC
clllSS II molecules
III virro
SpcclOclty assayS
tTgPl (lJ.lc/ml)
hTr,N (lO)lll/m\)
(lpg/ml)
tTC (660)IC/mt)
TI:PI (l)lll/l1ll)
PPD (10 .Jg/ml)
Nomlfigcn
D.Hill.ln~c
NIL
OX·6 (tIIltl-I-A)
OX.I1(llntl.!-E)
Hfi64 .(control MAb)
NQUlUh'ClJ
IUlirrolYlllphocytc prolifcnHivcrcsp<.lllsc.:s
(menncpm ... /·51))
46,01( /.l,HS {Il.l ...'. l.O)b
6,605 ,- ·129 ( 3.1 +1. O.l)
3,399 +/. 457 ( 1.6+'.0.2)
1,789 +/- 601 ( 0.8 +/- 0.3)
1,9,15 +1. 10l ( 0.9+/· 0.1)
1,897 +/. lM ( U.9 +/.0.1)
2,161 ...,. Sal
19,10" +/- 2,053 (0%).
32.,650 +/- 891 (3'1%)
32,376 +/- 1,9RR (31%)
47,91l +1· 4,02S (3%)
2 ](17 +/_ l(ll
a T (inc cells (104/wcH) were incuhnted ill the prescnce or :lllscncc of i\)dir.at~d alllir.ells
and IrrnJinte{{ thymic APe (106/well) for 3 days. Durin!: the Inst 18 lit or cultllre, rhe
cells were pulsed with I pel/well of JI-I_TdR. The rest of the assay W:lS done as d{~s(.rilll:tl
under M<lterlals<lnd Methods (Section 2.U).
b Values In the parenthesis represent 51 +/. SD.
C T line cells were incubated wltlllrrmliated APC ns llbove In the lJrt'scncc or nl}Sl~I\Cl: of
TgP2 at SJJg/mlandthelndlcated bleckingMAb: OX-6 (12.51Ig/1ll1),OX.17(L56
J.1g/ml) 81\d I-IBM p.llS Jig/mil. At these concellWltions. the OX·6 JlI1d OX.I? Mflbs
wete non toxic since they did net Inhihit con A stimulntion of nlt splenic cells.
c1 Percent Inhibition of proliferation W<lS cnkul<ltc(1 ns de~cTibed under M:ncrials alit!
Methods (Section 2.7).
176
5.2.fi 'lbe T9'P2-.p.ci~ic CD"+ '1' cells are MBC-unr.stricted
To address whether rTg:P2-specific T cells of F344 rats
are MHc-restricted, an MHC-restrlction assay was performed
using syngeneic (F344) as well as allogeneic (WKY and WF) rat
thymic APe to present TgP2 or its overlapping N- and c-
terminal 12mer peptides to TgP2-specific T cell line. The
results are shown 1n Figure 5. J. The T cell line proliferated
strongly to an lamer rTgP2 or an N-terminal 12mer (2695-2706)
but not to a c-tenl'linal 12rner (2702-2713) peptide in the
presence of syngeneic (F344 rat) APe. Howev'!!!:", the intensity
of proliferation was stronger in the presence of the 18mer
TgP2 than the N-terminal 12mer peptide. These results
indicate that the specificity of the T cell line is directed
to determinants within the N-terminal 12mer (2695-2706)
peptide. Unexpectedly, T line cells also proliferated when
allogeneic APe from WKY rats were used to present TgP2 or the
N-terminal but not C-tenninal 12mer peptide of tTgP2.
Presentation of the e-terminal 12mer peptide of rTgP2 by APe
from WKY rats to the TgP2 specific T cells from F344 rats did
not induce proliferation. In contrast, the T cell line
fdled to proliferate to the above Tg peptides when allogeneic
APe from WF rats were used. The observed proliferative
responses when WRY rat APe were used are not due to
allorecoqni tion because allogeneic APe either unpulsed
pulsed with the control peptide (TgPl) failed to induce
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Figure 5.3 The 'rqP2-speoific l" cell line reooqDi••• TgP2 or
an ll'-terminal 12••r (2695-2706) peptide in an KIIe-unrestricted
fashion. F344 rat T cells (1 x 10'/we11) were cultured with
irradiated (2000 rad) thymic APe (1 x 106/we11) from different
rat strains in triplicate wells of 96-101011 flat-bottomed micro
culture plates for 72 hrs. The cultures were pUlsed with 1
JjCi of 3H-TdR/well during the last 18 hr of CUlture. The
HHC-restr!ction assay was done as described under section
2.14. The values are expressed as 51 +/- SO of triplicate
cultures. The stimulation indices (51) obtained when T cells
alone were incubated with TgP2 at 20 1-!9/ml "" 0.3 +/- 0.1 ; 2
JJ9/ml =: 0.3 +/- 0.21 0.2 JJg/ml - 0.2 +/- 0.2; 0.02 J.lq/ml - 0.4
+/- 0.1. Background proliferative response of T line cells
when incubated with APe from different rat strail1S
follows: F344 ... 2,167; WKY ,.. 1,070; WF '" 357.
.1 1 10 100.01 .1 1 10 100
Peptides in vitro
-<>- 2695·2713 (lamer)
- 2695-2706 (N-termina112mer)
--tr- 2702-2713 (e-terminal 1Zmer)
..J.
C. WF rat APC
(RT_1u)
~
6. WKY rat APC
(RT.,k)
A. F344 rat APe
O
(RT.,I)
4 i
l2
.01 .1 1 10 100 .01
.g 30
.E
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178
significant T cell proliferative responses. The proliferative
responses were also not due to the mitogenic effects of TgP2
on T cells, because T cells incubated with graded doses of the
peptide did not exhibit significant T cell proliferative
responses (see legend to Figure 5.3). These data clearly
indicate that the rTgP2-specific T cell line is MHC-
unrestricted, is APe dependent for its activation, and
recognizes determinants within the "'-terminal 1211\er peptide
(2695-2706).
5.2.7 The TqP2-specit'io CDC· '1' cell line adoptively transfers
thyroid! tis to naive IIYllgeneio rats
Next, we sought to address whether or not rTgP2-mediatcd
EAT in F344 rats is a CD4' T cell-mediated disease. Pollowing
adoptive trans.!er of 1 x 108 Tgp2-prillled and TgP2-boost~d .Ll!:!
~ LNe, a moderate degree of mononuclear infiltration of
the thyroid (mild thyroiditis) was observed in 50\ P/6) of
the recipient rats 10 days post-transfer (Table 5.~ and
Figure 5.4 A-B). In contrast, a control group of rats
(3/group) that received we either from CFA-primed rats that
were con A-boosted i!:l...Jl.ll[.Q or ovalbumin-primed rats that were
ovalbumin-boosted in.....Jl.i.t.I, did not shoW' thyroid lesions
(Table 5.4). Furthermore, histological examination of the
thyroids from rats that were injected with T line cells (CD4'
CDS" TCR alB»~ (Figure 5.3) at 10e cells frat (4 rats/group)
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revealed extensive infiltration with mononuclear cells in loot
(4/4) of the rata (Table 5.4 and Figure 5.4 C-O). The data
clearly demonstrate for the first time that TqP2-induced rat
EAT is lIediated by CO... • ~ COS- • TeR at': T cells.
5.2.8 The 'l'gP2-iDduoed Tq-r••otiv, Iqa b directed to
deterJIinants witbin but not oubide the 'l'qP2 d t. on Tq
Since rTqP2 1.s seroloqically immunogenic (S.le), it was
of interest to see whether or not secondary immune response
sera would similarly react with ~ntact rTq and whether the
elicited IgG was directed to deterJIinants within the TqP2 site
on rTg. The results are shown in Figure 5.5. Analysis ot
pooled sera troll the Sllme rats as used 1n Ta.ble 5.1 (Expt. No.
1) by ELISA dellonstrated the presence of rTgP2-specific IgG
that react with intact rTq but not TgPl (control peptide)
(Fiqure 5. SA). Increased reactivity was also observed against
heat denatured rTg. 8 finding co.patib1e wi.th the notion that
peptide-induced Tg-reactive :IqG recoqnl2:es linear B cell
determinants. These data confirmed the results obtained
earlier with TgP2-prlJlled primary illllllune response sera (day 14)
as ShOWl1 in Figure S.lD-E. Day 28 sera obtained fr011 control
group rats (primed with CFA and Bordeti!llA Pertussis on day 0
and boosted with :IrA on day 7) did not sho,", reActivity to
rTgP2.
To determine whether or not TqP2-induced Tg-reactive IgG
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is directed to detenainants within the 'l'gP2 site on Tg, we
performed a coapetitive inhibition ELISA. The results arc
shown in Figure 5.58. The results indicate that th6
rTgp2-specific IgG that binds to intact rTg was not composed
of Aba specific for detenlnants outside the rTgP2 site,
because free rTgP2 but not TgPl inhibited ncar to camp] etlon
the binding of rTgP2-specific IgG to rTq (Figure 5.58). This
observation reflects the absence of "intramolecular
detenninant spreading" at the serological level in rTgP2-
induced rat EArl'.
~ Table 5.4 T gP2-specific CD4+ T cells adoptively transfer l:hyroiditis '[0 naive F344 Tats
Inmo In vitro InfiltratioD index Rats with Incidence
0 0.5 1.0 2.0 3.0 4.0 thyroid lesions
Bulls Culture I NCB
CFA+TgPZ TgPZ 3 3 3/6 50%
CFA+OV3 Qv, 3 013 0%
CFA ConA 3 0/3 0%
~b
TgPZ._ilk TgPZ 0 3 1 4/4 100%
a Primed-popliteal LNC from F3-H rats were boosted in viero with appropriate antigens at the indicated doses
(TgPZ =lOpglml; ConA = lOj.lg/mljOvalbumin '" 25 j-Ig/mt) fo~ j.5 t04 days, washed three times with HBSS
and injected i.p. into syngeneic rats at 1 x 108 viable cells/rat as described under Materials and Methods
(Section 2.14). The thyroids were obtained after 10 days post-transfer and histological examination was done as
described under Materials and Methcds (Section 2.9).
b FicoU<ut TgPZ-speeific eDT+ T line cells after 3.5 days of in viao stimulation with TgPl, were injected into
naive s)'ngeneic tats at 1 x 108 vi2ble cells/rat. Thyroids were collected 10 clays pon.U:lntter and histological
examination was performed as ~-:i.bed in ~'1aterialsand~ethods (section 2.9).
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Fiqura 5. U·D Phot.omicrograpbs ahowiuCj the TgP2-!ndueed
lIononucl••r infiltration in the t.lJyroid. Mononuclear cell
infiltration of the thyroJ.j, in F344 rats observed after Lp.
adoptive transfer of 1 x 108 syngeneic TgP2-primed LNC [1t. ( X
12.5) or B ( X 200)] or i. p. adoptive transfer of 1 x 108
syngeneic T1JP2-Bp~cific T line cells (0 ( X 12.5) or D ( X
200)]. Arrows indicate the accumulation of mononuclear cel.Is
in the thyroid.
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Fiqure s. SA '1'9P2~.p.citiCl I:qG reaoqni.. linear B ceU
dei:eminants on r'rg. Demonstration of immunoreactivity of
pooled TgP2-primed rat sera obtained 28 days after TgP7.-
priming (primed on day 0 and boosted on day 7) of F344 rats
(3/group) (of Table 5.1; Expt. No.1) to TgP2 (0.21 #9/wellj,
intact and heat denatured rTgs (1 /.'9/we11) by a direct ELISA
as described under seotion 2.19. The values arc expressed as
mean +/- SO of duplicate wells. Mean of background values was
0.149.
Figure s.~~ COllpetitive ELISA ot aerwa Ig'G-bindinq to rTg
using' tbe 181l1.er TgP2 or the 17IRer TgPl &. inhU:aitor(s).
Inhibition of binding of TgP2-!nduced Tg-react!ve IgG (to rTg
coated on the plate) present in TgP2-primed sera by free TyP2
but not TgPl. TgP2-primed serum (of Figure 5.5A) at 1/512
dilution was added to the wells with simultaneous addition of
five-fo1d dilutions of TgP2 or TgP1 starting at 200 molar
excess of rTg coated (1 ~g/well) on the PVC plate. Tho values
are expressed as mean +/- SD of triplicates. The assay was
done as described under Seot:ion 2.20. Maximum 0.0. 405
reading at 1/512 dilution of TgP2-primed serum in the absence
of any competitor peptide was 1.62 +/- 0.03. Mean of the
background values is 0.106.
3A.~
§ 2
'0
o
~
ci
01
Antigens all plate
--Q-TgP2
-e- Inlocl rTg
---f:r- Denatured rTg
--*-TgP1
lB:5b
o-I-~...-.-i.4---l
100 1000 10000100000
Reciprocal serum dilution
2 B.
H;-..------
\
o+-~~_~--l
.01 .1 1 10 1001000
Molar excess of peptides
lB'
5.3 Di.eu••!oD
The results presented in this chapter demonstrate that
the lamer homologous Tg: sequence, TgP2 (2695-2713) is
thyroiditogenic in rats and sho.... for the first time that Tg:
peptide-specific MHC-unrestricted CD4" T cells adoptively
transfer organ-specific autoimmune thyroiditis to naive
syngeneic rats.
The recognition of the lamer TgP2 by F344 rat T cells in
the context of both RTI-B and RTI-O HHe class II molecules
(Table 5.3) is analogous to the recognition of 17mer TgPl
described earlier (Table 4.3). However, neither of these Tg
sequences (TgPl and TgP2) encompass the putative MHe class II
(RTl·B l ) binding motif (S-----E) (Wegmann et aI, 1994; Zhao et
aI, 1994), but both of these Tg: peptides are pathogenic in
F344 rats (Table 4.1 and Table 5.1). ThUs, the data indicate
the lack of a correlation between haplotype-specific MHe class
II binding motif and RTI-BI-restrictelS pathogenic TgPl (Table
4.3) and TgP2 (Table 5.3) sequences. The present (Table 5.:Q
and previous (Table 4.3) data bring into question the
generality of the haplotype-specific MHe cll:lss II (RTI-S l )
binlSing motif (S-----E) in identifying pa't.hogcnic cpitopcs.
Moreover, the present data highlight the utility of haplotypc-
independent algorithms that search for putative T cell
epitopes (Margal!t et aI, 1987; Rothbard and Taylor, 1988). In
contrast, other investigators have identifieq T cell epitopes
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on autoantigens using Rothbard and Taylor (1988) tetramer
motif ....ith variable rates of success (Fuji and Lindstrom,
1988).
Distinct effector functions (Figure S.IA and s.le) Le,
T cell~ Ab responses, elicited by TgP2-priming in rats
of diverse MHe haplotypes may be a consequence of MHC control
of CD4· T cell subset (Thl or Th2) activation. These data are
analogous to those reported for various Ags such as the human
collagen type IV (heal IV) (Murray et a1, 1989) and a 30 mer
peptide of a chain of heal IV (Hurray et aI, 1992) in mice and
a 26mer peptide of HBP (Mustafa et aI, 1993) in rats.
Alternatively, the present findings (Figure 5.1) may also be
an effect of NHc-peptide ligand density (Murray et aI, 1994)
Le., high MflC class II/peptide density on the APC surface
favours Thl-like (proliferative) responses, while low MHC
class II/peptide density hvours Th2-like (non-proliferative)
responses. Additional experiments such as epitope
specificity, MHC-restriction, lymphokine analysis and
functional profile of Tgp2-specific T cell clones in various
rat strains are needed to extrapolate the phenomenon of MHC-
peptide ligand density to the pr(:sent findings.
The induction of TgP2~specific IgG (Figure S.lC) but not
T cell proliferative res/?onses in WF rats is in agreement with
the concept that peptide-specific non-proliferative Th cells
can help 8 cells to produce IgG (Evavold and Allen, 1991).
18.
The current results (Figure 5.1) also suggest that TqP2 aay be
recognized by both proliferative and non-proliferative (Th2)
T cells in P344 and WKY rats, because TgP2-priaing of these
two rat strains readily elicited both T- and 8-cell responses.
It is also possible that specific proliferative and non-
proliferative T c9116 may recognize distinct epitopes within
TgP2 analogous to the distinct epitope recognition within a
fibrinopeptide by specific proliferr,tive and non-proliferative
T cells (Peterson et aI, 1983). The present findings (Figure
5 .1A and 5. Ie) are in apparent contrast to the immunogenici ty
of TgPl (2495-2511) described earlier In the above rat strains
in which Tgpl-prindng of rats induced specific proliferative
T cell but not primary IgG responses (Figure 4.2A-B). Thus,
it is reasonable to speculate that TgP1- and TgP2-pr:i.ainq of
rats elicit T cells with distinct effector functions. The
present (Figure 5.1) and previous (Figure 4.2) data also
indicate that silllilar or distinct Tg peptides bind vi'.rious MIIC
class II moleCUles. Analogous findings were reported (or
peptides of AChR (Fuji and Lindstrom, 19881, and of MOP
(Vandenbark et aI, 1985) in rat strains of various MIIC
haplotypes. Thus, rocoqnition of Tg epitopes in various
inbred rat strains suggests that similar (duC! to thoir
promiscuity in MHe binding) or distinct Tg epitopes (due to
lack of promiscuity in MHC bindinq) may be recognized by
autoreactive T cells in the context of distinct or siJnilar MHC
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class II aolecules in patients with AlTO.
Der.onstration of J..n.....yUg but not~ processing of
hOlQOlogous 1'9 (rTg) as assessed by activation of 1'Tg-priUed
IJ{C by TgP2~ (Table 5.2) is particularly surprisina.
Analogous findings were reported earlier in mice ",!t::l diverse
"'g5 such as acetylcholine receptor (AChR) and renal tubular Ag
(RT~) (Yoko! et ai, 19B7; Heeger et aI, 1994). It was shown
earlier that AChR-prill'led LNe from C3H/He mice failed to
respond to the intact Aq ~, although the same LNC
proliferllted significantly to three distinct AChR peptides
(67-82; 146-162; 170-186) (Yoko! et aI, 1987). In another
study. it was shown that sOlie of the T cell clones isolated
frolll RTA-prilled aiee responded vigorously to It 22mer P2
peptide of RTA but not to an intact RTA in....Y1.tI2 (Heeqer et
aI, 1994).
The underlying .echanin for the results obtained in the
present one and previous studies (Yokol et aI, 1987; Heeger et
aI, 1994) is not clear. Several .echanisms have been proposed
or shown to explain how T-cell deteminants are selected for
presentation in the context of class II MH: molecules (Sercarz
et aI, 1993). Howevor, these mechanisms ramain poorly
understood. It can be proposed that the present findings may
be a result of altered A9 processing and presentation of Tq
epitopes by activated APC. These APe will be influenced by
the cytokines released as a result ot the inflaI:lJlation
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generated at the site of iuunization W'ith eFA ellulsion
containing rTg. This will subsequently lead to .i.n........Y.i
activation of P'lptide-specific T cells. consistent with this
possibility are the recent findings in the EAE model in which
T cell responses to cryptic T cell determinants of MBP arc
induced following challenge of mice with a dominant MBP
peptide (Acl-Ill (Lehmann et aI, 1992). The failure of TgP2-
primed LNC to proliferate to rTg in.....YJ..t.J; suggests that .1.n
:ti.tl:2 (inefficient) processing of Tg may not result in tho
generation of TgP2 sequence but rather leads to its masking or
destruction.
The in.....U:i2. activation of TgP2-specific T cells following
r'I'<j-priming of rats (Table 5.1) suggests that TgP2 but not
TqPl Illay be one of the few i_unopathoqenic deterllinants
within Tg participating in Tg-Illediated rat EAT. This finding
is analogous to previously known pathogenic Tg peptides in
mice (Hutchings et al, 1992; Texier et al, 1992). ThUS, it
would be interesting to test whether rTg-primed LN'e that were
TgP2-boosted~ could transfer thyroiditis to naive rats
in view of the t'indings that TgP2-prlmed and TgP2-boosted LNe
adoptively transfer thyroiditis to naive syngeneic rats (Table
5.4) •
The present demonstration of the failure of rTg-primod
we to proliferate to rTg 1n.....Yi.t.x:2 (Table 5.2) is not new in
thyroid autoimmunity, This finding confirms (Hirose ot all
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198Bb) and extends (Hunter, 1986: Williams et aI, 1986)
previous data reported for various autoantigens such as rTg,
MBP and mTg in diverse species. In both of the latter
studies, it was shown that adoptive transfer of antigen-primed
we to naive syngeneic animals mediated pathogenic
autoimmuni ty, although the Ag-primed LNe failed to
proliferate to corresponding Ag~ In the present
study, as to why the rTg-primed LNC from F344 rats fail to
proliferate against rTg~ is unknown. It is possible
that self-antiqen priming may elicit specific T suppressor
(Ts) or immunoregulatory cells that pravent or inhibit the
proliferative responses of 5e1f-Tg reactive T cells .1n...Y..1..t.I
as suggested earlier (Rose et aI, 1981). Alternatively, F344
rat T cells may be hyporesponsive to homologous Tg (rTg) as a
result of these cells being anergized in the periphery by Tg
epitope presenting B cells as hypothesized earlier (Weigle ct
aI, 1980). However, it is clear that tolerance to rTg is
incomplete, because challenge of F344 rats Iofith rTg in
adjuvants readily induces thyroiditis (Lillehoj et aI, 1981
and Lillehoj and Rose, 1982). It would be interesting to
examine Whether or not rTg-primed U1C that were rTg-boosted in
Y..i.t..L:Q will transfer thyroiditis to naive syngeneic rats
similar to other studies (Hunter, 1986; Williams et aI, 1986).
Adoptive induction of severe to mild thyroiditis with
Tgp2-specific T line cells and TgP2-primed LNC (bUlk LNC
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culture) respectively, may be due to the difference in the
number of pathogenic T cells present in the T cell line as
apposed to bulk LNe culture. This interpretation 1s
consistent with previous findings that cell dose used in
adoptive experiments critically influences the adoptive-
transfer of thyroiditis in .tIlee (Maron et aI, 1983). The
demonstration of TgP2-induced rat EAT as a CD4' T ce11-
mediated disease (Table 5.4 and Figure 5.4) is in agreement
with previous reports on adoptively-mediated thyroiditis with
rTg-primed LNe in rats (109 LNe/rat) (Twarog and Rose, 1970)
and with Tg-specific CD4' T cell lines and clones in mice
(Maron et a1, 1983: Romball and weigle, 1987; sugihara et a1,
1993). Induction of autoimmune (thyroid) lesions by the TgP2-
specific T cell line is organ-specific, because no lymphocytic
infiltration was observed in other organs such as livers and
kidneys of the recipient rats (data not shown) .
The N-terminal 12mer Tg peptide (2695-2706) (Table S.3)
recognized by the pathogenic CD4+ T line cells encompasses the
tetramer motif "nIQ" (Rothbard and Taylor, 19G8). This
observation further confirms the uti! i ty of haplotype-
independent algorithm (Rothbard and Taylor, 1988) for
identification of T cell epitopes on known autoantigens. The
stimulation of the Tgp2-specific T line cells (Table 5.3) with
heterologous TgP2 (hTgP2) (Halthiery et aI, 1987) [Which also
contains the tetramer motif "~" (Rothbard and Taylor,
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1988) ) is in general agree.ent with earlier reports that
thyroiditis-inducing T cell lines and clones recognize
conserved T cell epitopes on heterologous Tgs (Romball and
Weigle, 1981; Suqihara et aI, 19931 Champion et aI, 1987).
This observation, analogous to TgPl (Cb.pter4), has raised the
possibility that interspecies-conservative Tq epitopes may be
involved or important in the induction ot AlTO in humans.
The significant abrogation of the Tgp2-specific 'r cell
proliferative responses by HHe class II~Bpeclfic MAb (Table
5.3) may imply a role for MHe class II antigens 1n TgP2-
mediated rat EAT. However, it remains to be established
whether disease transfer requires TgP2-speclfic T cells
restricted by RTI-B or RTI-D class II moleCUles alone or both.
The ability of TgP2-specific T cell line to prOliferate at
a higher intensity against the l8mer TgP2 than the »-terminal
12aer Tg peptide (2695-2706) suggests that amino acid residues
flanking the core daterJIinant positivoly influence the peptide
recognition by T cells (Bhayani et aI, 1988; Vacchio et aI,
1989; Nelson et aI, 1994).
Although the TgP2-specific CD4" T call line adoptively
transfers severe thyroiditis to naive syngeneic rats (Table
5.4), the putative APr- that present Tg epitopes to these T
cells .iD.....:iiY.2 remain uJlknown. This question was raised
because these T cells failed to proliferate in the presence of
rTg-pulsed thY1llic APe (Table 5.3) or splenic APe 1n.....Y1..t.Dl
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(data not shown). Though TgP2 is generated by processing or
rTg by draining lymph node APC~ (Table S.2), it is not
known whether TgP2 is similarly c;zenerated by class II"
thyrocytes by thellselves in the tat"1}et organ (Hirose et ai,
1988a) leading to sUbsequent activation of thyroid-homing T
cells.in....-Y.iY.2. This can be tested by using untreated
thyrocytes (MHC class") obtained from unimmunized rats or IFN-
y treated thyrocytes (MHC class n") to activate the TgP2-
specific T cell hybridomas and assayIng for IL-2 reloase
analogous to tho experiments performed previously wJth an
imDlunodominant thyroxine containing 9mer pathogenic Tg peptide
(Champion et aI, 1991).
The mechanism(s) by which the TgP2-specific CD4" T cells
medIate thyroid pathology relllain(s) unknown. Several
possibilities can be entertained to explain it. TgP2-
specific CD'· T line cells llIay have direct cytolytic activity
against thyrocytes without any assistance from the endogenous
T cell pool (Maron et al, 1983) analogous to the cytotoxic
potential of encephalitogenic CD'· T cells against MBP-pulsed
astrocytes~ (Sun and Wekerle, 1986). Alternatively,
these CD'· T cells may activate distinct final effector cells,
such as Tg-specitic HHe class I-restricted COS· T cello from
the recipient lymphocyte pool, throug'h secretion of
lymphokines as sU9g'ested (Cohen and Livant, 1976; Sugihara et
aI, 1993). In that reqard, murine Tg-specific MHC class 1-
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restricted COS· T cells have been shown to have cytolytic
activity against TEe i..tLY.lt.l:2 in mice (Creemers at aI, 1983;
Remy et aI, 1989). This interpretation is also compatible
with previous reports on the incidence of EAT in H-2 mutant
mice in which a critical role for the H-2K (Tomazic and Rose,
1974; Maron and Cohen, 1979; 1980; Maron et aI, 1982) or H-20
(Maron et aI, 1962) gene products ....as suggested. However, such
data are not available in rats to draw any correlation.
Moreover, it is also possible that these thyroiditogenic CD4·
T cells may mediate their effector functions through a DTH
mechanism by secretion of lymphokines and activation of
macrophages.ia..:!.iY.Q. A role in thyroid pathology for TNF-a
(Taverne et aI, 1987) and IL-IB (Wilson et aI, 1990),
cytokines secreted by macrophages, has been suggested.
Analysis of lyrnphokine secretion profile or lymphokine mRNA
expression of the pathogenic TgP2-specific T cell line and
depletion of CD4· or COS· T cells or both in the recipient rats
may further the understanding of the mechanisms by which TqP2-
specific T cells mediate thyroid lesions in rats.
The results demonstrating the HHC-unrestricted nature of
the pathogenic TgP2-specific CD4· T cell line (Figure 5.3)
with an epitopc specificity for Tg sequence 2695-2706 are
unexpected. These T cells are called promiscuous T cellS.
These data are in apparent contrast to the MHC-restricted
naturl! of previously described thyroiditis-inducing T cell
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lines or clones (Sugihara et aI, 1993; Hiyama et aI, 1993;
Zerubavel- Weiss at aI, 1992) and T cells specific for other
conventional Ags (Z!nkernagEll and Doherty, 1974) in mice. The
present findings (Figure 5.3) are in line with previous
findings on MHC-unrestricted recognition of AChR by specHic
rat x mouse T-T hybridomas in Lewis rats in the context of
syngeneic (Lewis) and allogeneic (Sprague-Dawley) rat APC
(Tam! et ai, 1987). However, whether or not. these AchR-
specific T cell hybridomas recognize similar epitopes in an
MHC-unrestrlcted fashion was not investigated.
It is of interest to note that the activation of the MHC-
unrestricted Tgpz-speclflc T cell line is MHe class II-
dependent (Table 5. J) and APC-dependent (Figure 5.3). These
data are in contrast to an earlier report in which the authors
have shown that activation of the MHC-unrestricted hapten
(FITC)-specific CD4' T cells is MHC class 11- an" A,PC-
independent (Silciano et aI, 1986). T cell promiscuity has
also been reported in diverse species with CD4' T cells
specific for 9mer or l5mer peptides of tetanus toxin in the
context of distinct RLA-DR alleles (Panina-Bordignon et aI,
1989; Ho et aI, 1990), for a 16mer peptide of herpes simplex
virus glycoprotein D in the context of H-2 I-E alleles (Heber-
katz et aI, 1988), for a l7mer AChR peptide in the context of
H-2 I-A alleles (Infante et aI, 1991), and for a 20mer
mycobacterial epitope in the context of H-2 I-A alleles
195
(Vordemeier. 1994).
Furthermore, the MHC-unrestricted recognition of the
peptide reported in the present one and in other studies is
not unique to CD4· T cells. This phenomenon was also reported
by several investigators for cytotoxic T lymphocytes (CTL)
against diverse Ags such as the tetanus toxoid (Schmitt et aI,
1984), cyanogen bromide peptide fragments of ovalbumin
(Carbone et aI, 1988) I the nonprotein Ag hemin (Sherman and
Lara, 1989). the polyvalent Ag mucin (Barnd at aI, 1989;
Jerome et aI, 1991), 15mer peptides of HIV-l gp160 (Shirai et
ai, 1993), and a 23tner ras peptide (Yin et aI, 1994).
The mechanism(s) of T cell promiscuity Le., how T cells
recognize peptide in an MIle-unrestricted fashion, is not
known. Several possibilities can be entertained to explain
it. One possibility is that the lamer TgP2 or the l2mer Tg
peptide (2695-2706) might bind to rat MHC class II molecules
outside the peptide binding groove in an unconventio~al way
and be recognized by T cells analogous to bacterial
superantfgens (SAg) (Dellabona et aI, 1989). Additional
experiments such as analysis of Tcll va usage by the TgP2-
specific T cells and peptide competition studies with the
known SAg and the MHC class II bound peptides are needed to
address this possibility. In contrast to SAg (Peavy et aI,
1970), TgP2 is not mitogenic on unprimed rat splenocytes or
LNC (data not shown). Analogous to SAg (Janeway and Katz,
,..
1985; Lynch et aI, 1985). recognition of TqP2 by promiscuous
T cells is MIle class 11- (Table 5.) and APe-dependent (Figure
5.3).
Alternatively, T cell prolliscuity may involve ths
recognition, by TcR of a single T cell clone, of a s1_liar
"peptide conformation" assumed upon interaction of the peptide
with non-polymorphic residues of MHC class 11 molecules as
hypothesized earlier (panlna-Bordignon et 211, 1989). Thus, it
is possible that F344 rat T c~lls may recognize 11 particular
conformation of the 12m9r T9 peptide (269S-270G) adopted upon
its binding to MHC class II molecules on both FJ44 (syngeneic)
and WXY (allogeneic) rat APe (Figure 5.3). On the other hand,
T cell promiscuity may also involve the recognition of the
peptide in a conventional way in which the peptide int~racts
with the polymorphic residues of MHC cless II molecules
(Vordemeier et aI, 1994). The observations that the ISmer
TgP2 or the 12mer Tg peptide-pUlsed WP rat APC fail to
stimulate the T cell line indicate that T cell promiscuity
described in this stUdy is incomplete. 1. 0., some (FJol4; WKY)
but not all (WF) rat APC could trigger proliferation of the
'l'gP2-specific T coIl line (Figure 5.3). Those results are
analogous to tho~e results obtained in previous studies for
human (Panina-Bordignon et aI, 1989) and murine (Vordemeler,
1994) T cells specific for peptides of tetanus toxin and
mycobacterial protein, respectively. Two possibilities can be
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enterbined for the observed failure of TqP2-pulsed WF rat APe
to trigger the activation of the spGcific T cell line: One
possibility may be that the 12mer peptide may not bind to WF
rat MHC class II and thereby fail to activate the T cell line.
Alternatively, the 12mer peptide may bind to WF rat MIle class
II but adopts a different conformation from that formed on
F344 and WKY rat APC. The biological significance for the
generation of promiscuous T cells over l-lHC-restricted T cells
is unknown and remains conjectural.
As opposed to experimentallY induced autoimmune
thyroiditis in rats with Tg emulsion in adjuvant, the initial
triggering event in the spontaneous form of Hashimoto's
thyroiditis in humans is unknown. Among the several
mechanisms that have been proposed, molecular mimicry
(01clstone, 1987) has been attributed to be one of the
mechanisms that could trigger pathogenic autoreactivity. It b:
noteworthy that the N-terminal 12mer Tg epitope (2695-2706)
which is recognized by the thyroiditis-inducing TgP2-specitic
T cell line possess 67\ a.a. sequence homology with £18
peptide (V8P.rS~YIQTLI) (underlined residues are conserved
amino acidl;\) of adeno virus. Thi:=; sequence homology has
raised the possibility that thyroiditogenic T cells may be
tri.;Jgered by "molecular mimicry", however, its relevance to
pathogenic thyroid autoimmunity remains to be determined.
Thus, identification of pathogenic T epitopes within Tg in
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experimental ani.al lKIdela .... 111 eventually aid in the
definition ot cross-reactive T cell epitopes or -olecular
.llllies harboured In external nicrobial pathogens such
viruses and baehrh. This information Iotill provide an
important link between on environmental agent and an
immunological ettector syatelll associated with tormation of
AITD in humans (Weetman and MCGregor, 1994).
At present it is not known Whether both TgPl and TgP2 arc
itlportllnt ill the spontaneously induc.l!d thyroiditis oittlcr in
ani.alB or in huaana. It would be interesting to address the
relative importanoe of these pathogenic sequences, at both T
.nd B cell levels, in spontaneously induced thyroiditis in
rats and in HT patients. The rellulu that ",ill be obtdned by
these experillent& will reveal the fundamental !ii.Uaritie!! or
differences between the Induced and spontaneous -odel!! of
thyroiditis in tenlB of i_unodominance and crypticity of Tq
epltopes.
The findinqs of the absence of serological
"intramolecular detel'1llinant spreading" in the TgP2-mediated
rat EAT are in II.ppal:'ent contrast to II recent report on
II intramolecular determinant spreading" of tho autoimmune
rotlponse to 11.0 ovarill.n self-peptide in a murino model of
experillental autohullune oophoritis (EAOl (Lou and Tung, 1993).
These authors suggested that endogenous release of
autoantigens subsequent to a pathological injury in the ovary
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alght be the cause for ""etenlinant spreading· in this llnlaal
lIOdel (Lou and Tung. 1991). The findings of Lou and 'I'U.ng
(1993) have been extended to anililal .odela of other hUllan
llutoillJllUne diseases such as llIyasthenia gravis (Vincent et aI,
1994) r systelJlic lupus eryth..atocis (Jaaes at aI, 1995: Topfer
et aI, 1995). Thus, the absence of serological "deblOlinant
spreading" in rat EAT suggest that "determinant spreading" may
be governed by several parameters. These parameters may
include tho type of autoantigen and its concentration and
availability in the circulation, the kinetics of the imJIune
response, and the level of illlllunoregulatory mechanisms to that
autoantigen.
In conclusion, the findings presented in this Chapter and
in Chapter of will provide a siEplitied aodel for
studyinq/understancHnq iuunoregulatory lleChanislIs of EAT.
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Kapplng' of t_Wlo4oainant oen .pitop.. witbin
Thyroglobulin: I_unodoa!n&llt. shitt. Aaoll9 Heterologous
TbyroglobuliDS JnfluaDce tbe Induction of ]gO a••pOD••• to
Distinct B .pitop•• witbin • PatbogeDio Thyroglobulin Peptide
(2"5-2713) in 73•• Rat_
'.1 'Introduotion
Autoantibodies (Mba) to thyroglobulin (Tg) are a common
feature of experimental or clinical thyroid disease, but the
nature and location of the epitopes recognized by these Mba
remain mostly undefined (Kuppers et aI, 1992). Tq-specific
IgG are present in unlmmunhed anilllais (Dig-hlero et aI, 19B3).
healthy sUbjects (Ericsson et aI, 1985: Guilbert et aI, 1982:
Kohno et aI, 1988). lind patients with thyroid disease (Raitt
et aI, 1956). These findings have spurred efforts to
characterize Tg epitopes recognized only during the disease
process and to distinguish them froll those recognized by
natural AAbs (Rut" et aI, 1985; Piechaczyk ot al, 1987; 80unani
et aI, 1989; oietrich et aI, 1991; Bresler et aI, 1990b).
Such information would aid in the development of diagnostic
tools and in our understanding of the pathogenesis,
progression, and illllDunoregulation ot" thyroid dJ.sease.
A commonly used approach for the delineation of Tg
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detenlnants recognized by patients I sera or animal antisera
involves three steps: First, It. panel of lIOuse !!Abs ",ith
distinct specificities are raised against human (hTq) or J:lOuse
Tq (aTgj and used to .ap the relative topoloqraphy of
.clusters· of deteninants on the Tg .olecule. Second, in
cross-inhibition studies••urine Tg-specific KAbs are tested
for their capacity to inhibit the bindinq of patients' sera to
intact hTg, and/or to chellically or enzymatically derived or
recombinant hTg peptides {Dong et aI, 1989; Kohno et aI, 1985;
Henry et aI, 1990; 1992: Schultz et aI, 1992; Bresler et aI,
1990b: Piechaczyk et 41, 1987; Ruf et aI, 198]}. Third, hTg-
specific MAbs secreted by human-mouse B cell hybridomas llre
used as competitors 'lith hTq-speciflc murine HAbs (Fukuma et
aI, 1991).
These ef(orts have led to the MUnition of a limited
nuaber (4-6) of Tq epitopes that are recognized by patients!
sera {Nye et aI, 1geO; Chan et 011, 1987; PukUUl et aI, 19891
COilpared to the definition, by HAb panels, ot 5-7 antigenic
clusters on hotlOlogous Tg (cTql (Gleason et aI, 1990: Kotani
et al, 1985), and ot 6-12 antigenic I:lusters on heterologous
Tg (hTg) (Bounani et aI, 1992; Bresler et a1, 1990a and 1990b;
Piechaczyk et aI, 1987; Rut et aI, 1983).
In spite of these advances made in detininq the nUllber
of antigenic clusters on homoloqou5 YU!..Wl heteroloqous Tq
....ith mouse MAbs, the tactors that influence the immunogenicity
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of 'l'gs and the Tg lW!:ptides encollpassing luunododnant B cell
epitopes associated with AITD remain unknovn. In this study,
an attempt was lIade to address the above issue(s) by
Ill.onltoring IqG responses to the path0genlc hOlllologous Tq
peptides, TgPl (2695-2713) (Chapter C) and TgP2 (2495-25111
(Chapter 5), by priming of FJ44 rats with hOlllologous (rat) and
heterologous (mouae, bovine, porcine and human) Tgs.
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6.2.1 tbe '1'9" but bot tb. TqPl oOlltaiD. i_unodoainut B
cell .pitep. fa) in the COlltezt ot bo.oloqou. tbyroqlobuliD
To address the serological ilUllunodollinance of the
phylogenetically conserved pathogenic T9 pBptides, TgPl and
TgP2, in the context of homologous Tg IrTg) in rats, day 28
sera frolll rTg-pr!mcd F344 rats (2/group) (SeotioD 2.11) were
obtained. Analysis of the pooled sera by direct ELISA for IgG
responses to rTg, TqPl (2495-2511). TqP2 (2695-2713) I and
ovalbumin (control "9). showed immunoreactivity with intact
t'1'q but not ovalbunin (Fiqure 6.2A). Surprisingly, the same
sera reacted with pathoqenlc rat Tg peptide. TgP2 but not TqPl
(Figure 6.28). The data indicate that the pathogenic TqP2
but not TgPl sequence contains IlDunodollinant B cell
determinants in the context of hOllol09OUS Tq (rTg) in rats.
FurtherIOre. the rTq-!nduced :IqG titer to TgP2 is only 128-
fold lo....er than that observed against rTq itself (the end
titer points; of sera from r'I'q-pr!Jled rats aqainst rTq and TqP2
llre 1/64,000 and ~/512 dilution, respectivelY). These data
further suggest that TqP2 is one ot the tew illlmunodominlint B
cell epitopes within the huge Tg molecule (660 kDa).
RAT CSFWSKYIQTLKOgAOGAK
-------D-----HUMAN SS __ TS _
BOVINE S __ AS --ET-
(2695-27131
(2695-2706)
(2702-2713)
(2697-2715)
(2695-2713)
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'iqun lS.l coaparbOD of pri••ry uiDQ aoi4 ••qu&nc. of 'I'gP2
or rat, bovine, al'1l1 human Tg8. For comparative purposes, the
two 12mer overlapping truncated peptides ot rTgP2 are also
included in this figure (carayanniotis et aI, 1994).
.. The shaded position indicates an amino acid deletion on
rTgP2 corresponding to hTgP2.
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Piqure 6.2A ••activityor .ara fro. r'1'g-pri••4 .344 rata with
.intaot r'1'CJ but Dot on. Pooled sera (2/qroup} obtained 28
days after r1'q-priming, as described under Materials and
Methods (section 2.11) were tested in serial two-told
dilutions against rTg (1 J./og/well) or ovalbumin (1 I-Ig/well) by
a direct ELISA (section 2.19). The readings were taken at
0.0. 405 nm. The values are means of duplicate wells minus
means of background values lind expressed as mean +/- so. Hean
of back ground values was 0.190.
piqure 6.28 Tbe TCJPZ but Dot TqPl oontain. i_unodoabumt B
cell epitop... Pooled sera of rTg-primed F344 rats that were
used in Figure 6.28, were tested in serial two-fold dilutions
against TgPl (0.2 ~g/well) or TgP2 (0.2 1-19/",e11) by a direct
ELISA (SectioD 2.19). The readings were taken at 405 nlll. The
values are means of duplicate wells minus means of bac~ground
values. The values are expressed as lIIean +/- SO. l1ean of back
ground values was 0.204.
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1.2.2 Ifbe DOD~40.iD.DC. of TqPl rea.iD_ cotlotant; wber... the
reI.tin i_Wlodoalllabce of '1'qPZ vari.. aiqDifiout1y Dong
boteroloqou. !'q.
To address the serological imllunodollinance of
phylogenetically conserved rat TgPl and TgP2 sequences in the
context of heterologous Tg5, day 28 sera from F344 rats
(2/group) priJlled with Tg& of' ..ouae, bovine, porcine, and
human origin were analyzed by direct ELISA tor IgG responses
to TgPl and TqP2. The results are shown in Figure 6.3. No IqG
responses were elicited against TgPl, regardless ot the
heterologous Tq used for priming of Fl44 rats (Figure 6,JC).
The data indicate that TqPl is serologically non-dominant or
cryptic on Tgs or various species. surprisingly, heteroloqou8
Tqs varied draaatically in their capacity to elicit TgP2-
specific IgG responses (Figure 6.3A). Bovine 1'1;; (bTg) was as
efficient as rTg. whereas mTg was Iloderately efficient and
porcine or hUllIan Tg are not iuunoqenic at the TqP2 site
(Figure 6. 3A), although these Tg preparations elicited strong
IgG responses to corresponding Tg (Figure 6.30).
To address Whether the failure of sera from hTg-primcd
rat.s to react with .rTgP2 is due to amino acid sequence
differences within the determinant site, in an analogy to T
cell epitopes (Liu et aI, 199J), the hTg-primed Bera were
tested against human TgP2 (hTgP2). The hTg-primed F344 rat
sera failed to recognize hTgP2 itself (Figure 6.JC), thus
'07
excluding the possibility that absence of iDll1unoreactivityof
these sera to r'I'gP2 is due to amino acid sequence differences
between r'l'gP2 and hTgP2. Testing of the immuno-reactivity of
sera from pTg-primed rats against the pTgP2 was not possible.
because the primary amino acid sequence of pTg is not kno\ffl.
ThUS, monitoring of the serological response to the 18l11er TgP2
sequence presented 1n the context of diverse Tgs, revealed
lllrgc variations in the reladve inllunogenicity of this
peptide.
6.2.3 'l'he tine .pitope specificity ot TgP2-spsciUc IgG
inliuc84 by thyro<jlobulibl of variouB species varies
4ruatically
since linear B cell epitopes are known to be in the range
of 5 to 10 3mino acids in length, it is not known ""hether
TgP2-specific IqG induced by homologous and heterologous Tg-
priming recCXjnize si:llilar or distinct B epitopes within the
TgP2 site. Analysis of the reactivity of pooled serull samples
from rTg, mTg, or bTg-primed rats (of Figure 6.3) against two
overlapping 12l1er truncated peptides of rTgP2 revealed an even
more complex pattern of Ab responsiveness (Figure 6.5). The
rTg-induced Abs recoqnited epitopes within the carboxy-
tendnal (2702-2713) but not the amino-terminal (2695-2706) 12
mer peptide indicating the localization of dominant B cell
epftope(s) within the C-tendnal peptide 2702-2713.
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.iqure 6.3J.-O I"ubodoaillaDce of "gPa on behrologoua '19-
varies cSr...ticaUy. Reactivity of the sera froll homologous
or heterologous Tg-prined F344 rats (2/group) to CA) rTgP2,
(8) hTgP2. ee} rTqPl, lind (D) respective Tg in a direct ELISA
(section 2.19). The sera from homol<.lgou& Tg-primed animalB
employed in this experiment were the same that ....ere u9cd to
establish the data 1n Figure 6.2. The vllIlues represent mean
of triplicate wells minus the mean of the background value!>
and SO values did not exceed 10\ of the mean values. The mean
of background values ranged from 0.144 - 0.152. The details of
illUnunizations of rats with Tgs are described in section 2.11.
~Antigen A. rTgP2 8. hTgP2 C. TgPl O. Respective Tg Serum dilutionIn vivo
r1nf: Against peptides• 1/128mTgr- 1'21 11512bTg u I :, ' o 1/2048~pTg 1 • 1132,000Ell 1164,000
hTg o 1/128,000
0.0 1.0 2.0 0.0 1.0 2.0 0.0 1.0 2.0 0.0 1.0 2.0
Optical density at405 nm
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Piqure 6.4 Hydrophilicity profile. of corresponding '1'gP2
sequence on rat, bovine, and hUlllan Tgll. The hydrophilicity
profiles WE're generated based on the method described by Ilapp
and Woods (1981). The arrows indicate the N- and c-terminii
of the TgP2 sequences on rTg, bTg and hTq.
3...-----2 A. rTg ""9h
1 {gP2~:~~
4 i
-3
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~ B. bTg
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surprisingly, bTg-lnduced IgG recognized determinants Iotithin
the N-terminal (2695-2706) but not the C-terminal (2702-2713)
12mer peptide, indicating the localization of immunodominant
B cell epitope(s) within the peptide 2695-2706. Inter~stingly,
mTg-ellcited IgG bound neither of the 12mer peptides of rTgP2
suggesting that it recognized a core determinant of rTgJ>2
which was lost by the splitting of rTgP2 into two 12mer
peptides. This was further suggested by the lack of
reactivity of mTg-induced IgG with hTgP2 (Figure 6.38), Thus,
within the TgP2 site, heterologous Tg-inctuced TgP2-specific
IgG recognize B cell epitopes distinct from those of
homologolls Tg-induced TgP2-specific IgG and provides evidence
for tho presence of cluster of species-specific
immunodominant B cell epitopes at the TgP2 site.
It is of interest that at the T cell level there appear to be
at least two T cell epitopes with in TgP2, one in its N-
terminal half and the other epitope, likely to be, in ita
central region (Table 6.1).
6.2.4 The rTgP2 and hTgP2 sequences are .utually
reactive at thQ serological level
To examine the serological cross-reactivity among rat
and human TgP2 peptides, FJ44 rats (2/groUp) were immunized
with 12mer peptides of rTgP2 or 19mer hTgP2. The immune sera
were examined by direct ELISA for peptide-specific IgG. In
'11
Figura 15.5 Recoqnition ot dot-tinct B cell epitop•• within
TqP2 by ••ra troa rat, .C1U•• and bovine 'l'g-pri••d P344 rata.
Pooled Tg-primed sera of F344 rats that were used in the
experiment for Figure 6.2 and 6.3 were tested against two
12mer truncated peptides of rTgP2 in a direct ELISA as
described under Seo\ion 2.19. The overlapping 12mer truncated
peptides were used at 8 I1g/we11. The readings were taken at
405 nm. The values are expressed as mean of duplicate wells
minus mean background values. 1ne mean of the background
values ranged from 0.147 - 0.152.

.,
1<
Table 6.1 T gP2 sequence contains at least two distinct T celt epitopes
T cell hybrid CTI L proHferarion(cpmllDOOl
(polycbne) No antigen 269;-1713 269;-2706 2702-2713
4Gl 0.61 +/. 0.24 16.00 +/. z.n 0.36+1-0.07 0.30+1-0.17
4Hll 0.42 +/. 0.18 9.19+/-1.74 0.40 +/- 0.19 0.11 +/- 0.01
5D5 0.37 +1. 0.34 12.29 +/- 1.15 0.71 +/. 0.45 0.+3+1-0.19
IF7 0.29+/-0.09 8.27 +/-1.16 6.14+/-2.20 0.19+/-0.01
2A3 0.28 +/-0.02 5.48 +/- 3.96 4.89 +,. 0.03 0.37 +1-0.30
4G3 0.37 +/-0.09 10.56 +/- 0.20 12.01 +/-1.65 0.20 +/- 0.04
Polyclonal T cell hybricoo3s (1.5 x lO'+/weU) were cultured with irradiated (1500 tad) syngeneic
splenoc)'tes (5 X l05/\I;ell) in the presence of indicated antigens for 48 hr in 200,ul volume of DMEM.
10 in 96-welt flat.bottomed micro culture plates. T cell hybridoma aeth'arion and CTll assays were
performed as des;::ibed u:lder Materials and ~1ethods (sectionZ.l7). The peFtide concentrations used
were:n follows: <1.<1. 2695-1713 = 10 )Jg/mli <1.<1.2695-2106 = 25 }Jg/ml; <1.<1. 2i02-2713 = 25 pg/m1.
The v<Ill:e5 are ce:m of dUFlicate wells +J_ SD.
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addition, sera trom rTqP2-prt..ed rats (Figure 5.5A) were also
used. The r85ults are shown in Table 6.2. IgG from rTqP2-
and hTgP2-priaed rats exhibited mutual cross-reactivity,
though the peptides share only 79' primary IImino acid sequence
homoloqy. The heterogeneity of the ellcited rTgP2 and hTgP2-
specific IgG was analyzed by testing their reactivity with the
t1ol0 12111er truncated peptides representing the amino-end (2695-
2706) and the carboxyl-end (2702-2113) of the rTgP2 sequence
(see Figure 6.1). This analysis revealed that TgP2-speciflc
IgG reacted more strongly with the C-terminal than with the N~
terminal 12mer Tg peptide. These data indicate the relativQ
immunodominance of the C-terninal 12mer over the N-terminal
12mer peptide of rTgP2.
Interestingly, the l211ler peptides at:'e immunogenic
themselves since the elicited IgG reacted with the
corresponding peptide used for i.lIune challenge (Table 6.2).
However, the l2mer peptides were not mutually cross-reactive,
although they share en hexamer overlapping amino acid sequence
"UQTI.dS". Further1llore, the inability of the C-terminal
peptide (2695-2706)-specific IgG to react with the lamer rTgP2
(Table 6.2) may be due, at least in part, to its ability to
discriminate the different conformations adopted by the lamer
and 12mer peptides upon adsorption onto PVC plates as reported
for peptides ot streptococcus llIutans earlier (Lehner at aI,
1989). The data indicate that rTgP2
~
~
iim.
nIt)
SeNro
dilution
Secondary loG tsiP9n~es (Q D 405 om) aValnu
llrPZ Wpridg h T gPl
Ltl95.271J 2695.2706 270!.Z71J
namer) (lZmer) (llmer) _l]9mer)
rTgP2(l8mer) 1/128 > 2.00 1.63 >2.00 >2.00
(2695-1.113) 11512 >2.00 0.45 >2.00 >2.00
112MB >2.00 0.13 >2.00 >2.00
N-tenninallZmcr 1/64 0.40 1.31 <0.05 1.2.+
(2695-2706) 11256 0.12 0.37 <0.05 0.38
111024 <0.05 0.08 <0.05 0.10
Ctamfnal12mCT 1/64 0.07 <0.05 0.62 0.09
(2702-2713) 11256 <0.05 <0.05 0.15 <0.05
11102.4 <0.05 <0.05 <0.05 <0.05
hTIlPZ (19mer) 1112.8 > 2.00 1.09 2.18 >2.00
1/512 > 2.00 0.37 0.80 >2.00
112048 0.68 0.13 0.21 0.89
Peoled sera were obnlined from F3+4 rats primed either vdth 2.00 nmol of 18 mer tTgPl (3 rats/group)
or N.tcrminul or C-rermin:l112mcr rTi:PZ pcpddcs (2 rats/group) or human TePl (2 r.nslgroup) in CF/\
on 6y :ero and boon:ed .... ith 100 nQo} of tetpecrive peptldes on cia)' 7. Sel1l ,",'t."l'e collected on day Z8 and
tested against i:\dicau:d Ai! by an alkaline phosphatase based ELISA as described under Materials and
Me:hods (SI!.::tion 2.15). The rerulu are mean of duplicate or triplicate wells. The SD values did not
exceed 10% clmean values. No sisnificant JgG responses were detecred alainst control peptide, rTgPI
(d:u:l not sho,",'n). Background values; ranKed fTom 0.12 to 0.14.
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harbours two distinct immunogenic epltopes, of these, the c-
terminal 12mer (2702-2713) is relatively dominant over the N-
terminal 12mer (2695-2706) peptide.
".2.5 Variation in TgP2 i_unogenlcl ty ..ong beterologoua
thyroglobulin. ia not due to it. inaooes.ibility to peptlda-
specific IqG
Since opitope accessibility to Ab is an intrinsic feature
of antigenicity (Novotny et aI, 1986), I asked whether the
apparent lack of immunogenic! ty of TgP2 on porcine and human
Tgs (Figure 6.3A and 6.3C) is due to its insufficient exposure
on the surface of the Tg molecule. To address this, the
reactivity of peptide-induced IgG (of Table 6.2) with Tgs from
various species was assessed by direct ELISA. The results are
shown in Table 6.3. Regardless of the immunogen used,
significant IgG binding occurred on all Tgs tested (Table
6.3). However, Tg denaturation consistently allowed more
efficient binding of specific IgG from hTgp2-primed rats, a
finding consistent \o1ith the notion that the elicited Aba
recognize linear Tg epitopes. In contrast, heat denaturation
of Tgs did not generally increase its reactivity with IgG from
sera of rats immunized with the shorter 12mer terminal
peptides. An intriguing observation is that rTgP2-primed sera
".
reacted strongly with rat and mouse Tg5, weakly with bovine
and porcine Tgs and not at all with hTg, although the same
sera reacted with denatured 1'95 frolll all the species.
These results indicate that: (a) the lack of
immunogenic::ity of TgP2 on human and porcine Tgs cannot be
attributed to lack of accessibility of the epitopes within
the TgP2 site to l\bs of predetermined specificity since
specific IgG could readily bind to this Tg site, (b) the
peptide (lBller versus 12merl-lnduced IgG recognizes different
epitopes on Tg5 of vadolls species and some of these epitopes
are exposed while others are hidden within the TgP2 site, (e)
the observed "SKewness" of the serological response to the
121ller terminal peptides (Figure 6.5) also cannot be attributed
to differential accessibility, since IgG raised against these
peptides can bind to intact Tgs of various spec:!t:s tested, and
(d) the fine epitope specificity of the lamer rTgP2-~
the 19mer hTgP2-induced IgG is different.
"i
Table 6.3 Variarioe in Tg?2 immunoienici.~among heterologous Tgs is not due to iu differential
accessibility to prefc:med antibodies"
Aouaen Serom ., !X~~logical crQS!!.-m-;jvlp' (Q P 405 P;j1) arainn
in vivo dilution form ", m., bT, pTg hT,
2695·2713 1/128 !\:ad\'c 1.60 1.96 0.20 0.16 0.08
(lSmer) 1/512 1\ad\'c 1.00 l.H 0.04 0.07 0.02
1/128 Denatured. >2.00 >2.00 1.56 1.56 1.59
1/512 Denatured >2.00 >2.0~ 0.85 0.97 0.87
2695.2706 1111.8 l'\nive 1.30 1.00 0.80 1.49 0.89
(1lmer) 11512 l\:ative 0.39 0.28 0.24 D.H 0.17
11128 Denatured 0.94 0.91 >2.00 O.Sf 0.76
1/512 Denatured 0.29 0.26 0.99 0.11 0.19
2702.2713 1112.8 !\ative 0.90 2.2.0 0.49 0.70 0.66
(llmer) 11512 "'arive 0.30 0.79 0.13 0.18 0.18
1/128 Denatured 0.78 0.85 0.53 0.57 0.59
1/512 Denaru~<.d 0.20 0.22 O.ll 0.12 0.13
Human TgP2 11128 Native 0.27 0.58 1.54 1.24 0.51
11512 l\.. tive 0.12 0.14 0.60 0.37 0.20
1112.8 Denauned >2.00 >2.00 >1.00 >2.00 >2.00
11512 Denatured 1.38 1.82 >2.00 >2.00 1.34
·Cross-reactivity of pooled ~r;I from peptlde.primedFJ44 rna that were used in Table 6.1, ag;llinst intact
and heat denatured TIS of\"arious species ;liS indicated by ~ direct ELISA (Section 2.18). 0.0.405 nm
values represent means of duplicate wells. SO values did not exceed 5% of the mean values.
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The data described in this chapter (a) provide an
explanation for the differences rept'rted earlier in the
mapping or location of bnmunodominant 8 cell epitopes on Tg9
of various species, (b) provide the first evidence in EAT for
an bnmunopathogenic Tg sequence (TgP2) that encompasses
species-specific immuno-dollllMnt B cell epitopes, (e) suggest
that factors adjoining or distant from the epitopic alto
(TqP2l contribute to the variable immunodominance of Tgs at
this site, and (d) reveal that the hierarchial ilUlunodominance
of B cell epitopes existing at the level of the cOllplete Tg
molecule (dimeric rTg has a m.wt. of 660 kDa) also exists at
an lBmer (2.1 kDa) Tg peptide (rTgP2) level.
Fei!ltures intrinsic to the protein structure Buch as
surface accessibility (Novotny et aI, 1986), hydrophilicity
(Hopp and Woods, 1981), and segmental or local mobility
(Westho!, 1964; Geysen et aI, 1987) have been shown to
determine the location of immunodominant B cell epitopes on
large protein Ags. The present findings (Table 6.3), peptide-
induced IgG reacting w.:'th intact heterologous Tgs, demonstrate
that accessibility of epitopes (Novotny at aI, 1966) is
unlikely to be the intrinsic feature of Tgs which allows IgG
responses to TgP2. These data are consistent with earlier
results that accessibility ot epitopes on intact protei:! Ag do
not always correlate with their imrnunodOlliinance (Wilson et aI,
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1984; Geysen et aI, 1987). Furthermore, it is unlikely that
the present data are influenced by the hydrophilic nature
CHOpp and Woods, 1981) of Tq6 at TgP2 site, because the
hydrophilic index of the TgP2 sequence on rat, bovine and
human Tqs are very similar (Figure 6.4). These findings are
compatible with previous results which demonstrated that the
hydrophilic nature of an epitope on a protein Ag does not
always correlate with its immunodominance (Atassi, 1984). The
lack of crystalloqraphic resolution of Tg precludes us from
determining the role of seqmental mobility (Westhof, 1984) on
the variable immunogenicity of heterologous Tqs at the TgP2
site. However, it has been suggested that if peptide-induced
IgG reacts with both intact (Tainer, 1984; Westhof et aI,
1984) and denatured Ag (Berzofsky, 1985), then the epitoph..
site on a given protein is likely to be mobile. The
reactivity ot peptide (12mers of rTgP2; hTgP2) -induced IgG
....ith intact as well as heat ctenatured heterologous Tgs (Table
6.3), suggests that at least some epitopes within the TgP2
site on Tgs are mobile. These findings indicate that segmental
mobility does not influence the immunodominant shifts among
heterologous Tgs at the TgP2 site. Furthermore, the induction
of Tg-reactive IgG by short synt"etic peptides (Table 6. J) is
consistent with the notio:l that the ability of short synthetic
peptides to induce protein (intact Ag)-reactive Abs is not an
uncommon event (Green et aI, 1982) but occurs with high
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frequency (Niman et aI, 1983). On the other hand, the failure
to induce hTgp2-specific IgG following hTg-priminq is
consistent with the notion that demonstration of peptide-
reactive Abs following intact Ag-priming occurs with low
frequency (Jemmerson, 1987).
The present andysis of the molecular context of the
epitope within a given protein demonstrates that factors
adjoining or di~tant from the epitopic site on heterologous
Tgs influence its imrnunodominance. In this regard,
Scheerlinck et al (1993) have demonstrated in mice that the
presence of an immunodominant epieope within a recombinant
protein used for immune challenge skewed the serological
immune response away from the adjoining non-dominant epitope,
whereas t.he absence of such an immunodominant epitope within
the recombinant protein led to the induction of an IgG
response to the non-dominant epi tope. Rats similarlY
challenged with large recombinant fusion peptides of hT9
containing hTgP2 will help to clarify this question. It has
been shown earlier by several investigators that amino acid
residues distant from or flanking the epitopic site (Shasthri
et al, 1986; Oawe et a1, 1993) or the presence of
immunodominant. epitopes away trom the epitopic site (Nikcevich
et al, 1994) in a given protein .&.g profoundly influence the
immunogenicity of MHe class II-restricted T cell epitopes.
The precise intrinsic features contributing to the
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variable i1llllunodollinance of epitopes within the TgP2 site
a.cng heterologous Tgs are unknown. They may include
differential tertiary folding and/or post-tranfllational
lllodifications. Tertiary folding may exert its effect either
by masking the epitope(sl or by changing the hierarchy of
l_unodominant epitopcs. The data as shown in Table 6.3,
suggest that tertiary folding is unlikely to lIlediate its
effect by masking epitopes within the TgP2 site to peptide-
specific B cells..i.n...:i.1Y.2. On the other hand, the differential
tFlrtiarY folding among heterologous Tgs (as influenced by
primary Amino acid sequence differences) (Chan et aI, 1986)
may change the hierarchy of hUlIunodom!nant B cell epitopes and
thereby "skew" the illlllune response away from the epitopic site
within the TgP2. However, evidence is laCking: to support such
a contention. Post-translational modifications of Tg: such as
iodination (Sundick et al, 1987) and glycosylation (Salable ct
aI, 1976) have been shown to influence the illlmunogenicity of
Tgs. At present, evidence for such differences alloog
heterologous Tqs is lacking_ However, overall, the present
data suggest that factors intrinsic rather than extrinsic to
Tgs contribute to the differential imnunogenicity of
heterologous Tg5 at the TgP2 site.
Inconsistent detection of O'~igure 6 _3A) and distinct
epitope recognition withjn (Figure 6.5) the TgP2 site by
various Tg-induced IgG and consistent non-dominance of TgPl
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(Figure 6.3C) suggest that by serological screening, TgP2
might be variably detected where as TgPl might not be detected
at all. Thus, the present approach indicate that by
serological screening, some but not all Tg peptides associated
with AlTO will be identified.
Various investigators (Henry et aI, 19901 1992 ; Ruf et
aI, 198J; Dong et aI, 1989) have demonstrated that the
immunodominant Tg epitopes seen by autoantisera CRT patients'
sera) are not consistently detected by heteroantisera (Tq-
primed animal antisera). Henry et al (1992) demonstrated that
epitopes within the 1149-1250 and 1258-1295 region on hTg are
immuno-reactive with anti-hTg Abs from HT patients and rabbits
respectively but not vice versa. In another study, Dong et al
(1989) were able to localize immuno-reactive heteroepitopes
within a larger hT':J fragment (2644-2736) using anti-hTg Abs
from rabbits (heteroantisera) but not with sera from HT
patients (autoantisera).
The variable location or variation in the hierarchy of
immunodominant epi topes on hTg as described above seems to be
influenced by factors extrinsic to Tg such as spe,:"les. Thus,
it is possible that the non-dominance of hTgP2 or hTgPl
(Figure 6.3) in rats (heterologous species) in the context of
hTg may become immunodominant in autoimmuni?ed HT patients, a
possibility that can be easily tested by screening the HT
patients' sera directly against homologous TgP2 or TgPl
2"
sequences. Thus, intrinsic (present study) and extrinsic
(Henry et al, 1990;1992; Ruf et aI, 1983; Dong et aI, 1989)
factors to 1'9 effect the location and mapping of the
immunodominant B cell epitopes on Tgs. These findings need to
be considered in the development of diagnostic KAb kits.
In the present study, an interesting correlation emerged
bet.ween homologous Tg- and TgP2-induced IgG responses: the c-
terminal 12mer (2702-2713) peptide is dominant in the context
of both Tg I!lnd lamer TP2. In contrast, the N-torminal 12 mer
(2695-<l706) peptide is relatively less dominant in the context
of lamer TgP2 and Js non-dominant in the context of homologous
Tg. It. should be emphasized that the non-dominance of the N-
terminal 12mer Tg peptide (2695-2706) in the context o[ Tg is
not due to accessibility, hydrophilici ty. and seqmenta 1
mobility of this site within Tg (Table 6.J). However, it lIay
be attributed to the presence of an ilUllunodoliinant C!pi tope!
adjacent to or away trom it (Figure 5"'-8) as suqgested in
other studies (Scheerlinck et aI, 1993). The reason(s) for
such an intramolecular immunodol'llinance of 8 cell epitopcs
.... ithin the TgP2 Elite when rats were primed with TgP2 is/arc
unknown. The molecular mechanism by ....hich T cells provide
differential help for B cell clones with differC!nt
specificities on the same lamer pepUde is difficult to
explain in the context of existing models of T cell - B cell
interaction (Berzofsky, 1983; Ozaki and Berzofsky at aI,
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1987). In contrast to Tq. it is likely that both extrinsic
and intdnsic features to the peptide contribute to the
intramolecular immunodominance of B cell epitopes within TgP2.
These factors may be either the differences in the frequency
of B cells specific for the two 12mer peptides !n.....Y.iY2 and/or
the differences in the quantity of T help provided to peptide-
Gpecific B cells in....Y.iY..2. Additional experiments are warranted
to address those possibilities.
The induction of lowered anti-peptide Ab titers following
challenge with the 12-mer peptide(s) compared to an IBmer TgP2
challenge (Table 6.2) may be due to lowered receipt in
quantity of T help by peptide-specific B cells. This may be
an effect of lowered recruitment of Th cells because the 12mer
peptides may contain fewer T cell epitopes than the lamer
TgP2. Recruitment of more T cell help may be attributable to
the presence of at least two T cell epitQpes within TgP2
(Table 6.2). Furthermore, the presence of a third T cell
epitope within TgP2 is indirectly suggestP.d by the serological
immunogenicity of the c-terminal 12mer Tg peptide (2702-2713)
(Table 6.1).
The induction of TgP2- but not TgPl-specific IgG (Figure
6.2), and T cell (Table 5.2) responses in Tq-primed rats
suggest that TgP2 might be one of the few immunopathogenlc
determinants participating in rTg-mediated rat EAT. For these
reasons, TqP2-mediated rat EAT may serve as an excellent
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animal model for studying the immunopathoqenesis of liT in
humans. Although rTg contains linear B cell epitopes at the
TgP2 site, the role of autoreactive B cells specific for such
epitopes in the disease pathoqenesis is unknown. It is
possible that autoreactivity may be triggered by viral
infection (Onedera, 1990: srinivasappa et aI, 1.988) through
induction of cross-reactive B cells to epitopes accessible on
Tg. Autoreactive B cells thus generated might playa t-ole
either in steering Ag-processing (Davidson and Watts, 1989) or
in enhancement of Ag-presentation (Hutchings et ai, 1987;
Lanzavecchia, 1990) or in shaping the T cell repertoire
(BurJ.r.nardt et aI, 1992; Watts and Lanzvecchia, 1993). Antigen
processing and presentation events may contribute to the
initiation or diversification of the autoimmune response
(MamUla and Janeway, 1993: Lin et aI, 1991: Mamula et aI,
1994). Alternatively, it is also possible that some
autoreactive B cells specific for Tg may tolerize rather than
activate Tg-specific autoreactive T cells and thereby
contribute to the peripheral tolerance mechanism (Fuchs and
Matzinger, 1992: Gilbert and Weigle. 1994: Eynon and Parkar.
1993) •
It is worth noting that the N-terminal 12mer (2695-2706)
peptide of TgP2 that is recognized by a pathogenic T cell line
(Table 5.4) and is accessible to peptide-specific IgG (Table
6.3) has 61\ amino acid sequence homology with a 12mer peptide
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(VSPY8~YIOTLI) of ElB protein of adena virus. Whether this
homoloqous sequence has any relevance to pathogenic thyroid
autoimmunity remains to be clarified. The contribution of
anti~Tg Aba to pathogenic thyroid autoimmunity is also not
clearly established. Tg-specific Abs may potentiate T oe11-
mediated thyroiditis as sho",," earlier in rats (Rose et aI,
1973). In this regard, the findings (Table 5.4), TgP2-1nduced
rat EAT as a CD4+ T cell-mediated disease, clearly demonstrate
that peptide-specific T cells but not 19G playa pivotal role
in the induction of thyroid lesions.
In conclusion, the present findings may have implications
in the serological screening of Tg epitopes associated with
autoimmune thyroid disease (AlTO) , and may enhance our
understanding of the factors that influence the irnmunogenicity
of Tg at the serological level.
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CIllPTBR 7
Tbyrocytu Pail to stbul.t. Tbyroiditoqenic P.ptide
(269S-2713)-Speolfic r3"" Rat '1' cal.lsl X.plic.tiona tor
understanding ),ntigan Pr•••ntation in Thyroid ),utoiuunity
7.1 Introduotion
A decade ago, it wae hypothesized that ectopic or
aberrant expression of MHC class II Age on thyrocytes might
lead to presentation of their own autoantigens to infiltrating
T cells and in this way these class II" thyrocytes could play
a crucial role in the initiation of autoimmune thyroid disease
(AITO) (Botazzo et aI, 1983). Class II Ag expression on
thyrocytes and its role in thyroid autoimmunity have been
investigated in different ways: by immunohisto-chemical
studies of thyroid sections or FACS analysis of thyrocytes, by
analysis of the sign!lls required to induce class II Ags on
thyrocytes~, and by experiments aimed at the ability
of these thyrocytes to activate autoreactive T cells in 1\g
presentation studies.
A direct role for class II· thyrocytes was ahown .in.....Y.ll.r2
by their ability either to induce proliferative responses of
intrathyroldal T cell lines and clones from HT and GO patients
(Londei et al, 1985 ; Dayan, 1991) or to present viral
peptldes to specific T cells (Landei et al, 198~l.
"8
Furthermore, severa~ studies in rats (Hirose et aI, 1988a.
Ki.ura and Davie., 1991a and 1991b) and .ice (Charreire and
Mlchel-Bechet. 1982; Sala",ero and Charreire, 1983&; 1.983bl
1985a; 1985b; Salamero et aI, 19874) have deaonstrated the
proliferation or activation of T cells upon inCUbation ....ith
pri~ry thyroid Illonolayers or cultures. In contradiction, a
few reports have also shown that class II· thyrocytes failed
to activate the T cell c~ones or hybridomas (Ebner et aI,
1981; Stein and Stadecker, 1987) and have suggested that
thyrocytes by themselves do not function as APe. These
conflicting results suggested that activation of T celIe by
priaary thyroid lIonolayers as opposed to thyroid epithelial
cell (TEe) lines or clones may be attributed to contallination
of the foraer \lith APe such as dendritic cells. In addition,
the "g- and epitope-specificities of autoreactive T cells usee!
in the previous stUdies are largely not delineated. ThUS, it
remains unkno'M'n whether class II· thyrocytes in the inflamed
thyroid. without the assistance APe such as dendritic cells,
present Tq epitopes to T cells and initiate the
autoreactivity.
I have dt=monstrated earlier that an 1811er homologous
(rat) Tg peptide, TgP2 (2695-2713) is thyroiditogenic in FJ44
rats, and consists of non-dominant 'T"_ but dominant a-cell
determinants (Cblpter 5). TgP2-specl i to TcR a/P/, CD4' T line
cells wern also shown to adoptively transfer severe
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thyroiditis to naive syngeneic rats (Cbapter 5). Because of
the failure of the rTqP2-specific T cell line to proliferate
~ to r'l'q, I have hypothesized that Ia· thyrocytes in
the target organ may function as APC by presenting the
peptidlc sequence (TqP2) to specific CD"· T cells. Therefore,
in the present atudy, I have examined the possible "PC
function of thyrocytes by using II readily available risher rat
thyroid eplthdial cell line (FRTL-5) as APC. The thyrocytes
were IFN-y treated to induce HHe class II antigens on them.
These APC were used to activate TgP2 (2695-271J)-speciflc,
cloned rat x mouse T cell hybridoma derived from a C04· TgP2-
specific T cell line in F344 rats.
230
7.2 Result.
7.2 .. 1 Treataallt of 'R'I'L-5 oe118 ..i tb raCloablnant: IPN-y
ira4uc.. KBC 01••• 1.:': antigene
Previously it was reported that cloned FRTL-S cells
(thyrocytes) do not constitutively express HHC class II
antigens (Ags), but do so upon treatment with recombinant
IFN-y for 5 days~ (Platzer et aI, 1987). In the
present stUdy, treatment of FRTL-S cells with 100 U/ml of IFN-
y induced the expression of both RTI-B (OX~6) (961) and RT1-O
(OX-l7) (96.4%) class II Age as assessed by FACS analysis
(Figure 7 .lA). In contrast, FRTL·5 cells that were not
treated .... ith IFN-y failed to significantly express the class
II Ags (5-6\) (Figure 7.1S). However, both IFN-y untreated
and treated FRTL-5 cells expressed MHC class lAgs (RT1-A)
(OX-18) (99.S\) (Figure 7.IA-B). These data confirm that
thyrocytes do not constitutively express class II (Ia) Ags but
readily do so upon treatment with IFN-y.
7.2.2 PbenotypiCl cbar.oteriaation cf TgP2-111peCl!Uo 8F7-S or
cell bybri40lla
Following the fusion of CD4~, CDS- TgP2-specific T line
cells with mouse BW5147 a-/fr thY1llorna cells, 265 of 768 seed4:!d
wells showed hybridoma growth and 43 hybrids ....ere screened for
TgP2-specificity. Out of 43 T cell hybridomas tested, 20
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I'igure 1.1 Flow oyto••tric analy.i. of 'RTL-5 a.lh. FRTL-5
cells were incubated for 5 days in (A) the presence or (8) the
absence of recombinant rat IFN-y. Cells \lere detached from the
plastic surface by EDTA treatment as described under Materials
and Methods (uetion 2.21). Cells were w~shed, and stained
with OX-6 (RTI-B), OX-I? (RTI-D) and OX-I8 (RTI-A) HAbs
specific for MHC clllss II (RTI-B and RTI-D) and KHC class I
(RTI-A) "95 respectively or ....ith control isotype-1II.atched MAb
(88-64) specific for -.atrix protein of influenza virus type A.
Dead cells were gated out by incubating cells ....ith 5 JIog/tube
of propidlum iodide before subjectinq th':! cells to PACS
analysis. A miniauJI of 10,000 cells was counted. The results
are expressed a8 histograms of relative cell nuaber versus log
fluorescence ir:tensity (L.Y.I).
Relative Cell Number
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...-- HB64
!>
±.
"T1
Z
OX-17 ~
OX-18
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\JIII.--~HB64
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Z
~
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hybrids were TqP2-l5pecitic, and the reat of the 20 hybridoaas
were non-specific but responded to syngeneic splenic APe in
the absence of the peptide itself (data not shown). The SF?
T cell hybridolll8 was selected and cloned by 1111litlng dilution
(0.33 cells/well). The cloned 8F1-5 T cell hybridolla was used
in~ A9 presentation studies. As shown in Figure 7.21\,
the TgP2-apecitic T cell line after 4 days ot .J..n......:i.\
stimUlation with the peptide was W3/2S' (98.9\:). OX-S- (4\).
OX-19+ (98%), R73+ (99.8t), OX-22" (ll) and expressed weakly
OX-6 {RTI-B (lJ.3tJ and OX-I? (RTI-O) (7.9\) class II Ags.
surprisingly, the 8F1-S cloned T cell hybridoma expressed
both CD4 and COB Ilarkers near to lOot, suggesting that both
CD4 and COB 1II01ecules are expressed on the same T cell in
clonal T-T hybrid population. These data further suggest that
after fusion with BW5147 a'/B' cells, tllere was activation of
CDS genes that had been silent in the parent T cell line, and
release from stable repression of these loci in the long term
rat CD4· T cell line. In contrast to the T cell line, the
8P7-S T cell hybridoma did not express class II Aqs. The rest
of the phenotypic protile of the T cell hybridoma is similar
to the parental T cell line.
7.2.3 The cloned .'7-5 or cell hybrido•• reooqni1l8a TgP2 in an
KHC-unrutrioted f ••hion
To address whether or not the cloned 8F7-S T cell
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piqure 7.2 Flow cJtO••trlc .naly.is ot 'l'gP2-apecific (A) "
cell line, and (BI cloned 8P7-S T cell bybridoa.. FACS
analysis was performed as descrIbed under Materials and
Methods (8ecHon 2.13). Hote that t.he hybridoMa expresses
both COil (W3/25) and COB (OX-B) molGcules.
T Cell Line T Cell Hybrid
iil], W3125
otL~~.q,suox.•
. /\
o .: \.. ." .......,
§~OX.,0
/~\
o .: '. ..~ .......
10" 10' 10/ l(j'l PJ'
Log Fluorescence Intensity
it
'"
Table 7.1 Specificity of the polyclonal (BF7) and clonal (BF7-5) T cell
hybridomas derived {Tom TgP2.specmc CD4+ T cenline
CTLl proliferation (mean cDm/jOOOl
T cell hybri&llna
SF7 (polydone)
8F7*5 (clone)
TgPZ
36.3+/-3.6
31.2+;· 3.3
TgP!
1.0+1-0.1
1.2 +1-0.3
Noantillcn
1.1 +1-0.1
0.7 +/-0.5
T cell hybtidomas (1.5 x 1M/well) were cultured with irradiated (1500 rad) syn~eneic
~"plenocytes (5 x l05i...ell) in the presence or absence ofTgP2 (lOJ.lg/Irll) for 48 hr in
200 pi volume of DMEM.IO in 9(i.well flat.bottomed microculture plates. T cell
hybridoma activation and CTU assays weTc performed as described under :-'l:aerials
and )'1ethods (Section 2.17). The values are me:m of duplicate wells +/. SD.
2J5
hybridoma recognizes the peptide in an MHC-restricted fashion,
specificity and MHC-restriction a!!lsays were performed. The
results of the specificity assays are shown in Table 7.1 and
of MHC-restriction ar'9ay in Figure 7.J. The 8P7-5 T cell
hybridoma responded to TgP2 (Table 7.1) demonstrating the
TgP2-specificity of the T cell hybridoma. In the MHC-
restriction assay, splenic APC from syngeneic (FJ44) as well
as allogeneic (WKY and WF) rats were employed. The results
are shown in Figure 7. J. TgP2-pulsed FJ44, WK'i but not WF rat
l'.PC could activate the T cell hybridoma (Figure 7. Jl'.). The
data indicate that t.he T cell hybridoma recognizos the peptide
in an NHC-unrestricted fashion similar to the MHC-unrestricted
nature of the TgP2·specific T cell line described earl ler
(Figure 5.3). The activation of the 8F7-S T cell hybridoma
with TgP2-pulsed WK'i rat APe is equivalent to the degree of
activation observed with TgP2-pulsed FJ44 rat l'.PC. Activation
of the T cell h:rbridoma by peptide-pUlsed WKY rat APC i6 not
attributed to allorecognition because no activation was
observed in the presence of a control peptide, TgPI (Flgm"e
7.JB). These observations indicate that the 'J'CjP2-spccific T
cell hybridoma is MHC-unrestricted.
702." Both unpulsed or peptide-pulsed Ia' thyrocytos are
ineffective at activatinq the oloned 8F7-S T oell hybridoaa
To test whether or not laO thyrocytes (IFN-y treated
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Figure 7.:1 The 8F7-' T cell hybri40llla recD9Dille. TqP2 in an
MHC-unnstrictad rasbion. The 8F7-S T cell hybridoma cells
(lO~/we111 were incubated with graded dOGas of CA) TgP2 or (Bl
TqPl in the presence of syngeneic (FJ44) and allogeneic (WXY
and WF) rat Ape (5 x lOS/well) for 24 hrs. Subsequently, the
CTLL assay was perforned by incubating 104 CTLL cells/well
with 50 Jell of supernatant from hybridoma activation cultures
as described under Section 2.18. The results are expressed as
mean cpm +/- so of triplicate cultures. Background CTLL
proliferative responses (Illean cpm) when T cells were incubated
with Ape in the absence of peptide was as follows: F344 rat
APC: 17391 WKY rat Ape: 2010; WF rat APe: 1177.
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FRTL-5 cells) could act as APe by presenting the endogenously
generated 'l'9P2 sequence to the cloned 8F7-S T cell hybridomll.
hybridolla activation and CTLL assays were performed. As shown
in Figure 7.48, Ia' thyrocytes when used in graded doses
failed to activate the
TgP2-specific 8F7-5 T cell hybridoma, thus tailing to
act as APe as expected. This failure of activation of the
hybridoma is not due to the low APe (thyrocytes) number used
in the activation assay, because at similar cell numbers,
TgP2-pulsed splenocytes could readily activate the T cell
hybridoma (}o"!gure 7.40). Therefore, the observed results are
1 ikely to be due to the inability of TEe to present
endogenously generated TgP2 sequence to the T cell hybridoma
in the context of sel f-HHC.
Purthermore, an experiment was performed to test whether
or not pUlsing of la· thyrocytes with TgP2 could overcome this
defect. The results are shown in Figure 7.4C. Graded doses of
TgP2-pulsed la' thyrocytes did not activate the T cell
hybridollla, whereas similarly treated splenocytes did. These
resul ts demonstrate that Ia· thyrocytes cannol. present Tg
epitopes, either endogenously generated or exogenously pulsed,
by themselves, to autoreactive T cells in F344 rats. It is
likely that the inability of Ia· thyrocytes to present
exogenously pulse~ T9'P2 Illay be due to its inherent deficiency
in the expression of certaIn costimulatory molecules.
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Figure 7. of Neither unpul.ed nor peptide-pul.ed :Ie· thyrocyt8.
activate the cloned 8P7-5 'rqP2-specltic or oell hybridollla.
Graded numbers of la' (IFN-y untreated) or Ia+ (If'N-y treated)
thyrocytes or splenocytes of F344 rat were cultured with T
cell hybridoma cells (105/w.11) with (1 /J9/m1j or without
TgP2. After 24 hr of incubation, IL-2 content in the culture
supernatant was assessed by the proliferation of the IL-2
dependent CTLL line as described under section 2.18. Results
are expressed as mean cpm +;- SO of triplicate cultures.
Background CTLL proliferative responses (mean cpm) when T
cells were incubated lo1ith APC in the absence of peptide was
1475.
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7.2.5 Fixation or irradiation abrogate. antigen-pre.entation
capacity ot aplanocytes
It has been suggested that fixation or irradiation of
splenic APe prior to pUlsing with Ags abrogates activation of
costimulatory dependent MBP-specific rat x mouse T-T cell
hybridomas (Mannie at aI, 1990; Watkins and Mannie, 1993).
Chemical fixation of splenic APe is known to destroy mostly
uncharacterized costimulatory activities (Jenkins at ai, 1987
and 1988). similarly, I tested whether or not 8F7-S T cell
hybridoma requires costimulatory molecules for its activation.
For this purpose, splenic APe were either glutaraldehyde fixed
or irradiated and pulsed with TgP2. Then thea!:! TgP2 pulsed
APe were used to activate the 8F7-5 T cell hybridoma. The
results are shown in Figure 7.5. Glutaraldehyde fixation
completely abrogated the presentation of TgP2 by splenic APe
since the T cell hybridoma response (assessed by the CTLL
proliferative response) was similar to the background values.
This observation raised the possibility that the 8F7-S T cell
hybridoma requires cost!mulatory molecules. Furthermore,
irradiation of the splenic APe also dramatically reduced their
capacity to present TgP2 to the 8F7-S T cell hybridoma. These
results further suggest that the activation of the T cell
hybridoma requires yet undefined costimulatory molecules.
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Piqure 1.5 pizat!oD or irradiation abrogat.. antiqell-
pre••ntatioD by apleDocyt.. to the oloned 8.7-5 T call
hybri40... Glutaraldehyde fixed or Irradiated (1500 rad) or
live splenocytes at 5 x 105 /va11 were added to the culture
containing tho BF7-S T cell hybridoma cells at 105/well in the
presence or absence of peptide at the indicated doses for 24
hrs. subsequently, a CTLL assay was performed as described
under section 2.18. Results are expressed as mean cpm +/- SO
of triplicate cultures of proliferating CTLL cells.
Background CTLL proliferative responses (llean CplIl) when T
cells were incubated with APe alone were as follows: 1720;
709; 809 when live; irradiated; and fixed splenocytes were
used as APC respectively.
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1.2.6 The N-teniDal 12••r (2"5-2106) pepUde-pulsed
spillnocytes :but not lao tbyrooytes aotivate the olonlld 8P7-S
T call hybrido••
I have demonstrated earlier that FJ44 rat TgP2-specific
CD<l'. COS· T cell line recognizes T cell determinants within
the N-terminal (2695-2706) but not C-terminal (2702-2713)
12mer peptide of TgP2 (269~;-2713) (Figure 5.3). Therefore, I
tested whether or not 8F7-5 T cell hybridoma generated from
Tgp2-specific T cells would similarly recognize the N-terminal
but not the C-terminal 12mer peptide, and if so, whether the
12mcr Tg peptide-pulsed la' thyrocytes could similarly
activate the cloned 8F7-5 T cell hybridoma. The results are
shown in Figure 7.6. The results demonstrate that the 8F7-5 T
cell hybridoma recognizes the N-terminal 12mer (2695-2706) but
not the c-tenninal 12mer (2702-2713) Tg peptide. Ho",'ever, the
N-terminal 12-mer Tg peptide··pulsed, IFN-y treated (Ia·)
thyrocytes, like the 18mer TgP2-pulsed Ia· thyrocytes, also
failed to activate the 8F7-5 T cell hybridoma. These data
further emphasize that MHC-class II Ag expression alone on
thyrocytes (APC) is not sUfficient to present the Tg-peptide
to the 8F7-S T cell hybridoma but rather suggests that the T
cell hybridoma requires the expression of costimulatory
molecules on thyrocytes.
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Figure 7.6 The 12aer '1'q peptide-pula.d aplenocytell but not
Ia" thyrocyt•• activate the 8r1-5 T cell hybrido... Either
splenocytes (5 x 105/we11) or Ia" thyrocytes (IFN-y treated
FRTL-S cells) (5 x 105/well) were pulsed with the indicated
peptides and incubated with 105 8F7-5 T cell hybridoma
c,l1s/wel1 for 24 hr. A volume of 50 l.il of the hybridoma
culture supernatant was assayed for the support of C'rLL
proliferation. The results are expressed .1S mean +/- SO of
triplicate cultures. The assay was done as described under
Section 2.18. The peptides were used at 10 Ilq/ml when
thyrocytes were used as APe and at 2.5 Jlq/ml when splenocytes
were used as APe. Background CTLL proliferation (mean cpm)
when T cells were incubated with APe alone was as follows:
1451 and 668 when splenocytes and thyrocytes respective] y
were used as APe.
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'1.3 DilloUBaioD
The data described in this study (a) indicate that MHe
class II' thyrocytes fail to function as APe in activating the
TgP2 (2695-2713j-specific cloned 8F7-5 T cell hybridoma, (b)
question the APe function of thyrocytes at initiating
autoreactivity in the target organ, and (c) support the notion
that particular APe selectively interact with Ag-specific T
cells.
The failure of the 8F7-5 T cell hybridoma to be activated
by MHe class II" thyrocytes is unlikely to be due to its co-
expression of C04 and CD8 molecules (Figure 7.2), because it
could be readily activated by TgP2-pulsed splenocytes (Table
7.1). The expression of both CD4 and COB molecules by the
BF7-5 T cell hybridoma generated from C04', CDB- Tgp2-specific
T cell line (Figure 7.2) is surprising, but is in good
agreement with a previous report in which the authors reported
the expression ot both C04 and COB molecules by the rat x
mouse T cell hybridomas (Gocinski et aI, 1993). The present
findings (Figure 7.2) demonstrate that 100\ of the SF7-S T
cell hybridoma cells express COS molecules in contrast to the
T cell hybridomas reported in the studies of Gocinski et al
(1993) which express COB molecules in the range of 28\ to 9U.
The reason for this apparent discrepancy is unknown, but may
be attributed to the activation status of the T cells at the
time of their immortalization. Furthermore, the expression of
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both CD4 and CDS molecules is not unique to the 8F7-5
hybridoma alone, since a similar phenotypic profile was
observed with another TqP2-specit!c T cell hybridolla (3H2)
derived frotl the peptide-specific T cell line in the salle
fusion (data not shown).
The observation that unpulsed IFN-y treated (la')
thyrocytes fail to activate the 8F7-5 T cell hybridoma (Figure
7.48) is unexpected. This finding disagrees with previous
experimental findings (Hirose et aI, 1985aj. In the latter
study, the authors have shown that tho la' FRTL-S clone (18-6)
could readily activate not only autoreactive (F344) but also
alloreactive (Buffalo) rat CD4+ T line cells. However, the T
cells used in that study and the present one were derived
from the same species (rat) and strain (FJ44). The 13F7-S T
cell hybridoma is specific for the 12mer 1'9 sequence (269S-
2706) within the pathogenic l8mer TgP2 (2695-2713) sequence,
whereas the T cells used in the studies of Hirose et al
(1988a) are specific for non-thyroid Ags. ThUS, the distinct
results could reflect a difference in the activation
requirements of thQ T cell hybridomas~ T cell lines
employed. It is thus likely that the T cells used in the
studies of Hirose at a1 (1988a) may have different
costimu1atory requirements for their activation from that of
the 8F7-S T cell hybridoma used in the present stUdy. The
present results (Figure 7.6), abrogation of Ag-presentation
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capacity ot splenocytes by both fixation and irradiation,
support the notion that activation of the 8F7-S T cell
hybridoma requires costimulatory molecules. Similar to the
present findings, Watkins and Mannie (1993) have recently
demonstrated that activation of HBP-specific rat x mouse T-T
hybridomas could be abrogated when irradiated splenic cells
were used as APC to present MBP. In addition, these authors
have shown that the activation ot hybridomas was readily
reconsti tuted when Ag-pulsed irradiated splenic APe were mixed
with syngeneic live B cells or T cells or allogeneic APe but
not with solubl~ exogenous cytokines. These results led them
to suggest that the activation of T cell hybridomas require
membrane-associated costimulatory molecules. ThUS, it would
be interesting to test whether activation of the TgP2-specific
8F7-S T cell hybridoma, used in the present study, similarly
requires membrane costimulatory molecules. This may be
addressed by performing cell separation experiments with, for
example, the use of polycarbonate microporous cell culture
inserts as was employed earlier (Watkins and Mannie, 1993).
In contrast, the present findings (Figure 7.4B) that Ia"
thyrocytes by themselves do not function as APC, are in good
agreement with previous reports in mice (Ebner et al, 1987
and Stein and Stadecker, 1987). In that regard, Stein and
Stadecker (1987) have suggested that the unresponsiveness of
T cells with Ia· mouse TEe (M-S) was due to deficient
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expression of certain membrane costimulatory molecules by la-
mouse TEe. Thus, similar results in diverse species suggest
that la+ thyrocytes by themselves may not activate
costimulation dependent T cells. Different investigators have
shown that either PHA treatment (Stein and Stadecker, 1987) or
irradiation (C~irjak et aI, 1990) of murine thyrocytes (H-5
cell line) rendered these cells capable of activating both
autoreactive T cell lines and alloreactive T cell hybridomas.
These results suggested that either of these treatments might
have induced undefined costimulatory molecules on thyrocytco.
It would be interesting to examine whether similar treatment
of FRTL-S cells would render them capable of activating the
8F7-S T cell hybridoma. It is likely that the 8F7-5 T cell
hybridoma is not dependent irradiation induced
costimulatory molecules because irradiation of splenic APe
abrogates their ability to present TgP2 leading to activation
of the T cell hybridoma. Taken together, these various
results strongly suggest that the pathways of activation of
autoreactive T lymphocytes described here are different from
those postulated by Botazzo et a1 (1983) in which epithelial
cells express aberrant class II molecules and present Tg
epitopes without the help of other APC such as dendritic
cells. Furthermore, the current observations that both 18mer
and 12mer Tg peptide-pulsed Ia· thyrocytes failed to stimulate
the BF7-5 T cell hybridoma (Figure 7.4C and Figure 7.6) are
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surprising, given that 2Jmer hemagglutinin peptide-pulsed,
HLA-matched DR' thyrocytes (primary thyroid monolayers) from
a GO patient could stimulate the specific T cell line (Londe!
at aI, 1984). Thus, the distinct results observed in diverse
species with peptide-pulsed la' thyrocytes may either be due
to differences in activation requirements of T cell clones
~ T cell hybridomas or to the heterogeneity in the APe
population used i. e.. primary thyroid monolayers, but not
FRTL-S cells, may be coontaminated with APe such as dendritic
cells.
However, as to why the lamer (2695-2713) or the 12mer Tg
peptide (269S-2706)-pulsed, IFN-y treated (Ia') thyrocytes
have failed to stimulate specific T cells is unknown. It may
be argued that the observed results may be due to defective Ag
processing rather than mere failure to express costimulatory
moloculcs by Ia" thyrocytcs. I have not addressed the issue
of whether these Tg peptides require processing before being
presented by splenic APe or directly bind to class II
moleculQs on splenic APe. However, the failure of the Ia"
thyrocytes to present the 12mer Tg peptide (2695-2706) is
probably not due to defective Ag processing, because this
peptide is likley to bind directly to class II molecules.
This possibility is suggested because this l2mer Tg peptide is
smaller in size than most of the class II bound naturally
processed peptides which are in the range of 13-25 amino acids
248
in length (Rudensky et aI, 1991; 1992: Hunt et aI, 1992;
Nelson et ai, 1992: chicz et ai, 1992: 1993).
Furthermore, the differences in the immunogenicity of the
lamer and 121l'1er Tg peptides (Figure 7. 3A), as assessed by IL-2
release by the T cell hybrldoma, are not unusual. These
results may be a consequence of a positive effect of amino
acid residues flanking the stimulatory 12mer peptide on the
recognition and activation of the T cell hybridoma. This
interpretation is compatible with the findings that flanking
residues outside the minimal stimulatory peptide exert a
positive effect on the recognition and activation of T cells
(Bhayani et aI, 1988: vacchio at aI, 1989; Nelson et aI,
1994). In that regard, similar results were obtained earlier
with the TgP2-spec1fic T cell line (Figure 5.3).
Moreover, the inability of peptide-pulsed Ia' thyrocytcs
to activate specific T cells (Figure 7.4 and 7.6), also
contrast with several previous reports that Ag-pulsed lil' non-
lymphoid cells can serve as APC for Ia-restricted Th cells in
vitro (Fierz et al, 1985; Frei et aI, 1987; McCarron, 1985,
Umetsu et aI, 1985). Thus, the discrepancies in the reported
APC function of thyrocytes and other non-lymphoid cells may be
attributable to a variety of factors such as the lineage and
characteristics of APe, the heterogeneity of the final APC
popUlation, the species employed, and the nature and assay of
the responding cells.
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The differences in the handling of Tg peptide (2695-2706)
by splenocytes and lea· thyrocytes (Jo'!gure 7.6) as assessed by
the ability of Tg peptide (2695-2706)-pulsed splanocytes but
not la" thyrocytes to activate the specific T cells (Figure
7.6) suggest that activation of T cells does not depend
entirely on the nature of the peptide Ag but also involves the
inherent properties of APe. For example, APe differ in their
expression of the putative accessory or costimulatory
molecules with which they interact \<lith T cell surface ligands
(1.1u and Linsley, 1993). The present findings (Figure 7.6)
support the notion that a particular APe subset selectively
activates Ag-spocific T colIs (Mannie et aI, 1990; Sun et aI,
1993; St. Louis et aI, 1993). In this regard, Sun et al
(1993) have demonstrated that non professional APe such as the
la' T cell clone (LOA) or the Ia inducible rat glial cell
clone (FlO) can present MBP peptide analogs [69-84Gly and
(pao) 68-86] to encephalitogenic T cells specific for MBP
peptide (a.a 68-88), whereas the thymocytes could not. Mannie
et al (1990) also have demonstrated that rat x mouse T cell
hybridomas specific for MSP peptide (68-86) were activated by
particular APe subsets within sp1enocytes. In another study,
St. Louis et (1993) also demonstrated that costimulation
deficient, Ag-pulsed, IFN-y treated murine endothelial cells
readily induced T cell proliferative response in Th2 but not
in Thl clones.
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The observed faIlure of either unpulsed or Tq peptide-
pulsed Ia' thyrocytes to activate the TqP2-specific BP7-5 T
cell hybridoma is difficult to reconcile with t.i •..:. ~lnding that
the CD4° TgP2-specif!c T cell line adoptively induces severe
thyroiditis in naive syngeneic rats (Table 5.4). Thus, one
might speculate that thyrocytes can express costilo.ulatory
molecules such as B7 physiologically ..i.n...Y.i.Y2. and are able to
present Tg epitopes to T cells in natural or experimentally
induced autoimmune disorders or models. However, the recent
observation that la' thyrocytes do not express the 87 molecule
(Tandon et aI, 1994) raises the possibility that ra'
thyrocytes may not activate costimulatory dependent thyroid
antigen-specific T cells, and that APC other than Ii!o'
thyrocytes in the thyroid present Tg epitopes to T cells. On
the other hand, thyrocytes may not express costi.ulatory
molecule such as 87 under the influence of IFN-y either in
Y..i.t..L:2: or i.n....Yi.Y2, because the expression of 87 is differently
regUlated in APe of different lineages or in different
anatomical locations (Chelen et aI, 1995), In contrast to B7
expression, thyrocytes of HT p!ltients coexpress both ICl\M-l
and LFA-l ligands (Bagnsco et aI, 1995). Therefore, it is
necessary to examine the surface expression by la' FRTL-5
cells of different
costimulatory molecules such as 87 or its equivalent, leAM-I,
and HSA-l CLiu and Linsley, 1992) and to correlate the
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expression of costimulatory molecules with their ability to
activate TgP2-specific T cell hybridolll8. It should be noted
that 87 expression has been reported on hematopoietic cells,
but not on other 'Cell types (St. Louis et aI, 1993). It is
thus unlikely that la+ thyrocytes express this molecule, but
this could not be verified for lack of antibodies against th-e
rat homologue or murine B7 protein. It is IiJ<.ley that a role
for ICAM-l is not envisaged in the activation of the T cell
hybridoma since FRTL-5 cells are known to express ICAM-l under
basal condition itself (Tandon et ai, 19910). It would also be
interElliting to examine whether~ expression of IFN-y in
the thyroid, using a tissue-specific promoter, similar to IFN-
y transgenic mouse models described earlier (sarvetnick et aI,
1988; 1990), would lead to infiltration of thyroid by Tg-
specific autoreactive T cells in rats.
Based on the present findings, I hypothesize that
costimulation deficient class II· thyrocytes by presenting Tg
epitopes may provide signal I to Tg peptide-specific T cells,
whereas dendritic cells in the thyroid (Kabel et aI, 1988;
Hassman et aI, 1988: Voorby et aI, 1990) provide signal II in
a trans manner. Thereby, these two APe popUlations
synergistically activate the pathogenic Tg-specific T cells in
the inflamed thyroid. Activation of T cells by such a
mechanism has been shown earlier in~ model systems
(Liu and Janeway, 1992; St. Louis et aI, 1993).
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Alternatively, dendritic cells in the thyroid by themselves
could take up rTg secreted by thyrocytes or its cleavage
fraqments generated by thyroidal proteases (Dun" at aI, 1991)
and present Tg epitopes to thyroid-homing T cells. The
ability of 1a· thyrocytes to activate costimulatory
independent T cells should not be eXcluded, in view of tho
recent findings that 87' 1a· murine kidney tubule cells (1<TC)
readily activate costimulatory independent but not dependent
T cell hybridomas (Hagerty et aI, 1994).
It is well established by both~ (Gaspari at aI,
1988; Markmann at aI, 1998) and~ (La et aI, 1998.
Guerder at aI, 1994) experimental models, that Ag-presentation
by APe to T cells in the absence of co-stimulation (signal II)
results in T cell anergy or unresponsiveness. ThUS, it is
telllpting to speculate that laO thyrocytes with Mile class 11-
peptide complexes, may deliver tolerogenic rather than
activation signals to thyroid-Ag-specific T cells and induce
T cell paralysis. It remains to be established whether
peptide-pulsed Iao thyrocytes can similarly induce anergy in
the peptide-specific T cell hybridoma or thyroiditis-inducing
T line cells. This assumption can be tested by both~
(restimulation experiments) and.in....Yi..Y.2 (adoptive experiments)
analogous to the recent experiments performed with IFN-y-
treated (Ia") microvessel endothelial cells and
encephalitogenic T cells in Lewis rats (Boudoulous at 1'11,
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~995l. If Ia· thyrocytes do induce anergy in thyroid-Ag
specific T cells, then the ectopic or aberrant expression of
class II on thyrocytes 1..n.......Y..1 may serve as an extrathymic
mechanism for induction of peripheral tolerance rather than
activating Tg-reactive T cells leading to pathogenic thyroid
autoimmunity.
In summary, the findings reported in this chapter suggest
that the simple exprcflsion of class II molecules on thyrocyte~
does not confer APe function, thyrocytes may be deficit in the
expression of certain membrane costimulatory molecules, and
aberrant expression of class lIon thyrocytes in the diseased
thyroid may be a consequence but not the cause of an initial
autoimmune insult. These findings will help us to understand
the autoantigen-presentation in the thyroid gland.
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